WO2003059424A1 - Methods and systems for operating an aerosol generator - Google Patents

Methods and systems for operating an aerosol generator Download PDF

Info

Publication number
WO2003059424A1
WO2003059424A1 PCT/US2003/001516 US0301516W WO03059424A1 WO 2003059424 A1 WO2003059424 A1 WO 2003059424A1 US 0301516 W US0301516 W US 0301516W WO 03059424 A1 WO03059424 A1 WO 03059424A1
Authority
WO
WIPO (PCT)
Prior art keywords
aerosol
providing
predetermined
aerosolization
ventilator
Prior art date
Application number
PCT/US2003/001516
Other languages
French (fr)
Inventor
Niall Smith
John Power
James B. Fink
Michael Klimowicz
Original Assignee
Aerogen, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/284,068 external-priority patent/US7600511B2/en
Application filed by Aerogen, Inc. filed Critical Aerogen, Inc.
Priority to EP03702161.5A priority Critical patent/EP1474196B1/en
Priority to AU2003203043A priority patent/AU2003203043A1/en
Priority to JP2003559584A priority patent/JP4761709B2/en
Priority to ES03702161.5T priority patent/ES2603067T3/en
Publication of WO2003059424A1 publication Critical patent/WO2003059424A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06Ampoules or carpules
    • A61J1/065Rigid ampoules, e.g. glass ampoules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0031Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up by bursting or breaking the package, i.e. without cutting or piercing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033Details of the piercing or cutting means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0085Inhalators using ultrasonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/08Bellows; Connecting tubes ; Water traps; Patient circuits
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05BSPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B17/00Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups
    • B05B17/04Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods
    • B05B17/06Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations
    • B05B17/0607Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers
    • B05B17/0638Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers spray being produced by discharging the liquid or other fluent material through a plate comprising a plurality of orifices
    • B05B17/0646Vibrating plates, i.e. plates being directly subjected to the vibrations, e.g. having a piezoelectric transducer attached thereto
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D1/00Containers having bodies formed in one piece, e.g. by casting metallic material, by moulding plastics, by blowing vitreous material, by throwing ceramic material, by moulding pulped fibrous material, by deep-drawing operations performed on sheet material
    • B65D1/09Ampoules
    • B65D1/095Ampoules made of flexible material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2205/00General identification or selection means
    • A61J2205/10Bar codes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2205/00General identification or selection means
    • A61J2205/60General identification or selection means using magnetic or electronic identifications, e.g. chips, RFID, electronic tags
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/021Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes operated by electrical means
    • A61M16/022Control means therefor
    • A61M16/024Control means therefor including calculation means, e.g. using a processor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/04Tracheal tubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/06Respiratory or anaesthetic masks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0015Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors
    • A61M2016/0018Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical
    • A61M2016/0021Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical with a proportional output signal, e.g. from a thermistor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0015Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors
    • A61M2016/0018Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical
    • A61M2016/0024Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical with an on-off output signal, e.g. from a switch
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/60General characteristics of the apparatus with identification means
    • A61M2205/6045General characteristics of the apparatus with identification means having complementary physical shapes for indexing or registration purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/60General characteristics of the apparatus with identification means
    • A61M2205/6054Magnetic identification systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/60General characteristics of the apparatus with identification means
    • A61M2205/6063Optical identification systems
    • A61M2205/6072Bar codes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/82Internal energy supply devices
    • A61M2205/8206Internal energy supply devices battery-operated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/82Internal energy supply devices
    • A61M2205/8262Internal energy supply devices connectable to external power source, e.g. connecting to automobile battery through the cigarette lighter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00Ancillary equipment
    • A61M2209/08Supports for equipment
    • A61M2209/082Mounting brackets, arm supports for equipment
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2203/00Decoration means, markings, information elements, contents indicators

Definitions

  • the present invention is generally related to liquid aerosol generators.
  • the present invention is related to methods and devices for identifying the contents of a nebule to improve the delivery of the aerosolized liquid to the patient.
  • Aerosolization is important in a variety of industries. Merely by way of example, many pharmaceuticals can now be delivered to the lungs in liquid droplet form through use of an aerosol generator, such as a nebulizer inhaler. Aerosolization is also a useful technique to dispense deodorizers, perfumes, insecticides, or the like, into the atmosphere or to other target areas.
  • Aerosol generators can be configured to deliver a number of different pharmaceutical aerosols to the patient's lungs or other target areas of the body.
  • the aerosol generator will utilize a removable supply of a liquid pharmaceutical that is contained in some type of portable nebule, such as an ampoule, container, canister, reservoir, or the like.
  • the aerosol generator cannot identify the liquid in the nebule. Consequently, it has proven to be difficult to provide an efficient delivery of the aerosolized pharmaceutical to the patient. Since some of the pharmaceuticals to be aerosolized may be more effective when delivered near the beginning of a patient's breathing cycle, while other pharmaceuticals may be more effective when delivered near the end of the patient's breathing cycle it is preferable that the aerosol generator be able to identify the type of liquid disposed in the nebule so that the correct delivery sequence can be chosen to deliver the aerosol to the patient. While the existing nebulizers have proven to be effective within certain parameters, the existing nebulizers also present opportunities for improvements.
  • One area for improvement is the calculation and control of the precise time of aerosol delivery within a user's or patients breathing cycle. This is especially in issue with respect to patients that receive some of all of their inspiratory air from a ventilator device.
  • Existing nebulizers may deliver a constant flow of aerosol into the ventilator tubing, which can lead to a significant amount of aerosol lingering in the tubing or other elements of the overall ventilator system - this lingering aerosol may not be inhaled, as it collects while the patient is exhaling or otherwise not inhaling, resulting in a significant amount of aerosolized medication being pushed out of the system, such as during exhalation, without being inhaled by the patient.
  • Such situations are problematic for a number or reasons.
  • the dosage of drug that actually is inhaled by the patient may be significantly inaccurate because the amount of medication the patient actually receives into the patient's respiratory system may vary with fluctuations of the patient's breathing pattern. Further, a significant amount of drug that is aerosolized may end up being wasted, and certain medications are quite costly, thus health-care costs can be escalated. Further still, unused aerosolized medication will typically be released to the ambient atmosphere with a patent's exhalation. This can end up medicating individuals in the patient's surroundings and this may give rise to adverse effects with respect to such individuals.
  • Such individuals may be either health-care providers, who could be exposed to such air pollution over a prolonged period of time, or other patients, who may be in a weakened condition or otherwise overly sensitive to exposure to non-prescribed or excessive amounts of a medication.
  • an aerosol generator that can obtain information about the contents of the nebule.
  • the present invention provides devices and methods for improving a level of safety to the patient and for providing an increased efficiency of delivery of an aerosol to the patient
  • the present invention provides a method of creating an aerosol.
  • the method comprises providing an aerosol generator and coupling a nebule to an interface of the aerosol generator.
  • An identification marker is read on the nebule and the aerosol generator is operated according to an operation program based on the information read from the identification marker on the nebule.
  • the present invention provides a method of nebulizing a liquid.
  • the method comprises taking one or more breaths and measuring characteristics of the breath. Another breath is taken and an aerosol generator is operated based on the measured characteristics of the one or more measured breaths.
  • the present invention provides a method comprising providing a nebulizer system comprising a housing, an aerosol generator, a controller coupled to the aerosol generator, and a reservoir in communication with the aerosol generator.
  • a nebulizer system comprising a housing, an aerosol generator, a controller coupled to the aerosol generator, and a reservoir in communication with the aerosol generator.
  • a nebule having a body and a keying element is provided.
  • the nebule is inserted into the housing so that the key element provides access to the reservoir when properly keyed with the housing.
  • the liquid is transferred from the nebule into the reservoir and the aerosol generator is operated with the controller to aerosolize the liquid.
  • the present invention provides an aerosol generator comprising an interface.
  • a sensing device is coupled to the aerosol generator.
  • An ampoule having at least one identification marker that can detected by the sensing device is attachable to the interface.
  • the present invention provides a nebulizer system comprising a housing that defines a passageway that is adapted to deliver an aerosolized liquid to a user.
  • An aerosol generator is positioned to provide an aerosolized liquid into the passageway.
  • a controller having a memory and a plurality of aerosol generator operation programs that control operation of the aerosol generator is coupled to the aerosol generator.
  • a reader is configured to read an identification marker on a nebule having a supply of liquid for the aerosol generator, and is configured to send information from the identification marker to the controller.
  • the controller is further configured to operate the aerosol generator according to one of the operation programs based on the information from the marker.
  • the present invention provides a nebule comprising a nebule body holding a liquid that is adapted to be supplied to an aerosol generator of a nebulizer; and an identification marker on the nebule body, the identification marker having information identifying the liquid, wherein the identification marker is readable by a nebulizer to control operation of the aerosol generator based on the information.
  • the present invention provides a nebulizing element positioned to provide nebulized fluid into a ventilator breathing circuit to provide nebulized fluid to a patient receiving air from a ventilator.
  • a nebulizing element may also be referred to herein a an aerosolization element, and a ventilator may also be referred to herein as a respirator.
  • the present invention provides operation sequences by which aerosol is provided a predetermined points in a breath cycle provided by a ventilator.
  • the present invention provides for an operation sequence in which aerosol production begins at a predetermined point within an inhalation phase, which may also be referred to herein as an inspiratory phase, and stops at a second predetermined point within the same inhalation phase.
  • the present invention provides for an operation sequence, which may be referred to as an operation program, in which aerosol production begins at a predetermined point in an inhalation phase and stops at a point after the inhalation phase has ended, i.e. at a certain point in the exhalation phase.
  • the exhalation phase may also be referred to as the expiratory phase, and may encompass the entire period of time during which no inhalation phase is taking place; in other words, the exhalation phase may include not only the actual exhalation of the patient, but also any pause that may occur before or after exhalation.
  • the present invention provides an operation sequence in which aerosolization begins at a predetermined point within the exhalation phase and stops within that exhalation phase, or, alternatively, begins at a predetermined point within an exhalation phase and stops at a predetermined point in the succeeding inhalation phase.
  • the present invention provides for selection of a particular operating sequence from a plurality of available operating sequences.
  • the present invention provides for modes of operation, which modes may include one or more operating sequences.
  • the present invention provides for algorithms to set forth operation sequences, choice of operation sequences or choice of modes of operation.
  • the present invention provides for consideration of the identity of a drug to be administered in executing an algorithm, choosing a mode of operation, or selecting or running an operation sequence.
  • the present invention provides for nebulization of particular drug groups or drugs, such as, for example, antibodies, such as IgG or antibiotics, such as aminoglycosides, such as amikacin.
  • drug groups or drugs such as, for example, antibodies, such as IgG or antibiotics, such as aminoglycosides, such as amikacin.
  • the present invention provides for a nebulized droplet ejection device for use with a ventilator, wherein the device produces droplets by a vibratory apertured element during a selected interval of a breathing cycle.
  • the present invention provides for apparatus and methods for varying the particle size distribution of a nebulized mist by varying the aperture exit diameter of an apertured vibratory aerosolization element.
  • Figure 1 schematically shows a system of the present invention
  • Figures 2 to 4 illustrate an exemplary nebule and feed system interface of the present invention
  • Figure 5 shows an elevational view of another exemplary system of the present invention comprising an electromechanical sensor
  • Figure 6 shows a plan view of an ampoule and an electromechanical sensor of Figure 5;
  • FIGS 7 and 8 show an ampoule and feed system interface having an alternative threaded interface
  • Figure 9 is a cross sectional plan view illustrating another ampoule and feed system interface
  • Figure 10 is a plan view of an ampoule having an identification marker disposed in a non-helical configuration
  • Figure 11 illustrates a simplified flowchart illustrating one exemplary method of the present invention
  • FIG. 12 illustrates another simplified method of the present invention
  • FIG. 13 illustrates yet another simplified method of the present invention.
  • FIG 14 illustrates another simplified method of the present invention.
  • Figure 15 is a graph showing various modes of aerosolization over the course of breathing cycles
  • Figure 16a is a schematic cross-sectional representation of an aerosol generator in accordance with the present invention.
  • Figure 16b is a schematic cutaway cross-section detail of the aerosol generator represented in Figure 16a.
  • Figure 17 is a schematic perspective view of a nebulizer incorporated into a ventilator breathing circuit in accordance with the present invention.
  • Figure 18 is a schematic representation of algorithms of operating sequences in accordance with the present invention.
  • Figure 19 s an alternative schematic representation of the representation of Figure 18;
  • Figure 20 is a further schematic representation of algorithms of operating sequences shown in Figure 19 and in accordance with the present invention.
  • Figure 21 is a schematic representation of an algorithm by which an operating sequence may be chosen base on the combination of a plurality of independent sets of information.
  • the aerosol generator systems of the present invention include an aerosol generator coupled to a controller that is in communication with at least one sensor such that delivery sequence of the aerosol to the patient can be based at least in part on the information obtained with the sensors.
  • the system includes a nebule identification sensor to read an identification marker on the nebule so as to identify the type of liquid that is disposed within the nebule.
  • the system includes a breathing characteristic sensor that monitors and records the breathing characteristics of the patient so as to allow the controller to direct the delivery of the aerosol to coincide with the patient's breathing pattern.
  • the aerosol generator system includes both a nebule identification sensor and a breathing characteristic sensor.
  • FIG. 1 schematically illustrates an exemplary aerosol generating system 20 of the present invention.
  • the system 20 includes an aerosol generator (AG) 22 that is in communication with an output passageway 24, such as a ventilator circuit, mouthpiece, face mask, or the like.
  • a nebule 28 containing a liquid can be removably coupled to a feed system interface 26 to deliver a liquid to aerosol generator 22 for aerosolization.
  • a controller 30 is in communication with aerosol generator 22 to control the sequence of aerosolization of the liquid to the patient. Controller 30 can be coupled to a breathing sensor 32 that is in communication with output passageway 24 so as to monitor the breathing characteristics of the patient.
  • controller 30 can be coupled to nebule identification sensor 34 to identify the type of liquid that is disposed in nebule 28 by reading an identification marker that is provided on nebule 28. Controller 30 can take the information from flow sensor 32 and/or nebule sensor 34 and run the information through an algorithm to determine an efficient sequence of aerosolization. Typically, the controller will run a selected pre-programmed delivery or sequence program that is stored in controller 30 so as to deliver the aerosol to the patient in an optimal time of the patient's breathing cycle. Controller 30 can include a memory and a microprocessor so as to store and run the algorithm that selects the pre-programmed drug delivery sequence.
  • the memory of the controller can store a list or library of codes and/or drugs that are compatible with the aerosol generator, information about the drugs, such as a regime to be followed based on the particular drug, the time in the breathing cycle when the drug is best administered, the amount of the drug to be aerosolized, or the like.
  • Controller 30 will typically be in communication with at least one sensor.
  • one sensor can be a nebule identification sensor 34 that reads an identification marker on the nebule to identify the type of liquid disposed within the nebule.
  • the sensor can be a mechanical sensor, an electromechanical sensor, an electrical sensor, an optical sensor or the like.
  • Such sensors can be used to provide information to the controller for a number of purposes.
  • the identification information can be used to identify the type of drug so as to choose the delivery sequence program.
  • the identification information can be used as a quality control mechanism to prevent the aerosolization of an incompatible, unsafe, or unknown drug, and the like.
  • breathing characteristic sensor 32 can monitor the breathing characteristics of the user.
  • the sensor can send breathing characteristic information to the controller to allow the controller to select an appropriate delivery cycle of the aerosolized liquid to the patient.
  • breathing characteristic sensor 32 can be used to measure a breathing pattern of the patient, the peak flow, breathing rate, exhalation parameters, regularity of breathing, and the like. Such measured breathing characteristics can be delivered to controller 30 and run through a software algorithm to determine an appropriate sequence of delivery relative to the measured breathing cycle to the patient.
  • One exemplary breathing characteristic that may be sensed by sensor 32 is the cycle of a ventilator providing air to a patient; for example, the start of an inhalation cycle generated by the ventilator.
  • the sensor 32 may sense other parameters, for example, it may be an acoustic sensor that is activated through passing the respiratory flow of the patient through an acoustic chamber (not shown) so as to produce an acoustic tone, which is proportional to the inspiratory flow rate.
  • the frequency of the acoustic tone indicates the inspiratory flow rate at any instant of the breathing cycle.
  • the acoustic signal can be detected by the controller such that integration of the flow rate with time produces the tidal volume. Both the flow rate and the tidal volume can then be used by the controller to determine when the aerosol generator generates the droplets and at what mass flow rate such that maximum deposition of droplets is obtained.
  • the acoustic tone may be recorded to produce a record of the breathing pattern of the patient which may be stored in the microprocessor. This information can be later used to synchronize the ejection of droplets for the same patient. Such information may also be later employed for other diagnostic purposes. A more complete description of such a sensor is described in commonly owned, U.S. Patent 5,758,637, which was previously incorporated by reference.
  • the senor can be used to monitor the breathing characteristics of the patient throughout the delivery regime so as to ensure that the aerosol is efficiently delivered throughout the aerosolization procedure.
  • the controller can adjust the aerosol delivery based on any measured change in the breathing pattern of the patient during the aerosolization. With this monitoring and adjustment predetermined times for the beginning and ending of aerosolization can be reset based on the actual breathing of the patent.
  • the breathing sensor can be used to determine the breathing cycle of a tidal breath and to choose the appropriate preprogrammed delivery cycle that is stored in the memory of the controller.
  • the controller may be configured to provide aerosol based on the time.
  • the controller may be configured to start aerosol production at the beginning of an inhalation phase of a breathing cycle and stop at a point at which a predetermined percentage of the inhalation has taken place.
  • the controller may be configured to start aerosolization at a first point at which a first predetermined percentage has taken place and stop aerosolization at a second point at which a second predetermined percentage of that inhalation has taken place.
  • aerosol may begin during an inhalation phase and end during the subsequent exhalation phase.
  • the controller may be configured to begin aerosol production at a certain point during exhalation and stop during that exhalation or during the subsequent inhalation.
  • an aspect of the present invention may include a nebulizer comprising: an aerosol generator and a controller configured to have the controller begin aerosolization during exhalation and stop during that exhalation or in the subsequent inhalation.
  • the controller may be operable to allow for a choice of modes of operation, for example, a mode in which aerosolization begins once a certain breath characteristic is detected, such as a sufficient level of inhalation, and ends when there is no longer a sufficient level; another mode in which aerosolization begins once a certain breath characteristic is detected, such as a sufficient level of inhalation, and ends at a predetermined time within the inhalation cycle, such as for example, before the level of inhalation falls below that required for operation of an aerosolization element, or, alternatively, at any other point within the inhalation cycle, such as after the inhalation phase of the cycle before exhalation has begun, or after exhalation has begun.
  • the level of inhalation may be sensed by a pressure transducer.
  • a pressure transducer may monitor a drop in air pressure or a rise in air pressure within a chamber that is in fluid communication with the ventilator circuit.
  • a pressure drop may be sensed by a patient inhaling through the circuit, for example, in an instance in which the ventilator provides an assisted ventilation initiated by a patient's commencement of an inhalation.
  • a pressure rise may be sensed in an instance in which the ventilator pushes inhalation air to the patient without the patient initiating a breath.
  • Another mode in which the controller may be operable is a mode in which the on / off operation of the aerosol generator is triggered by time, which may be ascertained from an internal clock device, such as a clock built into a microprocessor, or from an external source.
  • Another mode in which the controller may be operable is in which the on / off operation of the aerosol is triggered by the controller receiving an external signal, such as a signal from a ventilator, which can correspond to the point in the ventilator's cycle of that is the start of an inhalation phase in which the ventilator begins to push inspiratory air into the ventilator circuit.
  • the controller may be operable between such modes, including a mode in which the aerosolization begins at a predetermined time in the breathing cycle and ends at a predetermined time in the breathing cycle.
  • the first and second predetermined times in the third mode may be during inhalation.
  • the first and second predetermined times may be during exhalation, or at the first predetermined time may be during exhalation and the second predetermined time may be during subsequent inhalation. These times may correspond to certain percentages of the inhalation phase taking place, or any other points of reference within a breathing cycle.
  • the first predetermined time and the second predetermined time may be designated as any point within a single breathing cycle, or alternatively, the first predetermined point may be at any point within one breathing cycle and the second predetermined point may be at any point in a subsequent breathing cycle.
  • the controller may make the determination of when to begin, and operate to begin aerosolization, and may make the determination of when to stop aerosolization to stop, and cause aerosolization to stop. The controller may make such determinations and take such actions based on accessing stored algorithms.
  • the controller may receive a signal from the ventilator that establishes a reference point, nonetheless, the controller, by making the determinations an taking the actions based on stored algorithms, and/or information obtained as to the identity of a drug to be administered, may cause aerosol production to begin and/or end independent of the instantaneous position of the ventilator with respect to the ventilator cycle.
  • the controller may be operable to allow for a single mode of operation, and such single mode of operation may be any mode, for example, as described above. For example, a mode in which aerosolization begins once a certain breath characteristic is detected, such as a sufficient level of inhalation, and ends when there is no longer a sufficient level. Similarly, the controller may operable in a mode in which aerosolization begins once a certain breath characteristic is detected, such as a sufficient level of inhalation, and ends at a predetermined time within the inhalation before there is no longer a sufficient level or an aerosolization element.
  • the mode may be a mode in which the aerosolization is commenced based on a signal from the ventilator indicating the attainment of a certain point within the ventilation output cycle or the inhalation cycle of the patient.
  • the ventilation output cycle of the ventilator may coincide with the inhalation cycle of the patient, such that the ventilation output phase of the ventilator output cycle and the inhalation phase of the inspiratory cycle of the patient occur substantially simultaneously. Such may be the case where a patient is completely passive and the only inhalation that occurs is by generation of air from the ventilator during the output phase of the ventilator cycle.).
  • Such point may be during the output phase of the output cycle of the ventilator or during the inhalation phase of the inhalation cycle of the patient.
  • the predetermined point can be chosen to coincide with a certain level of output from the ventilator or at a certain point in time during the ventilator output cycle. Such a predetermined point may be a specific point within the output phase of the ventilator cycle, or, a specific point within the non-output phase of the ventilator cycle, based, for example, on the timing of the previous or succeeding output phase of the ventilator.
  • the present invention provides for a ventilator along with the aerosol generator and controller.
  • a predetermined time may be based on the timing of a ventilator supplying air to a user.
  • the controller may be set to work off of the timing of the ventilator in one mode, while working off the patient's inspiratory effort in another mode, or mode that allows for a combination of the patient's inspiratory effort and the timing of the ventilator, for example, where the ventilator is set to assist the patient by supplying air upon the patient's effort or where the patient has not made a sufficient effort within a predetermined period of time.
  • the aerosol generators 22 of the present invention may be of the type, for example, where a vibratable member is vibrated at ultrasonic frequencies to produce liquid droplets.
  • Some specific, non-limiting examples of technologies for producing fine liquid droplets is by supplying liquid to an aperture plate having a plurality of tapered apertures and vibrating the aperture plate to eject liquid droplets through the apertures.
  • Such techniques are described generally in U.S. Patent Nos. 5,164,740; 5,938,117; 5,586,550; 5,758,637, 6,014,970, and 6,085,740, the complete disclosures of which are incorporated by reference.
  • the present invention is not limited for use only with such devices.
  • Figures 2 to 10 illustrate some exemplary feed system interfaces 26 and nebules 28 of the present invention.
  • nebule 28 can be an ampoule that comprises a body 36 with a top end 38 and a bottom end 40.
  • Bottom end 40 can include a tapered opening that can deliver the liquid from ampoule 28 into a fluid reservoir 42 adjacent aerosol generator 22.
  • Top end 38 can include a twist-off vent 44 that can be removed to create a drain vent in top end 38.
  • Some exemplary ampoules that can be used with the present invention are described in co-pending U.S. Patent Application S.N. 09/812,755, filed March 20, 2001, the complete disclosure of which was previously incorporated by reference.
  • the ampoules of the invention may be used to store a wide variety of liquids.
  • liquids that may be stored within the ampoules include various pharmaceuticals such as saline, albuterol, chromatin, budesinide, nicotine, THC, cocaine, antibodies, such as IgG, antibodies, such as aminoglycosides, and the like.
  • Other liquids that may be stored include insecticides, deodorizers, perfumes, and the like.
  • the ampoules of the invention may be used to store essentially any type of liquid that is capable of being aerosolized.
  • the ampoules of the invention may be constructed by blowing or vacuum-forming the ampoule in a mold, filling the ampoule with liquid, and melt-sealing the liquid into the ampoule.
  • the ampoules may further be provided with a set of removable tabs to provide a drain vent and a drain opening. Typically, these will be located in the top and bottom of the ampoule so that the liquid may drain by force of gravity once the openings are formed.
  • the tabs may be removed by twisting, cracking, or the like so that the opening may be formed.
  • the ampoules may be configured to be opened simply by piercing the top and/or bottom end. Such piercing elements may conveniently be incorporated into the aerosolization device.
  • the ampoules may be provided with a thick enough wall to minimize droplet spillage. For instance, the wall thickness may be greater than about 0.030 inch.
  • the ampoule may further be configured so that the diameter of the drain opening minimizes the drip potential for the fluid stored within the ampoule. For example, larger diameter openings may be provided when storing higher viscosity fluids and smaller diameter openings may be used for low viscosity fluids.
  • the ampoules of the present invention can include a connection or keying element 46, such as a thread or a tab so as to accurately align the ampoule 28 with a nebulizer feed system interface 26.
  • the feed system interface 26 will have a corresponding feature or slot 48 to engage the connection element.
  • ampoule 28 can include a helical keying element 46 that is shaped to mate with the corresponding keying feature 48 in feed system 26. To insert the ampoule into feed the system, the ampoule is moved axially (in the direction of arrow 50) until helical keying element 46 is positioned adjacent the corresponding keying feature 48.
  • the ampoule 28 is rotated to mate the keying element 46 and the keying feature 48 together so as to pull the ampoule 28 axially downward until the bottom end 40 of the ampoule 28 opens slit seal membrane 52 in feed system 26 ( Figures 3 and 4).
  • ampoule 28 includes an identification marker 35 to identify to the controller, the liquid that is within ampoule 28.
  • Identification marker 35 can be a bar code (e.g., embossed or printed), one or more bumps or protrusions, a radio frequency identifier, a small chip containing stored information, or other suitable identification technology.
  • information regarding the contents of the ampoule is conveyed through a series of protrusion identification markers 35 on the ampoule 28 that are sensed by their interaction with an optical detector 56 during the rotational engagement of ampoule 28 with the feed system interface 26.
  • a miniature light source 58 and the optical sensor 56 are coupled to the feed system 26 such that a passing protrusion 35 affects the sensed light in a manner such that the sensor 56 may provide information (e.g., typically binary information, i.e., a "0" or a "1") based on position, number, or absence of the protrusion.
  • information e.g., typically binary information, i.e., a "0" or a "1”
  • rotation of an ampoule 28 as it is threadedly inserted into the nebulizer feed system 26 may count the number of bumps or provide a code such as "1-0-1-0" so as to inform the nebulizer controller 30 ( Figure 1) the type of medicant or other liquid that is disposed in the ampoule.
  • a single sensor can read the code imparted by a series of protrusions as the ampoule 28 is moved axially into the nebulizer feed system 26 while it is rotated through the threaded features in the housing of feed system 26.
  • Figure 5 illustrates another exemplary nebule identification sensor 34 and ampoule 28.
  • Nebule sensor 34 can include an electromechanical switch that contacts the protrusions on the nebule as it is inserted into the feed system.
  • the nebule includes a helical keying element 46 that interacts with a corresponding helical keying feature (not shown) to position the ampoule within feed system interface 26.
  • nebule sensor 34 can include one or more metal contacts 60, such that rotation of the ampoule 28 can cause the protrusion identification markers to contact the metal contacts 60, 60'.
  • a unique electrical identification signal can be generated to identify the liquid in the ampoule to the controller.
  • the controller can then select and run a delivery program that provides an efficient delivery of the identified liquid.
  • FIG. 7 Another exemplary ampoule 28 and feed system interface 26 is illustrated in Figures 7 and 8.
  • an ampoule bottom end 40 having a keying tab 46 can interact with a spiral slot 48 in the feed system interface 26.
  • the keying element(s) engage the spiral slot 48 so as to pull the ampoule down into the interface ( Figure 8).
  • the bottom end of the ampoule can protrude through slit seal membrane 52 so as to be able to deliver the liquid to reservoir 42.
  • Identification markers 35 can be sensed by the identification sensors (not shown), as described in the above embodiments.
  • the ampoule protrusion identification markers 35 can be in a single helix configuration or a double helix configuration.
  • the identification markers are in a double helix arrangement so that as the first set of protrusions is read, providing a binary code to the system, the second set of protrusions can provide a complementary binary code (read by a second optical detector, not shown) as ampoule 28 is screwed into nebulizer feed system 26 ( Figures 2 to 4).
  • the binary code of the first series of protrusions might, for example, convey the code "1-0-1-0" as each of protrusions are sensed as the ampoule is screwed into the nebulizer feed system housing, while the second series provides the complementary code of "0-1-0-1".
  • the controller can check that when a particular binary code is transmitted by the first set of protrusions, the complementary binary code is sensed by the second set of protrusions.
  • the system can prevent the potential mis-information that might be transmitted were there only a single set of protrusions provided to convey the information, and the insertion was done incorrectly.
  • Such interaction further allows the system to check against a situation in which one or more ampoule protrusions are damaged to the extent of effecting the sensing function, because the system will have the code provided by the second series of protrusions to check against the information provided by the first set of protrusions.
  • the second set of protrusions may be used to provide more code combinations for different drugs.
  • the controller of the aerosol generator can determine which of 9 drugs or medicants are disposed in the ampoule. For example, the following distribution of bumps or protrusion can deliver a signal to the controller to indicate the identity of the following drugs:
  • the protrusion identification markers 35 are disposed in a helical configuration that has a pitch that substantially matches the pitch of the helical keying element 46, such that as the helical keying element is rotated and moved through the corresponding keying feature 48, the protrusion identification markers pass by the optical sensor 56 or metal contacts 60. It should be appreciated however, that the identification markers 35 can be disposed in a variety of non-helical patterns, as will be described in relation to Figures 9 to 10.
  • Figure 9 illustrates one exemplary embodiment of an ampoule 28 having identification markers 35 that are disposed in a non-helical arrangement.
  • ampoule includes a keying slot 62 adjacent a bottom end of ampoule 28 to allow the ampoule to be inserted into feed system interface 26. If keying slot 62 does not correspond with the keying tab 64 on the interface, the ampoule will be prevented from being seated within the interface and the liquid in the ampoule will be prevented from being delivered to reservoir 42. In situations where the keying slot matches the keying tab, as ampoule 28 is inserted axially into feed system and twisted to engage the keying slots with the keying tabs, the identification marker 35 will simultaneously pass across nebule sensor 34.
  • the illustrated embodiment includes a bar code reader that reads a bar code identification marker, but it should be appreciated that the identification marker 35 and identification sensor 34 can include any of the other types of identification markers and sensors or their equivalents, as described above.
  • Figure 10 illustrates an ampoule 28 that includes bump identification markers that are disposed on the ampoule such that axial insertion of the ampoule (without rotation) into the feed system interface 26 contacts the bump identification markers 35 against the electromechanical contacts 60.
  • Ampoule 28 can include a retainer or click positive position feedback element 66, and/or alignment means for aligning the ampoule into the feed system.
  • ampoule 28 can include other keying elements and/or orientation elements to ensure that the ampoule is properly oriented when it is inserted into the aerosolization device.
  • keying elements and orientation elements can be found in co-pending U.S. Patent Application 09/812,755, filed March 20, 2001, the complete disclosure of which was previously incorporated herein by reference.
  • the identification markers 35 can be disposed on the ampoule relative to such keying or orientation elements in any position in which the sensors can sense the markers and determine the type of medicament or drug that is disposed in the ampoule.
  • the present invention identifies the contents of the nebule to improve the operation of the aerosol generator.
  • an aerosol generator is provided (Step 100) and a nebule is coupled to a nebule interface of the aerosol generator (Step 102).
  • An identification marker on the nebule is read by the aerosol generator (Step 104) and the aerosol generator is operated according to an operation program based on the information read from the identification marker on the nebule (Step 106).
  • the aerosol generator is operated with a controller ( Figure 1).
  • the controller typically includes a memory that stores a plurality of operation programs for delivering each of the compatible specific types of drugs or medication. After the identification marker is read by a sensor, the information is passed to the controller so that a correct operation program can be selected to operate the aerosol generator.
  • the operation program can control the start and stop times of the aerosol generator, the aerosol production rate, the amplitude of vibration of the aerosolization element, the frequency of aerosolization, and the like.
  • the information from the identification marker may be used for other purposes.
  • the systems of the present invention 20 may optionally include an output device 68, such as a printer, audio speaker, or LCD.
  • the identification information received by the sensor matches a code entry inside the controller memory
  • the drug name, dosage information, or other pertinent information can be made available to the user by displaying or announcing the information via the attached output devices.
  • the identification markers can be used for preventing the wrong drug from being administered to the patient by setting the aerosol generator controller to operate the aerosol generator only on the reception and identification of one or more particular drug codes/identification markers to the exclusion of others: e.g.
  • one patient's nebulizer may be set to accept nebules containing, and coded for, drug A and drug B, while another patient's nebulizer may be set to only operate if a nebule contains, and is coded for, drug A.
  • the identification marker is positioned adjacent a sensor through use of a keying element on the nebule.
  • the keying elements can interact with a corresponding keying feature on the aerosol generator interface to position the identification marker adjacent the sensor.
  • the keying elements on the nebule can be used to control the types of nebules that can be coupled to the aerosol generator system.
  • a nebulizer system and a nebule comprising a nebule body with a keying element e.g., threads, tabs, slots, and the like
  • the nebule can be inserted into the housing.
  • the nebule can access a reservoir of the system (Step 114). Thereafter, the liquid from the nebule will be transferred into the reservoir for aerosolization (Step 116).
  • the aerosol generator can then be operated with a controller to aerosolize the liquid (Step 118).
  • the keying elements, identification markers, or both can be used to ensure that only nebules which are compatible with the feed system and aerosol generator are used.
  • the aerosol generator systems of the present invention can include a keying feature that mates only with certain types of nebules.
  • nebules containing steroids may have a different keying element than nebules containing antibiotics. Therefore, patients using the aerosol generator only for steroidal delivery will be prevented from keying the nebule containing an antibiotic to the aerosol generator and inadvertently nebulizing the antibiotic, and vice versa.
  • the controller of each individual system can be programmed to only have available sequence delivery programs (which may be referred to as operation sequences, or algorithms for operation sequences) for selected medicants or drugs that are found in a library of codes and drugs in the controller memory.
  • sequence delivery programs which may be referred to as operation sequences, or algorithms for operation sequences
  • the controller will not deliver the aerosol to the patient.
  • the controller can provide an output informing the user that the installed nebule is incompatible with the system.
  • the present invention can measure the characteristics of a persons inhaled breath, typically a tidal breath, to control the operation of the aerosol generator.
  • a person can take one or more breaths (Step 120) and the characteristics of the breath can be measured (Step 122).
  • the breathing characteristics that can be measured include, but are not limited to, a breathing pattern, peak inspiratory flow rate, breathing rate, exhalation parameters, regularity of breathing, tidal volume, and the like and can estimate a user's tidal volume based on such information.
  • the user can take another tidal breath and the aerosol generator can be operated based on the measured characteristics of the tidal breath (Step 124).
  • the controller may base the timing of operation of the aerosol generator so that aerosol is generated at specific time periods within a breathing cycle, (Step 125, Figure 13a). For example, the controller may operate the aerosol generator for the first 50 percent of inspiration. Alternatively, the controller may operate the aerosol generator to generate aerosol after a portion of inhalation has taken place and to cease producing aerosol after another portion of inhalation has taken place. For example, the controller may cause aerosol to be generated beginning after 20% of the inspiration has taken place and cause aerosol production to cease after 70% of inspiration has taken place.
  • the controller may cause aerosol production to start after, for example, after 90%) of exhalation has taken place and, for example, cause aerosol production to stop after 30%) of the following inspiration has taken place.
  • the specific timing within the breathing cycle that aerosolized medication is provided into the breathing circuit greater efficiency of drug administration can be achieved.
  • continuous aerosolization may yield only about 10%> to about 15%> efficiency (Fig 15a)
  • aerosolization during the entire inhalation phase of the breathing cycle may yield about 15%) to about 25% efficiency (Fig 15b)
  • delivery during a predetermined portion of the inhalation phase beginning, for example, at the onset of inhalation may provide a drug yield between about 60%> to about 80%> efficacy (Fig 15c).
  • the present invention by controlling delivery to a predetermined percentage of the breathing cycle, such as a predetermined percentage of the inhalation phase of the breathing cycle, provides far greater efficiency than either continuous delivery or delivery during the entire inhalation phase. Further, and surprisingly, the percentage of increase in efficiency in delivery for such a predetermined portion of the inhalation phase (Fig. 15c) over delivery during the entire inhalation phase (Fig. 15b) is itself far greater than the increase in efficiency of delivery during the inhalation phase (Fig. 15b) over simply continuously providing aerosol (Fig. 15a).
  • the starting and stopping of aerosol generation may be controlled on the level of accuracy of microseconds or milliseconds, thus providing accurate dosing.
  • the timing of aerosol generation can be done based solely on a predetermined timing within a breathing cycle, on timing in conjunction with the length of a prior breath or portions thereof, on other breathing characteristics, on particular medication being administered, or a combination of any of these criteria (Step 135, Figure 13b).
  • the aerosolization element may be constructed of a variety of materials, comprising metals, which may be electroformed to create apertures as the element is formed, as described, for example, in U.S. patent No. 6,235,177 assigned to the present assignee and incorporated by reference herein in its entirety. Palladium is believed to be of particular usefulness in producing an electroformed, multi-apertured aerosolization element, as well as in operation thereof to aerosolize liquids. Other metals that can be used are palladium alloys, such as PdNi, with, for example, 80 percent palladium and 20% nickel. Other metals and materials may be used without departing from the present invention.
  • the aerosolization element 70 (referring now to Figs.
  • the aerosolization element 16a and 16b may be configured to have a curvature, as in a dome shape, which may be spherical, parabolic or any other curvature.
  • the aerosolization element may be formed to have a dome portion 73 over its majority, and this may be concentric with the center of the aerosolization element, thus leaving a portion of the aerosolization element that is a substantially planar peripheral ring portion 75.
  • the aerosolization element has a first face 71, a second face 72 and a plurality of apertures 74 (Fig. 16b) therethrough.
  • the first face 71 may comprise the concave side of the dome portion 72 and the second face 72 may comprise the convex side of the dome portion 72 of the aerosolization element 70.
  • the apertures may be tapered to have a narrow portion 76 at the first face 71 and a wide portion 78 at the second face 72 of the aerosolization element 70.
  • a liquid will be placed at the first face of the aerosolization element, where it can be drawn into the narrow portion 76 of the apertures 74 and emitted as an aerosolized mist or cloud 79 from the wide portion 78 of the apertures 74 at the second face 72 of the aerosolization element 70.
  • the aerosolization element may be mounted on an aerosol actuator 80, which defines an aperture 81 therethrough. This may be done in such a manner that the dome portion of the aerosolization element protrudes through the aperture 81 of the aerosol actuator 80 and the substantially planar peripheral ring portion 74, on the second face 72 of the aerosolization element 70 abuts a first face 82 of the aerosol actuator 80.
  • a vibratory element 84 may be provided, and may be mounted on the first face 82 of the aerosol actuator 80, or alternatively may be mounted on an opposing second face 83 of the aerosol actuator 80.
  • the aerosolization element may be vibrated in such a manner as to draw liquid through the apertures 74 of the aerosolization element 70 from the first face to the second face, where the liquid is expelled from the apertures as a nebulized mist.
  • the aerosolization element may be vibrated by a vibratory element 84, which may be a piezoelectric element.
  • the vibratory element may be mounted to the aerosol actuator, such that vibration of the vibratory element may be mechanically transferred through the aerosol actuator to the aerosolization element.
  • the vibratory element may be annular, and may surround the aperture of the aerosol actuator, for example, in a coaxial arrangement.
  • the aerosolization element or the aerosol generator comprising the aerosolization element 70, the aerosol actuator 80 and the vibratory element 86 may be replaced with a respective assembly that has apertures of a different size, such as a different exit diameter, to produce a mist having a different aerosol particle size.
  • a circuitry 86 may provide power from a power source.
  • the circuitry may include a switch that may be operable to vibrate the vibratory element and thus the aerosolization element, and aerosolization performed in this manner may be achieved within milliseconds of operation of the switch.
  • the circuitry may include a controller 87, for example, a microprocessor that can provide power to the vibratory element 84 to produce aerosol from the aerosolization element 70 within milliseconds or fractions of milliseconds of a signal to do so.
  • a controller 87 for example, a microprocessor that can provide power to the vibratory element 84 to produce aerosol from the aerosolization element 70 within milliseconds or fractions of milliseconds of a signal to do so.
  • aerosol production may begin within about .02 to about 50 milliseconds of such a signal and may stop within about .02 to about 50 milliseconds from the cessation of a first signal or a second signal either of which may act as a trigger to turn of aerosolization.
  • aerosol production may begin and end within about .02 milliseconds to about 20 milliseconds of such respective signaling.
  • aerosol production may begin and end within about .02 milliseconds to about 2 milliseconds of such respective signaling. Further, this manner of aerosolization provides full aerosolization with a substantially uniform particle size of low velocity mist 79 being produced effectively instantaneously with operation of the switch.
  • a nebulizer 85 which may have a top portion 93 through which liquid (either directly or within a nebule) may be provided, in accordance with the present invention may be incorporated into a ventilator breathing circuit of a ventilated patient.
  • the breathing circuit may comprise a "Y" connector 88, which may in turn have an inlet portion 89, an endotracheal tube portion 90 and an outlet portion 91.
  • the inlet portion 89 carries air provided from the ventilator 92 toward the patient.
  • the endotracheal tube portion 90 of the Y connector 88 carries the incoming air to the patient's respiratory tract; this direction is represented by arrow a.
  • the endotracheal tube portion 90 also carries the patient's exhalation to the outlet portion 91 of the Y connector 88, and the outlet portion may lead to an exhaust, represented by arrow b, to remove the patient's exhalation from the system.
  • the nebulizer 85 of the present invention aerosolization element generates an aerosol cloud 94 that remains substantially within the inlet portion 89 of the Y connector 88 when there is no inspiratory air flowing through the inlet portion, by virtue of the aerosolization element, as described above, producing a low velocity mist. In this manner, aerosol that is generated when there is no inhalation air being provided will not be carried out through the outlet portion 91 of the Y connector and lost to the ambient environment.
  • a dose of aerosolized medication may be preloaded, i.e., produced and placed substantially within the inlet portion 89 prior to an inhalation phase being sent by the ventilator 92.
  • such medication can be swept into a patient's respiratory system at the very start of the inhalation cycle. This may be of particular benefit in the case of neonatal patients and in other instances in which only the initial blast of inhalation phase will reach the target portion of the respiratory system.
  • the switch may be operable by a pressure transducer, which may be positioned in the mouthpiece of the nebulizer.
  • the pressure transducer may be in electrical communication with the circuitry, and a microprocessor may also be in electrical communication with the circuitry, and the microprocessor may interpret electrical signals from the pressure transducer, and may also operate the switch to begin aerosolization. In this manner, nebulization can begin substantially instantaneously with the inhalation of a user upon the mouthpiece.
  • An example of such a sensor switch can be found in co-assigned and co-pending U.S. application Ser. No. 09/705,063 assigned to the present assignee, the entire content of which is hereby incorporated herein by reference.
  • Another transducer may be used to sense the absence or presence of liquid in the reservoir, by sensing, for example, a difference between vibration characteristics of the aerosolization element, such as, for example, differences in frequency or amplitude, between wet vibration and substantially dry vibration.
  • the circuitry may, for example by way of the microprocessor, turn the vibration off when there is essentially no more liquid to aerosolize, i.e., when the end of the dose has been achieved, thus minimizing operation of the aerosolization element in a dry state.
  • the switch may prevent vibration prior to delivery of a subsequent dose into the reservoir.
  • An example of such a switch is shown in co- assigned and co-pending U.S. application Ser. No. 09/805,498, the entire content of which is hereby incorporated herein by reference.
  • the aerosol generator controllers of the present invention can be coupled to both a nebule identification sensor and a breathing characteristic sensor so as to identify the liquid that is delivered to the aerosol generator and to monitor the breathing characteristics of the patient (Steps 130 to 140).
  • the aerosol generator can be operated (and a pre-programmed delivery program can be selected) to run the aerosol generator, based at least in part on the information obtained from the identification sensor and breathing characteristic sensor (Step 140).
  • the controller can select the best time during the patient's breathing cycle to deliver the aerosol, based upon a predetermined regimen for that drug that is stored in memory.
  • an estimate of the patient's age and/or distress can be made, for example, by measuring the tidal volume and breathing rate. Such measurements can influence the efficiency requirements of the dose per breath.
  • These or other variables can be used in establishing various regimes for aerosol delivery, in particular delivery into the breathing circuit of a ventilator. These regimes can be stored in memory and then accessed by the controller as appropriate for a given patient condition.
  • the best time to delivery may be halfway through the inhalation phase of a breath when impaction would be reduced since inhalation flows are reducing.
  • antibiotics may be delivered at the beginning of a ventilator provided inhalation, and the aerosol delivery may stop after a predetermined percentage of the inhalation has been provided.
  • One class of antibiotics that may be administered in accordance with the present invention is the class known as the aminoglycoside class of antibiotics.
  • antibiotics such as aminoglycosides including amikacin
  • amikacin can be used to treat pulmonary infection conditions that typically arise when patients are mechanically ventilated, and the amikacin, or other aminoglycoside or other antibiotic, can be delivered directly to the target of treatment, the pulmonary tract, avoiding side effects that may otherwise arise from intravenous administration. Further, because of the great cost of such drugs, far greater efficiency is achieved through this pulmonary delivery.
  • delivery of aerosol during a beginning percentage of the inhalation phase of a breathing cycle may yield up between about 60%> and about 80%> efficiency, an this is significantly higher than efficacy of continuous aerosolization or aerosolization for an entire inhalation phase of an inhalation cycle.
  • a selection between a first, second and third regime is shown.
  • a regime may be selected manually or automatically, for example, through the application of an algorithm that selects an operation program based on information that is either input or stored.
  • a user may operate a mechanical switch to select a regime, or may enter such a selection into an electronic input device, such as a keyboard.
  • the controller may automatically choose a regimen, as described above, by matching a drug code on a drug nebule with a library of drug-regimen combinations. (It should be noted that in Figs. 18, 19 and 20, schematic flow charts of operation sequence algorithms are depicted.
  • Steps depicted in a rectangle are essentially states of operation, actions or modalities.
  • Steps depicted in diamonds indicate either a selection or the continuance of the previous state of operation, action or modality until a predetermined condition is satisfied.
  • Two successive diamonds refer to satisfaction of a first condition and of a second condition respectively, the second of which may be a subset of the first.
  • step 200 a choice is made to follow a particular regime.
  • regime I is a regime in which aerosol is generated continuously (step 202).
  • Regime II provides aerosol generation during the inhalation phase only (step 204).
  • step 206 aerosol generation is set to start at the start of the inhalation phase and, in step 208, aerosol generation is set to stop when the inhalation phase stops.
  • step 210 aerosol generation begins at the start of the inhalation phase.
  • step 212 when the inhalation phase ends, aerosol generation stops (step 214).
  • Regime III provides for inhalation during a predetermined percentage of the inhalation phase (step 216).
  • a predetermined percentage of an inhalation (or exhalation) phase may be based on a measured time from a discrete point in the ventilator cycle, such as the instantaneous commencement of inspiratory air generation by the ventilator.
  • such predetermined percentage may be based on the time interval between successive discrete points in the ventilator, such as successive commencements of successive inhalation air generation by the ventilator.
  • such percentages may be based upon air pressure in the ventilator circuit, or any other parameter.
  • a first predetermined point is set to correspond with the completion of a first predetermined percent of the inhalation.
  • a second predetermined point is set to correspond to a second predetermined percent of inhalation percent being completed.
  • the first predetermined point may correspond to 20%> of the inhalation phase being completed
  • the second predetermined point may correspond to a point at which 70%> of that same inhalation has taken place.
  • aerosol generation begins at the first predetermined point in the inhalation phase.
  • step 224 when the second predetermined point is reached, the controller carries out step 214 and stops the aerosol generation.
  • regimes may be followed, for example, in which aerosol generation begins during the inhalation phase and ends during the exhalation phase, or begins during exhalation and ends during that exhalation, or begins during exhalation and ends in the subsequent breath cycle, for example, at a predetermined point in the subsequent inhalation phase. Accordingly, turning to Fig. 19, a selection may be made, at step 230, between regimes II (step 232) and III (step 234) as described above, and another regime, regime IV (steps 236 - 242), which is also available for selection.
  • aerosol generation may begin at a first predetermined point (step 236), and this first predetermined point may be after a predetermined percentage of the inhalation phase has taken place, or it may be a predetermined point after the inhalation phase has been completed. For example, this point may be a predetermined point after a predetermined percent of the exhalation phase has taken place, or may be a predetermined point prior to the start of the subsequent inhalation phase. Aerosol generation may stop during exhalation (regime IVa, step 238), at the completion of exhalation (regime IVb, step 240), or aerosol generation may continue into the next breath cycle (regime IVc, step 242), and stop, for example, after a predetermined point during the subsequent inhalation phase.
  • first predetermined point may be after a predetermined percentage of the inhalation phase has taken place, or it may be a predetermined point after the inhalation phase has been completed. For example, this point may be a predetermined point after a predetermined percent of the exhalation
  • a regime is selected.
  • the aerosol generator controller selects an operation sequence based on selected regime.
  • the controller receives a signal indicating that ventilator has begun to supply an inhalation phase.
  • the signal may be a signal provided directly by the ventilator.
  • the signal may be provided by a sensor, and such sensor may sense the commencement of an inhalation phase provided by the ventilator, as described above, by sensing a pressure change in the breathing circuit.
  • the controller carries out selected operation sequence.
  • step 258 the controller turns on aerosol generator upon commencement of inhalation phase provided by the ventilator.
  • the controller continues to operate the aerosol generator until a point at which the inhalation phase completed (step 260).
  • step 262 controller turns off aerosol generator.
  • the controller does not take any action to begin aerosol generation, until a predetermined point in the inhalation phase, corresponding to a percentage of the inhalation phase being completed (step 264).
  • the controller turns on aerosol generator.
  • aerosol generation continues until a second predetermined point inhalation phase, corresponding to a second percentage point of completion of the inhalation phase.
  • the controller carries out step 262 and turns off aerosol generator.
  • aerosol generation begins after a predetermined point of completion of the inhalation phase (step 264) and this point may be predetermined to occur after the inhalation phase has been completed and the exhalation phase has begun (step 270).
  • step 272 the controller turns the aerosol generator on to begin aerosolization. Variations can be made as to the point at which the aerosol generation is turned off. If it is desired that aerosol generation be completed before the completion of the exhalation phase (regime IVa), then aerosol generation may continue until a predetermined point prior to the subsequent inhalation (step 276). Alternatively, it may be desirable to continue aerosolization until the end of exhalation, which may correspond to the point of commencement of the subsequent inhalation, as in regime INb (step278). Alternatively, it may be desired to follow a regimen such as regime IVc, where aerosol generation continues through into the subsequent breath cycle (step 280), until, for example, a predetermined percent of the subsequent inhalation phase has been completed (step 282).
  • step 276 for regime IVa step 278 for regime IVb or step 282 for regime IVc
  • step 262 the controller carries out step 262 and stops the aerosol generator.
  • the process may continue with the next signal indicating that the ventilator has begun to provide an inhalation phase, step 254.
  • step 256 may not be a discrete step but rather the following of an operation sequence according to a selected regime.
  • step 252 the controller may select an operating sequence (step 252) after receiving a signal that the ventilator has commenced to provide an inhalation phase (step 254).
  • Steps may also be combined, such as, for example, in regime TV steps 264 and 270 may be combined as a single step, as these two steps represent successive criteria for the determining a single first predetermined point has been met.
  • step 274 may be combined with steps 276, 278 or 280, as step 274 is the predicate for the condition test specified in each of the other successive tests, steps 276, 278 or 280.
  • the algorithm examples may be altered to form other operating sequences.
  • an operating sequence may call for the controller to start aerosol generation at the start of the inhalation cycle provided by the nebulizer, as in regime II, at step 258, and turn off the aerosol generator at a point at which a predetermined percentage of the inhalation phase has been completed, as in regime III, step 268 (and step 262).
  • other criteria may be used to trigger the turning on or off of the aerosol generator.
  • the start of aerosolization may be triggered by the sensing of a particular pressure or change in pressure in the ventilator circuit, and may end by following the turning off sequence of regimes III (steps 268 and 262) or IV (steps 274, 276, 278 or 280 and 282, followed by step 262, as described above.
  • Figure 21 is a schematic representation of an algorithm by which an operating sequence, for providing nebulized drug to a patient receiving air from a ventilator, may be chosen based on the combination of a plurality of independent sets of information, in this case, drug identity and a signal from the ventilator.
  • a library of drug regimes is provided, the library based on various drugs that may be administered.
  • the identity of a particular drug is provided to the system, and this may be provided, as described above, by a marker on a nebule containing the drug, the marker being read by the system.
  • the controller looks up a regime from the library of stored regimes to select a regime based on the particular drug to be administered.
  • step 306 the controller receives a signal from the ventilator.
  • step 308 the controller then chooses an operation sequence based in part on the drug identity and drug regime and in part on the independent information provided by the signal from the ventilator.
  • step 310 the controller carries out the operation sequence, which may be producing aerosol at a predetermined interval in the ventilation cycle based on the drug and the regime provided for the drug factored in with the inhalation cycle of the ventilator.

Abstract

A nebule (28) having an identification marker/label (35) which is adapted to engage an aerosol generator (22). The marker/label (35) can be sensed by a sensing device (34) on the aerosol generator (22) so as to identify the contents of the nebule (28) for use by the aerosol controller (30). The controller (30) can then control the aerosol generator (22) based upon the identity of the contents of the nebule.

Description

METHODS AND SYSTEMS FOR OPERATING AN AEROSOL
GENERATOR
CROSS-REFERENCES TO RELATED APPLICATIONS
The present application is related to pending U.S. Patent Application Nos. 09/876,542, filed June 7, 2001, 09/876,402, filed June 7, 2001, and 09/812,987, filed March 20, 2001, the complete disclosures of which are incorporated herein by reference.
The present application is a continuation-in-part of U.S. Patent Application No. 09/849,194, filed May 4, 2001, which claims the benefit of Ireland patent application No. PCT/IE/00051, filed May 5, 2000, which are incorporated herein in their entirety.
The present application is a continuation-in-part of U.S. Patent Application S.N. 09/812,755, filed March 20, 2001, which is incorporated herein in its entirety.
The present application is a continuation-in-part and claims the benefit of U.S. Provisional Application 60/349,763, filed January 15, 2002, which is incorporated herein in its entirety.
The present application is a continuation-in-part and claims the benefit of U.S. Provisional Application Nos. 60/349,805, filed January 15, 2002; 60/380,655, filed May 14,
2002; 60/408,743, filed September 5, 2002; and 60/ , filed January 8, 2003, entitled
"Methods and Systems for Operating an Aerosol Generator", which are incorporated herein in their entirety.
The present application is a continuation-in-part of U.S. Patent Application No. 10/284,068, filed October 30, 2002, which claims the benefit of U.S. Provisional Application Nos. 60/344,484, filed November 1, 2001 and 60/381,830, filed May 20, 2002, which are incorporated herein in their entirety. BACKGROUND OF THE INVENTION
The present invention is generally related to liquid aerosol generators. In particular, the present invention is related to methods and devices for identifying the contents of a nebule to improve the delivery of the aerosolized liquid to the patient.
The ability to aerosolize or nebulize small liquid droplets is important in a variety of industries. Merely by way of example, many pharmaceuticals can now be delivered to the lungs in liquid droplet form through use of an aerosol generator, such as a nebulizer inhaler. Aerosolization is also a useful technique to dispense deodorizers, perfumes, insecticides, or the like, into the atmosphere or to other target areas.
Aerosol generators can be configured to deliver a number of different pharmaceutical aerosols to the patient's lungs or other target areas of the body. Typically, the aerosol generator will utilize a removable supply of a liquid pharmaceutical that is contained in some type of portable nebule, such as an ampoule, container, canister, reservoir, or the like.
While the existing aerosol generators have proven to be effective, the existing aerosol generators suffer some limitations. One problem with existing aerosol generators is that users may inadvertently install and nebulize an incorrect drug nebule into the aerosol generator. As can be appreciated, delivery of the wrong drug can be extremely dangerous, if not fatal.
Another problem with existing aerosol generators is that the aerosol generator cannot identify the liquid in the nebule. Consequently, it has proven to be difficult to provide an efficient delivery of the aerosolized pharmaceutical to the patient. Since some of the pharmaceuticals to be aerosolized may be more effective when delivered near the beginning of a patient's breathing cycle, while other pharmaceuticals may be more effective when delivered near the end of the patient's breathing cycle it is preferable that the aerosol generator be able to identify the type of liquid disposed in the nebule so that the correct delivery sequence can be chosen to deliver the aerosol to the patient. While the existing nebulizers have proven to be effective within certain parameters, the existing nebulizers also present opportunities for improvements.
One area for improvement is the calculation and control of the precise time of aerosol delivery within a user's or patients breathing cycle. This is especially in issue with respect to patients that receive some of all of their inspiratory air from a ventilator device. Existing nebulizers may deliver a constant flow of aerosol into the ventilator tubing, which can lead to a significant amount of aerosol lingering in the tubing or other elements of the overall ventilator system - this lingering aerosol may not be inhaled, as it collects while the patient is exhaling or otherwise not inhaling, resulting in a significant amount of aerosolized medication being pushed out of the system, such as during exhalation, without being inhaled by the patient. Such situations are problematic for a number or reasons. First, the dosage of drug that actually is inhaled by the patient may be significantly inaccurate because the amount of medication the patient actually receives into the patient's respiratory system may vary with fluctuations of the patient's breathing pattern. Further, a significant amount of drug that is aerosolized may end up being wasted, and certain medications are quite costly, thus health-care costs can be escalated. Further still, unused aerosolized medication will typically be released to the ambient atmosphere with a patent's exhalation. This can end up medicating individuals in the patient's surroundings and this may give rise to adverse effects with respect to such individuals. Moreover, in a hospital environment such individuals may be either health-care providers, who could be exposed to such air pollution over a prolonged period of time, or other patients, who may be in a weakened condition or otherwise overly sensitive to exposure to non-prescribed or excessive amounts of a medication.
For these reasons, it is desired to provide an aerosol generator that can obtain information about the contents of the nebule. In particular, it is desired to provide methods and devices, which can determine the type of liquid disposed in the drug so as to provide an improved level of safety to the patient and an increased efficiency in the delivery of the aerosol to the patient. Further, for these reasons, it is desired to provide methods and devices that can provide aerosol to a patient at a selected interval of the breathing cycle. It is also desired to provide methods and devices that can provide aerosol to a patient at a selected interval wherein the interval is selected based on the identity of the drug to be administered.
BRIEF SUMMARY OF THE INVENTION
The present invention provides devices and methods for improving a level of safety to the patient and for providing an increased efficiency of delivery of an aerosol to the patient
In one method, the present invention provides a method of creating an aerosol. The method comprises providing an aerosol generator and coupling a nebule to an interface of the aerosol generator. An identification marker is read on the nebule and the aerosol generator is operated according to an operation program based on the information read from the identification marker on the nebule.
In another method, the present invention provides a method of nebulizing a liquid. The method comprises taking one or more breaths and measuring characteristics of the breath. Another breath is taken and an aerosol generator is operated based on the measured characteristics of the one or more measured breaths.
In yet another method, the present invention provides a method comprising providing a nebulizer system comprising a housing, an aerosol generator, a controller coupled to the aerosol generator, and a reservoir in communication with the aerosol generator. A nebule having a body and a keying element is provided. The nebule is inserted into the housing so that the key element provides access to the reservoir when properly keyed with the housing. The liquid is transferred from the nebule into the reservoir and the aerosol generator is operated with the controller to aerosolize the liquid.
In another aspect, the present invention provides an aerosol generator comprising an interface. A sensing device is coupled to the aerosol generator. An ampoule having at least one identification marker that can detected by the sensing device is attachable to the interface.
In another aspect, the present invention provides a nebulizer system comprising a housing that defines a passageway that is adapted to deliver an aerosolized liquid to a user. An aerosol generator is positioned to provide an aerosolized liquid into the passageway. A controller having a memory and a plurality of aerosol generator operation programs that control operation of the aerosol generator is coupled to the aerosol generator. A reader is configured to read an identification marker on a nebule having a supply of liquid for the aerosol generator, and is configured to send information from the identification marker to the controller. Typically, the controller is further configured to operate the aerosol generator according to one of the operation programs based on the information from the marker.
In another aspect, the present invention provides a nebule comprising a nebule body holding a liquid that is adapted to be supplied to an aerosol generator of a nebulizer; and an identification marker on the nebule body, the identification marker having information identifying the liquid, wherein the identification marker is readable by a nebulizer to control operation of the aerosol generator based on the information.
In another aspect, the present invention provides a nebulizing element positioned to provide nebulized fluid into a ventilator breathing circuit to provide nebulized fluid to a patient receiving air from a ventilator. It will be appreciated that a nebulizing element may also be referred to herein a an aerosolization element, and a ventilator may also be referred to herein as a respirator.
In another aspect, the present invention provides operation sequences by which aerosol is provided a predetermined points in a breath cycle provided by a ventilator. In one aspect, the present invention provides for an operation sequence in which aerosol production begins at a predetermined point within an inhalation phase, which may also be referred to herein as an inspiratory phase, and stops at a second predetermined point within the same inhalation phase. In another aspect, the present invention provides for an operation sequence, which may be referred to as an operation program, in which aerosol production begins at a predetermined point in an inhalation phase and stops at a point after the inhalation phase has ended, i.e. at a certain point in the exhalation phase. It will be appreciated that the exhalation phase may also be referred to as the expiratory phase, and may encompass the entire period of time during which no inhalation phase is taking place; in other words, the exhalation phase may include not only the actual exhalation of the patient, but also any pause that may occur before or after exhalation. In another aspect, the present invention provides an operation sequence in which aerosolization begins at a predetermined point within the exhalation phase and stops within that exhalation phase, or, alternatively, begins at a predetermined point within an exhalation phase and stops at a predetermined point in the succeeding inhalation phase.
In another aspect, the present invention provides for selection of a particular operating sequence from a plurality of available operating sequences. Similarly, the present invention provides for modes of operation, which modes may include one or more operating sequences.
In another aspect, the present invention provides for algorithms to set forth operation sequences, choice of operation sequences or choice of modes of operation.
In another aspect, the present invention provides for consideration of the identity of a drug to be administered in executing an algorithm, choosing a mode of operation, or selecting or running an operation sequence.
In another aspect, the present invention provides for nebulization of particular drug groups or drugs, such as, for example, antibodies, such as IgG or antibiotics, such as aminoglycosides, such as amikacin.
In another aspect, the present invention provides for a nebulized droplet ejection device for use with a ventilator, wherein the device produces droplets by a vibratory apertured element during a selected interval of a breathing cycle.
In another aspect, the present invention provides for apparatus and methods for varying the particle size distribution of a nebulized mist by varying the aperture exit diameter of an apertured vibratory aerosolization element. For a further understanding of the nature and advantages of the invention, reference should be made to the following description taken in conjunction with the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 schematically shows a system of the present invention;
Figures 2 to 4 illustrate an exemplary nebule and feed system interface of the present invention;
Figure 5 shows an elevational view of another exemplary system of the present invention comprising an electromechanical sensor;
Figure 6 shows a plan view of an ampoule and an electromechanical sensor of Figure 5;
Figures 7 and 8 show an ampoule and feed system interface having an alternative threaded interface;
Figure 9 is a cross sectional plan view illustrating another ampoule and feed system interface;
Figure 10 is a plan view of an ampoule having an identification marker disposed in a non-helical configuration;
Figure 11 illustrates a simplified flowchart illustrating one exemplary method of the present invention;
Figure 12 illustrates another simplified method of the present invention;
Figure 13 illustrates yet another simplified method of the present invention; and
Figure 14 illustrates another simplified method of the present invention.
Figure 15 is a graph showing various modes of aerosolization over the course of breathing cycles;
Figure 16a is a schematic cross-sectional representation of an aerosol generator in accordance with the present invention;
Figure 16b is a schematic cutaway cross-section detail of the aerosol generator represented in Figure 16a.
Figure 17 is a schematic perspective view of a nebulizer incorporated into a ventilator breathing circuit in accordance with the present invention;
Figure 18 is a schematic representation of algorithms of operating sequences in accordance with the present invention;
Figure 19 s an alternative schematic representation of the representation of Figure 18; Figure 20 is a further schematic representation of algorithms of operating sequences shown in Figure 19 and in accordance with the present invention.
Figure 21 is a schematic representation of an algorithm by which an operating sequence may be chosen base on the combination of a plurality of independent sets of information.
DETAILED DESCRIPTION OF THE INVENTION The aerosol generator systems of the present invention, in one aspect, include an aerosol generator coupled to a controller that is in communication with at least one sensor such that delivery sequence of the aerosol to the patient can be based at least in part on the information obtained with the sensors. In some exemplary embodiments, the system includes a nebule identification sensor to read an identification marker on the nebule so as to identify the type of liquid that is disposed within the nebule. In other exemplary embodiments, the system includes a breathing characteristic sensor that monitors and records the breathing characteristics of the patient so as to allow the controller to direct the delivery of the aerosol to coincide with the patient's breathing pattern. In yet other exemplary embodiments, the aerosol generator system includes both a nebule identification sensor and a breathing characteristic sensor.
Figure 1 schematically illustrates an exemplary aerosol generating system 20 of the present invention. The system 20 includes an aerosol generator (AG) 22 that is in communication with an output passageway 24, such as a ventilator circuit, mouthpiece, face mask, or the like. A nebule 28 containing a liquid can be removably coupled to a feed system interface 26 to deliver a liquid to aerosol generator 22 for aerosolization. A controller 30 is in communication with aerosol generator 22 to control the sequence of aerosolization of the liquid to the patient. Controller 30 can be coupled to a breathing sensor 32 that is in communication with output passageway 24 so as to monitor the breathing characteristics of the patient. Additionally or alternatively, controller 30 can be coupled to nebule identification sensor 34 to identify the type of liquid that is disposed in nebule 28 by reading an identification marker that is provided on nebule 28. Controller 30 can take the information from flow sensor 32 and/or nebule sensor 34 and run the information through an algorithm to determine an efficient sequence of aerosolization. Typically, the controller will run a selected pre-programmed delivery or sequence program that is stored in controller 30 so as to deliver the aerosol to the patient in an optimal time of the patient's breathing cycle. Controller 30 can include a memory and a microprocessor so as to store and run the algorithm that selects the pre-programmed drug delivery sequence. The memory of the controller can store a list or library of codes and/or drugs that are compatible with the aerosol generator, information about the drugs, such as a regime to be followed based on the particular drug, the time in the breathing cycle when the drug is best administered, the amount of the drug to be aerosolized, or the like.
Controller 30 will typically be in communication with at least one sensor. As noted above, one sensor can be a nebule identification sensor 34 that reads an identification marker on the nebule to identify the type of liquid disposed within the nebule. The sensor can be a mechanical sensor, an electromechanical sensor, an electrical sensor, an optical sensor or the like. Such sensors can be used to provide information to the controller for a number of purposes. For example, the identification information can be used to identify the type of drug so as to choose the delivery sequence program. Moreover, the identification information can be used as a quality control mechanism to prevent the aerosolization of an incompatible, unsafe, or unknown drug, and the like.
Another type of sensor that can be coupled to controller 30 is a breathing characteristic sensor 32 that can monitor the breathing characteristics of the user. The sensor can send breathing characteristic information to the controller to allow the controller to select an appropriate delivery cycle of the aerosolized liquid to the patient. Typically, breathing characteristic sensor 32 can be used to measure a breathing pattern of the patient, the peak flow, breathing rate, exhalation parameters, regularity of breathing, and the like. Such measured breathing characteristics can be delivered to controller 30 and run through a software algorithm to determine an appropriate sequence of delivery relative to the measured breathing cycle to the patient. One exemplary breathing characteristic that may be sensed by sensor 32 is the cycle of a ventilator providing air to a patient; for example, the start of an inhalation cycle generated by the ventilator. The sensor 32 may sense other parameters, for example, it may be an acoustic sensor that is activated through passing the respiratory flow of the patient through an acoustic chamber (not shown) so as to produce an acoustic tone, which is proportional to the inspiratory flow rate. The frequency of the acoustic tone indicates the inspiratory flow rate at any instant of the breathing cycle. The acoustic signal can be detected by the controller such that integration of the flow rate with time produces the tidal volume. Both the flow rate and the tidal volume can then be used by the controller to determine when the aerosol generator generates the droplets and at what mass flow rate such that maximum deposition of droplets is obtained. Further, the acoustic tone may be recorded to produce a record of the breathing pattern of the patient which may be stored in the microprocessor. This information can be later used to synchronize the ejection of droplets for the same patient. Such information may also be later employed for other diagnostic purposes. A more complete description of such a sensor is described in commonly owned, U.S. Patent 5,758,637, which was previously incorporated by reference.
In some embodiments, the sensor can be used to monitor the breathing characteristics of the patient throughout the delivery regime so as to ensure that the aerosol is efficiently delivered throughout the aerosolization procedure. In such embodiments, the controller can adjust the aerosol delivery based on any measured change in the breathing pattern of the patient during the aerosolization. With this monitoring and adjustment predetermined times for the beginning and ending of aerosolization can be reset based on the actual breathing of the patent. In other embodiments, however, the breathing sensor can be used to determine the breathing cycle of a tidal breath and to choose the appropriate preprogrammed delivery cycle that is stored in the memory of the controller. In other embodiments, the controller may be configured to provide aerosol based on the time. For example, the controller may be configured to start aerosol production at the beginning of an inhalation phase of a breathing cycle and stop at a point at which a predetermined percentage of the inhalation has taken place. Alternatively, the controller may be configured to start aerosolization at a first point at which a first predetermined percentage has taken place and stop aerosolization at a second point at which a second predetermined percentage of that inhalation has taken place. Alternatively, aerosol may begin during an inhalation phase and end during the subsequent exhalation phase. Alternatively, the controller may be configured to begin aerosol production at a certain point during exhalation and stop during that exhalation or during the subsequent inhalation. Thus, an aspect of the present invention may include a nebulizer comprising: an aerosol generator and a controller configured to have the controller begin aerosolization during exhalation and stop during that exhalation or in the subsequent inhalation. In addition, the controller may be operable to allow for a choice of modes of operation, for example, a mode in which aerosolization begins once a certain breath characteristic is detected, such as a sufficient level of inhalation, and ends when there is no longer a sufficient level; another mode in which aerosolization begins once a certain breath characteristic is detected, such as a sufficient level of inhalation, and ends at a predetermined time within the inhalation cycle, such as for example, before the level of inhalation falls below that required for operation of an aerosolization element, or, alternatively, at any other point within the inhalation cycle, such as after the inhalation phase of the cycle before exhalation has begun, or after exhalation has begun.
The level of inhalation may be sensed by a pressure transducer. Such a transducer may monitor a drop in air pressure or a rise in air pressure within a chamber that is in fluid communication with the ventilator circuit. In this manner, a pressure drop may be sensed by a patient inhaling through the circuit, for example, in an instance in which the ventilator provides an assisted ventilation initiated by a patient's commencement of an inhalation. Similarly, a pressure rise may be sensed in an instance in which the ventilator pushes inhalation air to the patient without the patient initiating a breath. Another mode in which the controller may be operable is a mode in which the on / off operation of the aerosol generator is triggered by time, which may be ascertained from an internal clock device, such as a clock built into a microprocessor, or from an external source. Another mode in which the controller may be operable is in which the on / off operation of the aerosol is triggered by the controller receiving an external signal, such as a signal from a ventilator, which can correspond to the point in the ventilator's cycle of that is the start of an inhalation phase in which the ventilator begins to push inspiratory air into the ventilator circuit. The controller may be operable between such modes, including a mode in which the aerosolization begins at a predetermined time in the breathing cycle and ends at a predetermined time in the breathing cycle. The first and second predetermined times in the third mode may be during inhalation. Alternatively, the first and second predetermined times may be during exhalation, or at the first predetermined time may be during exhalation and the second predetermined time may be during subsequent inhalation. These times may correspond to certain percentages of the inhalation phase taking place, or any other points of reference within a breathing cycle.
Alternatively, the first predetermined time and the second predetermined time may be designated as any point within a single breathing cycle, or alternatively, the first predetermined point may be at any point within one breathing cycle and the second predetermined point may be at any point in a subsequent breathing cycle. The controller may make the determination of when to begin, and operate to begin aerosolization, and may make the determination of when to stop aerosolization to stop, and cause aerosolization to stop. The controller may make such determinations and take such actions based on accessing stored algorithms. The controller may receive a signal from the ventilator that establishes a reference point, nonetheless, the controller, by making the determinations an taking the actions based on stored algorithms, and/or information obtained as to the identity of a drug to be administered, may cause aerosol production to begin and/or end independent of the instantaneous position of the ventilator with respect to the ventilator cycle.
The controller may be operable to allow for a single mode of operation, and such single mode of operation may be any mode, for example, as described above. For example, a mode in which aerosolization begins once a certain breath characteristic is detected, such as a sufficient level of inhalation, and ends when there is no longer a sufficient level. Similarly, the controller may operable in a mode in which aerosolization begins once a certain breath characteristic is detected, such as a sufficient level of inhalation, and ends at a predetermined time within the inhalation before there is no longer a sufficient level or an aerosolization element.
Alternatively, the mode may be a mode in which the aerosolization is commenced based on a signal from the ventilator indicating the attainment of a certain point within the ventilation output cycle or the inhalation cycle of the patient. (The ventilation output cycle of the ventilator may coincide with the inhalation cycle of the patient, such that the ventilation output phase of the ventilator output cycle and the inhalation phase of the inspiratory cycle of the patient occur substantially simultaneously. Such may be the case where a patient is completely passive and the only inhalation that occurs is by generation of air from the ventilator during the output phase of the ventilator cycle.). Such point may be during the output phase of the output cycle of the ventilator or during the inhalation phase of the inhalation cycle of the patient. The predetermined point can be chosen to coincide with a certain level of output from the ventilator or at a certain point in time during the ventilator output cycle. Such a predetermined point may be a specific point within the output phase of the ventilator cycle, or, a specific point within the non-output phase of the ventilator cycle, based, for example, on the timing of the previous or succeeding output phase of the ventilator. In another aspect, the present invention provides for a ventilator along with the aerosol generator and controller. In an aspect of the invention, a predetermined time may be based on the timing of a ventilator supplying air to a user. In this manner, the controller may be set to work off of the timing of the ventilator in one mode, while working off the patient's inspiratory effort in another mode, or mode that allows for a combination of the patient's inspiratory effort and the timing of the ventilator, for example, where the ventilator is set to assist the patient by supplying air upon the patient's effort or where the patient has not made a sufficient effort within a predetermined period of time.
In regard to the aerosol generators 22 of the present invention, they may be of the type, for example, where a vibratable member is vibrated at ultrasonic frequencies to produce liquid droplets. Some specific, non-limiting examples of technologies for producing fine liquid droplets is by supplying liquid to an aperture plate having a plurality of tapered apertures and vibrating the aperture plate to eject liquid droplets through the apertures. Such techniques are described generally in U.S. Patent Nos. 5,164,740; 5,938,117; 5,586,550; 5,758,637, 6,014,970, and 6,085,740, the complete disclosures of which are incorporated by reference. However, it should be appreciated that the present invention is not limited for use only with such devices.
Figures 2 to 10 illustrate some exemplary feed system interfaces 26 and nebules 28 of the present invention. As shown in Figure 2, nebule 28 can be an ampoule that comprises a body 36 with a top end 38 and a bottom end 40. Bottom end 40 can include a tapered opening that can deliver the liquid from ampoule 28 into a fluid reservoir 42 adjacent aerosol generator 22. Top end 38 can include a twist-off vent 44 that can be removed to create a drain vent in top end 38. Some exemplary ampoules that can be used with the present invention are described in co-pending U.S. Patent Application S.N. 09/812,755, filed March 20, 2001, the complete disclosure of which was previously incorporated by reference.
The ampoules of the invention may be used to store a wide variety of liquids. Merely by way of example, liquids that may be stored within the ampoules include various pharmaceuticals such as saline, albuterol, chromatin, budesinide, nicotine, THC, cocaine, antibodies, such as IgG, antibodies, such as aminoglycosides, and the like. Other liquids that may be stored include insecticides, deodorizers, perfumes, and the like. Hence, it will be appreciated that the ampoules of the invention may be used to store essentially any type of liquid that is capable of being aerosolized.
The ampoules of the invention may be constructed by blowing or vacuum-forming the ampoule in a mold, filling the ampoule with liquid, and melt-sealing the liquid into the ampoule. The ampoules may further be provided with a set of removable tabs to provide a drain vent and a drain opening. Typically, these will be located in the top and bottom of the ampoule so that the liquid may drain by force of gravity once the openings are formed. The tabs may be removed by twisting, cracking, or the like so that the opening may be formed. In some cases, the ampoules may be configured to be opened simply by piercing the top and/or bottom end. Such piercing elements may conveniently be incorporated into the aerosolization device.
Various materials may be used to construct the ampoules, such as moderate durometer polymer materials, thermoplastic synthetics, such as low density polyethylene and polypropylene, and the like. The ampoules may be provided with a thick enough wall to minimize droplet spillage. For instance, the wall thickness may be greater than about 0.030 inch. The ampoule may further be configured so that the diameter of the drain opening minimizes the drip potential for the fluid stored within the ampoule. For example, larger diameter openings may be provided when storing higher viscosity fluids and smaller diameter openings may be used for low viscosity fluids.
The ampoules of the present invention can include a connection or keying element 46, such as a thread or a tab so as to accurately align the ampoule 28 with a nebulizer feed system interface 26. The feed system interface 26 will have a corresponding feature or slot 48 to engage the connection element. In the exemplary embodiment illustrated in Figures 2 to 4, ampoule 28 can include a helical keying element 46 that is shaped to mate with the corresponding keying feature 48 in feed system 26. To insert the ampoule into feed the system, the ampoule is moved axially (in the direction of arrow 50) until helical keying element 46 is positioned adjacent the corresponding keying feature 48. Thereafter, the ampoule 28 is rotated to mate the keying element 46 and the keying feature 48 together so as to pull the ampoule 28 axially downward until the bottom end 40 of the ampoule 28 opens slit seal membrane 52 in feed system 26 (Figures 3 and 4).
In the exemplary embodiments, ampoule 28 includes an identification marker 35 to identify to the controller, the liquid that is within ampoule 28. Identification marker 35 can be a bar code (e.g., embossed or printed), one or more bumps or protrusions, a radio frequency identifier, a small chip containing stored information, or other suitable identification technology. In the embodiments depicted in Figures 2 to 4, information regarding the contents of the ampoule is conveyed through a series of protrusion identification markers 35 on the ampoule 28 that are sensed by their interaction with an optical detector 56 during the rotational engagement of ampoule 28 with the feed system interface 26. In this particular embodiment, a miniature light source 58 and the optical sensor 56 are coupled to the feed system 26 such that a passing protrusion 35 affects the sensed light in a manner such that the sensor 56 may provide information (e.g., typically binary information, i.e., a "0" or a "1") based on position, number, or absence of the protrusion. Thus, rotation of an ampoule 28 as it is threadedly inserted into the nebulizer feed system 26 may count the number of bumps or provide a code such as "1-0-1-0" so as to inform the nebulizer controller 30 (Figure 1) the type of medicant or other liquid that is disposed in the ampoule. A single sensor can read the code imparted by a series of protrusions as the ampoule 28 is moved axially into the nebulizer feed system 26 while it is rotated through the threaded features in the housing of feed system 26. Figure 5 illustrates another exemplary nebule identification sensor 34 and ampoule 28. Nebule sensor 34 can include an electromechanical switch that contacts the protrusions on the nebule as it is inserted into the feed system. As shown in Figure 5, the nebule includes a helical keying element 46 that interacts with a corresponding helical keying feature (not shown) to position the ampoule within feed system interface 26. As the ampoule is rotated and moved axially downward, the protrusion identification markers will contact and actuate a metal spring-like contact 60 of nebule sensor 34 so as to create a circuit and send an identification electrical signal to controller 30 to identify the type of drug in ampoule 28. As shown in the plan view of Figure 6, nebule sensor 34 can include one or more metal contacts 60, such that rotation of the ampoule 28 can cause the protrusion identification markers to contact the metal contacts 60, 60'. By changing the spacing and number of protrusion identification markers, a unique electrical identification signal can be generated to identify the liquid in the ampoule to the controller. In turn, the controller can then select and run a delivery program that provides an efficient delivery of the identified liquid.
Another exemplary ampoule 28 and feed system interface 26 is illustrated in Figures 7 and 8. As shown in Figure 7, an ampoule bottom end 40 having a keying tab 46 can interact with a spiral slot 48 in the feed system interface 26. As the ampoule is inserted and rotated within the feed system interface 26, the keying element(s) engage the spiral slot 48 so as to pull the ampoule down into the interface (Figure 8). Similar to the above embodiments, the bottom end of the ampoule can protrude through slit seal membrane 52 so as to be able to deliver the liquid to reservoir 42. Identification markers 35 can be sensed by the identification sensors (not shown), as described in the above embodiments.
The ampoule protrusion identification markers 35 can be in a single helix configuration or a double helix configuration. In exemplary embodiments, the identification markers are in a double helix arrangement so that as the first set of protrusions is read, providing a binary code to the system, the second set of protrusions can provide a complementary binary code (read by a second optical detector, not shown) as ampoule 28 is screwed into nebulizer feed system 26 (Figures 2 to 4). Thus, the binary code of the first series of protrusions might, for example, convey the code "1-0-1-0" as each of protrusions are sensed as the ampoule is screwed into the nebulizer feed system housing, while the second series provides the complementary code of "0-1-0-1". In this manner, the controller can check that when a particular binary code is transmitted by the first set of protrusions, the complementary binary code is sensed by the second set of protrusions. Thus, the system can prevent the potential mis-information that might be transmitted were there only a single set of protrusions provided to convey the information, and the insertion was done incorrectly.
Such interaction further allows the system to check against a situation in which one or more ampoule protrusions are damaged to the extent of effecting the sensing function, because the system will have the code provided by the second series of protrusions to check against the information provided by the first set of protrusions.
Alternatively, the second set of protrusions may be used to provide more code combinations for different drugs. In exemplary embodiments, by providing three bumps or protrusions on each side of the ampoule, the controller of the aerosol generator can determine which of 9 drugs or medicants are disposed in the ampoule. For example, the following distribution of bumps or protrusion can deliver a signal to the controller to indicate the identity of the following drugs:
Drug Type Number of Bumps on Side 1 Number of Bumps on Side 2
Drug A 1 0
Drug B 2 0
Drug C 3 0
Drug D 1 1
Drug E 2 1
Drug F 3 1
Drug G 2 2
Drug H 2 3
Drug I 3
In the embodiment illustrated in Figures 2 to 8, the protrusion identification markers 35 are disposed in a helical configuration that has a pitch that substantially matches the pitch of the helical keying element 46, such that as the helical keying element is rotated and moved through the corresponding keying feature 48, the protrusion identification markers pass by the optical sensor 56 or metal contacts 60. It should be appreciated however, that the identification markers 35 can be disposed in a variety of non-helical patterns, as will be described in relation to Figures 9 to 10.
Figure 9 illustrates one exemplary embodiment of an ampoule 28 having identification markers 35 that are disposed in a non-helical arrangement. As illustrated, ampoule includes a keying slot 62 adjacent a bottom end of ampoule 28 to allow the ampoule to be inserted into feed system interface 26. If keying slot 62 does not correspond with the keying tab 64 on the interface, the ampoule will be prevented from being seated within the interface and the liquid in the ampoule will be prevented from being delivered to reservoir 42. In situations where the keying slot matches the keying tab, as ampoule 28 is inserted axially into feed system and twisted to engage the keying slots with the keying tabs, the identification marker 35 will simultaneously pass across nebule sensor 34. The illustrated embodiment includes a bar code reader that reads a bar code identification marker, but it should be appreciated that the identification marker 35 and identification sensor 34 can include any of the other types of identification markers and sensors or their equivalents, as described above.
Figure 10 illustrates an ampoule 28 that includes bump identification markers that are disposed on the ampoule such that axial insertion of the ampoule (without rotation) into the feed system interface 26 contacts the bump identification markers 35 against the electromechanical contacts 60. Ampoule 28 can include a retainer or click positive position feedback element 66, and/or alignment means for aligning the ampoule into the feed system.
Variations to the above description may be made in accordance with the present invention. For example, ampoule 28 can include other keying elements and/or orientation elements to ensure that the ampoule is properly oriented when it is inserted into the aerosolization device. A more detailed description of such keying elements and orientation elements can be found in co-pending U.S. Patent Application 09/812,755, filed March 20, 2001, the complete disclosure of which was previously incorporated herein by reference. In such embodiments, the identification markers 35 can be disposed on the ampoule relative to such keying or orientation elements in any position in which the sensors can sense the markers and determine the type of medicament or drug that is disposed in the ampoule.
Methods of the present invention will now be described. In one method, the present invention identifies the contents of the nebule to improve the operation of the aerosol generator. As illustrated in Figure 11, an aerosol generator is provided (Step 100) and a nebule is coupled to a nebule interface of the aerosol generator (Step 102). An identification marker on the nebule is read by the aerosol generator (Step 104) and the aerosol generator is operated according to an operation program based on the information read from the identification marker on the nebule (Step 106).
Typically, the aerosol generator is operated with a controller (Figure 1). The controller typically includes a memory that stores a plurality of operation programs for delivering each of the compatible specific types of drugs or medication. After the identification marker is read by a sensor, the information is passed to the controller so that a correct operation program can be selected to operate the aerosol generator. The operation program can control the start and stop times of the aerosol generator, the aerosol production rate, the amplitude of vibration of the aerosolization element, the frequency of aerosolization, and the like.
It should be appreciated that, in addition to using the identification marker information to control the operation of the aerosol generator, the information from the identification marker may be used for other purposes. For example, as shown in Figure 1, the systems of the present invention 20 may optionally include an output device 68, such as a printer, audio speaker, or LCD. When the identification information received by the sensor matches a code entry inside the controller memory, the drug name, dosage information, or other pertinent information can be made available to the user by displaying or announcing the information via the attached output devices. Additionally, the identification markers can be used for preventing the wrong drug from being administered to the patient by setting the aerosol generator controller to operate the aerosol generator only on the reception and identification of one or more particular drug codes/identification markers to the exclusion of others: e.g. one patient's nebulizer may be set to accept nebules containing, and coded for, drug A and drug B, while another patient's nebulizer may be set to only operate if a nebule contains, and is coded for, drug A.
Typically, the identification marker is positioned adjacent a sensor through use of a keying element on the nebule. The keying elements can interact with a corresponding keying feature on the aerosol generator interface to position the identification marker adjacent the sensor. In other methods, however, the keying elements on the nebule can be used to control the types of nebules that can be coupled to the aerosol generator system. In such methods, as shown in Figure 12, a nebulizer system and a nebule comprising a nebule body with a keying element (e.g., threads, tabs, slots, and the like) are provided (Steps 110, 112). The nebule can be inserted into the housing. If the keying element is properly keyed with a housing of the nebulizer system, the nebule can access a reservoir of the system (Step 114). Thereafter, the liquid from the nebule will be transferred into the reservoir for aerosolization (Step 116). The aerosol generator can then be operated with a controller to aerosolize the liquid (Step 118).
The keying elements, identification markers, or both can be used to ensure that only nebules which are compatible with the feed system and aerosol generator are used. For example, as a first precaution, the aerosol generator systems of the present invention can include a keying feature that mates only with certain types of nebules. For example, nebules containing steroids may have a different keying element than nebules containing antibiotics. Therefore, patients using the aerosol generator only for steroidal delivery will be prevented from keying the nebule containing an antibiotic to the aerosol generator and inadvertently nebulizing the antibiotic, and vice versa.
Additionally or alternatively, the controller of each individual system can be programmed to only have available sequence delivery programs (which may be referred to as operation sequences, or algorithms for operation sequences) for selected medicants or drugs that are found in a library of codes and drugs in the controller memory. Thus, if the identification marker on a nebule that is coupled to the aerosol generator is not one of the drugs on the list stored in the controller memory, the controller will not deliver the aerosol to the patient. Optionally, the controller can provide an output informing the user that the installed nebule is incompatible with the system.
In other exemplary methods, the present invention can measure the characteristics of a persons inhaled breath, typically a tidal breath, to control the operation of the aerosol generator. As shown in Figure 13, a person can take one or more breaths (Step 120) and the characteristics of the breath can be measured (Step 122). The breathing characteristics that can be measured include, but are not limited to, a breathing pattern, peak inspiratory flow rate, breathing rate, exhalation parameters, regularity of breathing, tidal volume, and the like and can estimate a user's tidal volume based on such information. The user can take another tidal breath and the aerosol generator can be operated based on the measured characteristics of the tidal breath (Step 124). It should be appreciated however, that instead of a tidal breath, the person can take other types of breath. Alternatively, the controller may base the timing of operation of the aerosol generator so that aerosol is generated at specific time periods within a breathing cycle, (Step 125, Figure 13a). For example, the controller may operate the aerosol generator for the first 50 percent of inspiration. Alternatively, the controller may operate the aerosol generator to generate aerosol after a portion of inhalation has taken place and to cease producing aerosol after another portion of inhalation has taken place. For example, the controller may cause aerosol to be generated beginning after 20% of the inspiration has taken place and cause aerosol production to cease after 70% of inspiration has taken place. The controller may cause aerosol production to start after, for example, after 90%) of exhalation has taken place and, for example, cause aerosol production to stop after 30%) of the following inspiration has taken place. By controlling the specific timing within the breathing cycle that aerosolized medication is provided into the breathing circuit, greater efficiency of drug administration can be achieved. With reference to Figs. 15a- 15c, for example, continuous aerosolization may yield only about 10%> to about 15%> efficiency (Fig 15a), aerosolization during the entire inhalation phase of the breathing cycle may yield about 15%) to about 25% efficiency (Fig 15b), and delivery during a predetermined portion of the inhalation phase beginning, for example, at the onset of inhalation, may provide a drug yield between about 60%> to about 80%> efficacy (Fig 15c). Accordingly, the present invention, by controlling delivery to a predetermined percentage of the breathing cycle, such as a predetermined percentage of the inhalation phase of the breathing cycle, provides far greater efficiency than either continuous delivery or delivery during the entire inhalation phase. Further, and surprisingly, the percentage of increase in efficiency in delivery for such a predetermined portion of the inhalation phase (Fig. 15c) over delivery during the entire inhalation phase (Fig. 15b) is itself far greater than the increase in efficiency of delivery during the inhalation phase (Fig. 15b) over simply continuously providing aerosol (Fig. 15a).
By utilizing an aerosol generator that produces aerosol by the electric powering a vibratable member that causes an aperture plate to eject liquid at one face thereof, through its apertures, as a mist from the other face thereof, as generally described above (and as described generally in U.S. Patent Nos. 5,164,740; 5,938,117; 5,586,550; 5,758,637, 6,085,740; and 6,235,177, the complete disclosures of which are, and have been above, incorporated herein by reference), the starting and stopping of aerosol generation may be controlled on the level of accuracy of microseconds or milliseconds, thus providing accurate dosing. The timing of aerosol generation can be done based solely on a predetermined timing within a breathing cycle, on timing in conjunction with the length of a prior breath or portions thereof, on other breathing characteristics, on particular medication being administered, or a combination of any of these criteria (Step 135, Figure 13b).
The aerosolization element may be constructed of a variety of materials, comprising metals, which may be electroformed to create apertures as the element is formed, as described, for example, in U.S. patent No. 6,235,177 assigned to the present assignee and incorporated by reference herein in its entirety. Palladium is believed to be of particular usefulness in producing an electroformed, multi-apertured aerosolization element, as well as in operation thereof to aerosolize liquids. Other metals that can be used are palladium alloys, such as PdNi, with, for example, 80 percent palladium and 20% nickel. Other metals and materials may be used without departing from the present invention. The aerosolization element 70 (referring now to Figs. 16a and 16b) may be configured to have a curvature, as in a dome shape, which may be spherical, parabolic or any other curvature. The aerosolization element may be formed to have a dome portion 73 over its majority, and this may be concentric with the center of the aerosolization element, thus leaving a portion of the aerosolization element that is a substantially planar peripheral ring portion 75. The aerosolization element has a first face 71, a second face 72 and a plurality of apertures 74 (Fig. 16b) therethrough. The first face 71 may comprise the concave side of the dome portion 72 and the second face 72 may comprise the convex side of the dome portion 72 of the aerosolization element 70. The apertures may be tapered to have a narrow portion 76 at the first face 71 and a wide portion 78 at the second face 72 of the aerosolization element 70. Typically, a liquid will be placed at the first face of the aerosolization element, where it can be drawn into the narrow portion 76 of the apertures 74 and emitted as an aerosolized mist or cloud 79 from the wide portion 78 of the apertures 74 at the second face 72 of the aerosolization element 70.
The aerosolization element may be mounted on an aerosol actuator 80, which defines an aperture 81 therethrough. This may be done in such a manner that the dome portion of the aerosolization element protrudes through the aperture 81 of the aerosol actuator 80 and the substantially planar peripheral ring portion 74, on the second face 72 of the aerosolization element 70 abuts a first face 82 of the aerosol actuator 80. A vibratory element 84 may be provided, and may be mounted on the first face 82 of the aerosol actuator 80, or alternatively may be mounted on an opposing second face 83 of the aerosol actuator 80. The aerosolization element may be vibrated in such a manner as to draw liquid through the apertures 74 of the aerosolization element 70 from the first face to the second face, where the liquid is expelled from the apertures as a nebulized mist. The aerosolization element may be vibrated by a vibratory element 84, which may be a piezoelectric element. The vibratory element may be mounted to the aerosol actuator, such that vibration of the vibratory element may be mechanically transferred through the aerosol actuator to the aerosolization element. The vibratory element may be annular, and may surround the aperture of the aerosol actuator, for example, in a coaxial arrangement. In some embodiments of the present invention, the aerosolization element or the aerosol generator comprising the aerosolization element 70, the aerosol actuator 80 and the vibratory element 86 may be replaced with a respective assembly that has apertures of a different size, such as a different exit diameter, to produce a mist having a different aerosol particle size. A circuitry 86 may provide power from a power source. The circuitry may include a switch that may be operable to vibrate the vibratory element and thus the aerosolization element, and aerosolization performed in this manner may be achieved within milliseconds of operation of the switch. The circuitry may include a controller 87, for example, a microprocessor that can provide power to the vibratory element 84 to produce aerosol from the aerosolization element 70 within milliseconds or fractions of milliseconds of a signal to do so. For example, aerosol production may begin within about .02 to about 50 milliseconds of such a signal and may stop within about .02 to about 50 milliseconds from the cessation of a first signal or a second signal either of which may act as a trigger to turn of aerosolization. Similarly, aerosol production may begin and end within about .02 milliseconds to about 20 milliseconds of such respective signaling. Likewise, aerosol production may begin and end within about .02 milliseconds to about 2 milliseconds of such respective signaling. Further, this manner of aerosolization provides full aerosolization with a substantially uniform particle size of low velocity mist 79 being produced effectively instantaneously with operation of the switch.
With reference to Fig. 17, a nebulizer 85, which may have a top portion 93 through which liquid (either directly or within a nebule) may be provided, in accordance with the present invention may be incorporated into a ventilator breathing circuit of a ventilated patient. The breathing circuit may comprise a "Y" connector 88, which may in turn have an inlet portion 89, an endotracheal tube portion 90 and an outlet portion 91. The inlet portion 89 carries air provided from the ventilator 92 toward the patient. The endotracheal tube portion 90 of the Y connector 88 carries the incoming air to the patient's respiratory tract; this direction is represented by arrow a. The endotracheal tube portion 90 also carries the patient's exhalation to the outlet portion 91 of the Y connector 88, and the outlet portion may lead to an exhaust, represented by arrow b, to remove the patient's exhalation from the system. The nebulizer 85 of the present invention aerosolization element generates an aerosol cloud 94 that remains substantially within the inlet portion 89 of the Y connector 88 when there is no inspiratory air flowing through the inlet portion, by virtue of the aerosolization element, as described above, producing a low velocity mist. In this manner, aerosol that is generated when there is no inhalation air being provided will not be carried out through the outlet portion 91 of the Y connector and lost to the ambient environment. Accordingly, a dose of aerosolized medication may be preloaded, i.e., produced and placed substantially within the inlet portion 89 prior to an inhalation phase being sent by the ventilator 92. In this manner, such medication can be swept into a patient's respiratory system at the very start of the inhalation cycle. This may be of particular benefit in the case of neonatal patients and in other instances in which only the initial blast of inhalation phase will reach the target portion of the respiratory system.
The switch, described above, may be operable by a pressure transducer, which may be positioned in the mouthpiece of the nebulizer. The pressure transducer may be in electrical communication with the circuitry, and a microprocessor may also be in electrical communication with the circuitry, and the microprocessor may interpret electrical signals from the pressure transducer, and may also operate the switch to begin aerosolization. In this manner, nebulization can begin substantially instantaneously with the inhalation of a user upon the mouthpiece. An example of such a sensor switch can be found in co-assigned and co-pending U.S. application Ser. No. 09/705,063 assigned to the present assignee, the entire content of which is hereby incorporated herein by reference.
Another transducer may be used to sense the absence or presence of liquid in the reservoir, by sensing, for example, a difference between vibration characteristics of the aerosolization element, such as, for example, differences in frequency or amplitude, between wet vibration and substantially dry vibration. In this manner, the circuitry, may, for example by way of the microprocessor, turn the vibration off when there is essentially no more liquid to aerosolize, i.e., when the end of the dose has been achieved, thus minimizing operation of the aerosolization element in a dry state. Likewise, the switch may prevent vibration prior to delivery of a subsequent dose into the reservoir. An example of such a switch is shown in co- assigned and co-pending U.S. application Ser. No. 09/805,498, the entire content of which is hereby incorporated herein by reference.
As shown schematically in Figure 14, in exemplary embodiments, the aerosol generator controllers of the present invention can be coupled to both a nebule identification sensor and a breathing characteristic sensor so as to identify the liquid that is delivered to the aerosol generator and to monitor the breathing characteristics of the patient (Steps 130 to 140). In such embodiments, the aerosol generator can be operated (and a pre-programmed delivery program can be selected) to run the aerosol generator, based at least in part on the information obtained from the identification sensor and breathing characteristic sensor (Step 140).
If it is known what type of medication or drug is being delivered, the controller can select the best time during the patient's breathing cycle to deliver the aerosol, based upon a predetermined regimen for that drug that is stored in memory. As an additional benefit, an estimate of the patient's age and/or distress can be made, for example, by measuring the tidal volume and breathing rate. Such measurements can influence the efficiency requirements of the dose per breath. These or other variables can be used in establishing various regimes for aerosol delivery, in particular delivery into the breathing circuit of a ventilator. These regimes can be stored in memory and then accessed by the controller as appropriate for a given patient condition. For example, for a bronchodilator the best time to delivery may be halfway through the inhalation phase of a breath when impaction would be reduced since inhalation flows are reducing. For steroids, it may be best to deliver towards the end of the inhalation phase of a breath. For antibiotics, it may be best to slightly pre-load, i.e. deliver aerosol during the exhalation phase, or deliver right at the start of the breath. For example, antibiotics may be delivered at the beginning of a ventilator provided inhalation, and the aerosol delivery may stop after a predetermined percentage of the inhalation has been provided. One class of antibiotics that may be administered in accordance with the present invention is the class known as the aminoglycoside class of antibiotics. This class of antibiotics has typically been administered intravenously, however, such delivery may have unwanted side effects, which may be systemic. An object of the present invention is the administration of antibiotics, such as aminoglycosides including amikacin by delivering it in aerosolized form into the breathing circuit of a patient on a ventilator. In this manner, amikacin can be used to treat pulmonary infection conditions that typically arise when patients are mechanically ventilated, and the amikacin, or other aminoglycoside or other antibiotic, can be delivered directly to the target of treatment, the pulmonary tract, avoiding side effects that may otherwise arise from intravenous administration. Further, because of the great cost of such drugs, far greater efficiency is achieved through this pulmonary delivery. As noted above, with reference to Fig 15c, delivery of aerosol during a beginning percentage of the inhalation phase of a breathing cycle may yield up between about 60%> and about 80%> efficiency, an this is significantly higher than efficacy of continuous aerosolization or aerosolization for an entire inhalation phase of an inhalation cycle.
As described above, various regimes of aerosolization can be followed, depending on the situation. For example, in Fig 18, a selection between a first, second and third regime is shown. A regime may be selected manually or automatically, for example, through the application of an algorithm that selects an operation program based on information that is either input or stored. For manual selection, a user may operate a mechanical switch to select a regime, or may enter such a selection into an electronic input device, such as a keyboard. Alternatively, the controller may automatically choose a regimen, as described above, by matching a drug code on a drug nebule with a library of drug-regimen combinations. (It should be noted that in Figs. 18, 19 and 20, schematic flow charts of operation sequence algorithms are depicted. Although items therein will be referred to as steps for ease of discussion, they refer more broadly herein to states of operations or modalities in which a system may exist or cycle through. Steps depicted in a rectangle are essentially states of operation, actions or modalities. Steps depicted in diamonds indicate either a selection or the continuance of the previous state of operation, action or modality until a predetermined condition is satisfied. Two successive diamonds refer to satisfaction of a first condition and of a second condition respectively, the second of which may be a subset of the first.)
In step 200, a choice is made to follow a particular regime. In this case, regime I is a regime in which aerosol is generated continuously (step 202). Regime II provides aerosol generation during the inhalation phase only (step 204). In this case, in step 206, aerosol generation is set to start at the start of the inhalation phase and, in step 208, aerosol generation is set to stop when the inhalation phase stops. In step 210, aerosol generation begins at the start of the inhalation phase. In step 212, when the inhalation phase ends, aerosol generation stops (step 214).
Regime III provides for inhalation during a predetermined percentage of the inhalation phase (step 216). A predetermined percentage of an inhalation (or exhalation) phase may be based on a measured time from a discrete point in the ventilator cycle, such as the instantaneous commencement of inspiratory air generation by the ventilator. Alternatively, such predetermined percentage may be based on the time interval between successive discrete points in the ventilator, such as successive commencements of successive inhalation air generation by the ventilator. Alternatively, such percentages may be based upon air pressure in the ventilator circuit, or any other parameter. With respect to Regime III, in this case, in step 218, a first predetermined point is set to correspond with the completion of a first predetermined percent of the inhalation. In step 220, a second predetermined point is set to correspond to a second predetermined percent of inhalation percent being completed. For example, as described above, the first predetermined point may correspond to 20%> of the inhalation phase being completed, and the second predetermined point may correspond to a point at which 70%> of that same inhalation has taken place. In step 222, aerosol generation begins at the first predetermined point in the inhalation phase. In step 224, when the second predetermined point is reached, the controller carries out step 214 and stops the aerosol generation.
Similarly, as noted above, other regimes may be followed, for example, in which aerosol generation begins during the inhalation phase and ends during the exhalation phase, or begins during exhalation and ends during that exhalation, or begins during exhalation and ends in the subsequent breath cycle, for example, at a predetermined point in the subsequent inhalation phase. Accordingly, turning to Fig. 19, a selection may be made, at step 230, between regimes II (step 232) and III (step 234) as described above, and another regime, regime IV (steps 236 - 242), which is also available for selection. In regime IV, aerosol generation may begin at a first predetermined point (step 236), and this first predetermined point may be after a predetermined percentage of the inhalation phase has taken place, or it may be a predetermined point after the inhalation phase has been completed. For example, this point may be a predetermined point after a predetermined percent of the exhalation phase has taken place, or may be a predetermined point prior to the start of the subsequent inhalation phase. Aerosol generation may stop during exhalation (regime IVa, step 238), at the completion of exhalation (regime IVb, step 240), or aerosol generation may continue into the next breath cycle (regime IVc, step 242), and stop, for example, after a predetermined point during the subsequent inhalation phase.
In this example, with the controller having a selection choice between operation sequences corresponding to regimes II, III and IV, schematic representation of the operation sequences are shown in Fig. 20. In step 250, a regime is selected. In step 252, the aerosol generator controller selects an operation sequence based on selected regime. In step 254 , the controller receives a signal indicating that ventilator has begun to supply an inhalation phase. The signal, as described above, may be a signal provided directly by the ventilator. Alternatively, the signal may be provided by a sensor, and such sensor may sense the commencement of an inhalation phase provided by the ventilator, as described above, by sensing a pressure change in the breathing circuit. In step 256, the controller carries out selected operation sequence. In the case of regime II (step 258), the controller turns on aerosol generator upon commencement of inhalation phase provided by the ventilator. The controller continues to operate the aerosol generator until a point at which the inhalation phase completed (step 260). In step 262, controller turns off aerosol generator.
In the case of regime III, the controller does not take any action to begin aerosol generation, until a predetermined point in the inhalation phase, corresponding to a percentage of the inhalation phase being completed (step 264). In step 266, at a predetermined point in the inhalation phase, the controller turns on aerosol generator. In step 268, aerosol generation continues until a second predetermined point inhalation phase, corresponding to a second percentage point of completion of the inhalation phase. At this point, the controller carries out step 262 and turns off aerosol generator. With respect to regime IV, aerosol generation begins after a predetermined point of completion of the inhalation phase (step 264) and this point may be predetermined to occur after the inhalation phase has been completed and the exhalation phase has begun (step 270). In step 272, the controller turns the aerosol generator on to begin aerosolization. Variations can be made as to the point at which the aerosol generation is turned off. If it is desired that aerosol generation be completed before the completion of the exhalation phase (regime IVa), then aerosol generation may continue until a predetermined point prior to the subsequent inhalation (step 276). Alternatively, it may be desirable to continue aerosolization until the end of exhalation, which may correspond to the point of commencement of the subsequent inhalation, as in regime INb (step278). Alternatively, it may be desired to follow a regimen such as regime IVc, where aerosol generation continues through into the subsequent breath cycle (step 280), until, for example, a predetermined percent of the subsequent inhalation phase has been completed (step 282). In these regimes, aerosolization will continue until the satisfaction of these conditions (step 276 for regime IVa, step 278 for regime IVb or step 282 for regime IVc), at which point the controller carries out step 262 and stops the aerosol generator. The process may continue with the next signal indicating that the ventilator has begun to provide an inhalation phase, step 254.
Further, the choice of which operating sequence to follow may rely at least in part on the identity of a drug to be administered, which information can be considered by the controller as described above. In addition, it should be appreciated that modifications may be made to these examples without departing from the present invention. For example, a system may be configured, or a method may be carried out, to be able to select more than three initial regimes to follow. For example, regimes I, II, III and TV as described above may be simultaneously selectable. Further, various steps may be altered; for example, some steps may not be discrete steps. Thus, step 256 may not be a discrete step but rather the following of an operation sequence according to a selected regime. Similarly, the order of the steps may be changed, such as the controller may select an operating sequence (step 252) after receiving a signal that the ventilator has commenced to provide an inhalation phase (step 254). Steps may also be combined, such as, for example, in regime TV steps 264 and 270 may be combined as a single step, as these two steps represent successive criteria for the determining a single first predetermined point has been met. Likewise, step 274 may be combined with steps 276, 278 or 280, as step 274 is the predicate for the condition test specified in each of the other successive tests, steps 276, 278 or 280. The algorithm examples may be altered to form other operating sequences. For example, an operating sequence may call for the controller to start aerosol generation at the start of the inhalation cycle provided by the nebulizer, as in regime II, at step 258, and turn off the aerosol generator at a point at which a predetermined percentage of the inhalation phase has been completed, as in regime III, step 268 (and step 262). In a similar manner, other criteria may be used to trigger the turning on or off of the aerosol generator. For example, as described above, the start of aerosolization may be triggered by the sensing of a particular pressure or change in pressure in the ventilator circuit, and may end by following the turning off sequence of regimes III (steps 268 and 262) or IV (steps 274, 276, 278 or 280 and 282, followed by step 262, as described above.
Figure 21 is a schematic representation of an algorithm by which an operating sequence, for providing nebulized drug to a patient receiving air from a ventilator, may be chosen based on the combination of a plurality of independent sets of information, in this case, drug identity and a signal from the ventilator. In step 300, a library of drug regimes is provided, the library based on various drugs that may be administered. In step 302, the identity of a particular drug is provided to the system, and this may be provided, as described above, by a marker on a nebule containing the drug, the marker being read by the system. In step 304, the controller looks up a regime from the library of stored regimes to select a regime based on the particular drug to be administered. In step 306, the controller receives a signal from the ventilator. In step 308, the controller then chooses an operation sequence based in part on the drug identity and drug regime and in part on the independent information provided by the signal from the ventilator. In step 310, the controller carries out the operation sequence, which may be producing aerosol at a predetermined interval in the ventilation cycle based on the drug and the regime provided for the drug factored in with the inhalation cycle of the ventilator. These descriptions are illustrative, and accordingly, the order of the steps may be altered, and other variations, additions and modifications, as described above, may be made still in accordance with the present invention.
While all the above is a complete description of the preferred embodiments of the inventions, various alternatives, modifications, and equivalents may be used. Accordingly, although the foregoing invention has been described in detail for purposes of clarity of understanding, it will be obvious that certain modifications may be practiced within the scope of the appended claims.

Claims

WHAT IS CLAIMED IS:
1. A method of creating an aerosol, the method comprising: providing an aerosol generator; coupling a nebule to an interface of the aerosol generator; reading an identification marker on the nebule; and operating the aerosol generator according to an operation program based on the information read from the identification marker on the nebule.
2. A method as in claim 1 wherein operating comprises selecting the operating program from a plurality of stored operation programs.
3. A method as in claim 1 comprising informing a user of the type of liquid based on the information read from the identification marker.
4. A method as in claim 3 wherein information comprises displaying the type of liquid on an output display.
5. A method as in claim 1 wherein the identification marker comprises a bar code, wherein reading comprises reading the bar code with a bar code reader.
6. A method as in claim 1 wherein the identification marker comprises a protrusion, wherein reading comprises sensing the protrusions with an optical sensor.
7. A method as in claim 1 wherein the identification marker comprises a protrusion, wherein reading comprises contacting a sensor against the protrusion.
8. A method as in claim 1 wherein coupling comprises opening a sealing membrane with the nebule.
9. A method as in claim 1 wherein coupling comprises engaging at least one helical thread of the nebule with a threaded feature of the interface.
10. A method as in claim 9 wherein the identification markers are disposed in a helical configuration that follows a pitch of the helical thread(s).
11. A method of nebulizing a liquid, the method comprising: taking one or more breaths; measuring at least one breath characteristic; taking a subsequent breath; and operating an aerosol generator based on one or more of the measured breath characteristics.
12. A method as in claim 11 further comprising identifying a liquid in the aerosol generator and further modifying the operation of the aerosol generator based on the identification of the liquid in the aerosol generator.
13. A method as in claim 11 wherein the breath is a tidal breath.
14. A method as in claim 13 wherein identifying is carried out upon insertion of the nebule into a housing of the aerosol generator.
15. A method as in claim 11 wherein measuring comprises monitoring at least one of a group consisting of: breathing pattern, one or more discrete time points in a breath cycle, peak inspiratory flow rate, breathing rate, exhalation parameters, regularity of breathing, and tidal volume.
16. A method as in claim 11 wherein operating comprises controlling the start and stop times of the aerosol generator.
17. A method as in claim 11 wherein operating comprises establishing an operating program based on the measured breathing characteristics.
18. A method as in claim 17, wherein the operating program controls start and stop times of the aerosol generator.
19. A method of creating an aerosol, the method comprising: providing an aerosolization element comprising a first face, a second face, and a plurality of apertures therethrough; providing a vibratory element in mechanical communication with the aerosolization element such that vibration of the vibratory element may cause the aerosolization element to vibrate; providing an interface to receive a nebule in such a manner that fluid from the nebule may be deposited on the first face of the aerosolization element; coupling a nebule to an interface of the aerosol generator; reading an identification marker on the nebule; and vibrating the aerosolization element generator according to an operation program based on the information read from the identification marker on the nebule.
20. A method as in claim 19 wherein operating comprises selecting the operating program from a plurality of stored operation programs.
21. A method as in claim 19 comprising informing a user of the type of liquid based on the information read from the identification marker.
22. A method as in claim 19 wherein information comprises displaying the type of liquid on an output display.
23. A method as in claim 19 wherein the identification marker comprises a bar code, wherein reading comprises reading the bar code with a bar code reader.
24. A method as in claim 19 wherein the identification marker comprises a protrusion, wherein reading comprises sensing the protrusions with an optical sensor.
25. A method as in claim 19 wherein the identification marker comprises a protrusion, wherein reading comprises contacting a sensor against the protrusion.
26. A method as in claim 19 wherein coupling comprises opening a sealing membrane with the nebule.
27. A method as in claim 19 wherein coupling comprises engaging at least one helical thread of the nebule with a threaded feature of the interface.
28. A method as in claim 27 wherein the identification markers are disposed in a helical configuration that follows a pitch of the helical thread(s).
29. A method of nebulizing a liquid, the method comprising: providing a vibratory aerosolization element comprising a first face, a second face, and a plurality of apertures therethrough; taking one or more breaths; measuring at least one breath characteristic; taking a subsequent breath; providing liquid to the first face of the aerosolization element; and vibrating the aerosolization element based on one or more of the measured breath characteristics.
30. A method as in claim 29 further comprising: identifying a liquid provided to the aerosolization element; and basing the operation of the aerosol generator based on the identification of the liquid in the aerosol generator.
31. A method as in claim 29 wherein the breath is a tidal breath.
32. A method as in claim 31 wherein identifying is carried out upon insertion of the nebule into a housing within which the aerosolization element is situated .
33. A method as in claim 29 wherein measuring comprises monitoring at least one of a group consisting of: breathing pattern, one or more discrete time points in a breath cycle, peak inspiratory flow rate, breathing rate, exhalation parameters, regularity of breathing, and tidal volume.
34. A method as in claim 29 wherein operating comprises controlling the start and stop times of vibration of the aerosolization element.
35. A method as in claim 29 wherein operating comprises establishing an operating program based on the measured breathing characteristics.
36. A method as in claim 35, wherein the operating program controls start and stop times of vibration of the aerosolization element.
37. A method for nebulizing a liquid, comprising: providing a nebulizer system comprising a housing, an aerosol generator, a controller coupled to the aerosol generator, and a reservoir in communication with the aerosol generator; providing a nebule comprising a nebule body configured to hold a liquid, wherein the nebule body comprises a key element; inserting the nebule into the housing, wherein the key element provides access to the reservoir when properly keyed with the housing; transferring the liquid from the nebule into the reservoir; and operating the aerosol generator with the controller to aerosolize the liquid.
38. A method as in claim 37, wherein the nebulizer further comprises a slit seal membrane disposed over the reservoir, wherein insertion of the nebule into the housing provides communication from the nebule, through the slit seal membrane, to the reservoir.
39. A method as in claim 37, wherein the housing includes a tab, wherein the key element comprises a slot, and wherein insertion of the nebule causes the tab to fit within the slot when properly keyed.
40. A method as in claim 37, wherein the aerosol generator comprises a plate having a plurality of apertures, and wherein the aerosol generator operating step comprises vibrating the plate
41. A method as in claim 40, wherein the aerosol generator plate comprises a curvature.
42. A method as in claim 40, wherein the plate comprises a dome shape.
43. A method as in claim 37 wherein the key element is a helical thread, and the housing comprises a threaded feature, wherein inserting the nebule comprises rotating the nebule.
44. A method as in claim 37 comprising identifying the liquid disposed within the nebule, and modifying the operation of the aerosol generator based on the type of liquid identified.
45. A method for nebulizing a liquid, comprising: providing a nebulizer system comprising a housing, an aerosol generator, the aerosol generator comprising an aerosolization element having a first face, a second face and a plurality of apertures therethrough, a vibratory element, a controller coupled to the vibratory element, and a reservoir in fluid communication with the first face of the aerosolization element of the aerosol generator; providing a nebule comprising a nebule body, the nebule body configured to hold a liquid, and a key element; inserting the nebule into the housing, wherein the key element provides access to the reservoir when properly keyed with the housing; transferring the liquid from the nebule into the reservoir; and - operating the aerosol generator with the controller controlling vibration of the vibratory element to draw liquid through the apertures of the aerosolization, from the first face to the second face, to aerosolize the liquid.
46. A method as in claim 45, wherein the nebulizer further comprises a slit seal membrane disposed over the reservoir, wherein insertion of the nebule into the housing provides communication from the nebule, through the slit seal membrane, to the reservoir.
47. A method as in claim 45, wherein the housing includes a tab, wherein the key element comprises a slot, and wherein insertion of the nebule causes the tab to fit within the slot when properly keyed.
48. A method as in claim 45 wherein the key element is a helical thread, and the housing comprises a threaded feature, wherein inserting the nebule comprises rotating the nebule.
49. A method as in claim 45 comprising identifying the liquid disposed within the nebule, and modifying the operation of the aerosol generator based on the type of liquid identified.
50. A method as in claim 45 comprising monitoring at least one breathing characteristic of a user and modifying the operation of the aerosol generator based on the user's breathing characteristics.
51. A method as in claim 45 comprising monitoring breathing characteristics of a user and modifying the operation of the aerosol generator based on the user's breathing characteristics.
52. A method for nebulizing a liquid, the method comprising: providing a nebulizer comprising a housing having a gas flow passageway, and aerosol generator, a controller, and a reader; placing a nebule having a liquid into the housing; reading an identification marker on the nebule with the reader to identify the liquid; transferring liquid from the nebule to the aerosol generator; and operating the aerosol generator with the controller using an operation program selected by the controller based on the identified liquid to provide an aerosolized liquid in the gas flow passage.
53. A method as in claim 52, wherein the operation program controls start and stop times for the aerosol generator
54. A method as in claim 52, wherein the operation program controls aerosol production rates of the aerosol generator.
55. A method as in claim 52, wherein the operation program selected by the controller is selected from a plurality of stored operation programs.
56. A method as in claim 55, wherein the plurality of operation programs are indexed to one or more liquids.
57. A method as in claim 56, wherein the selection of an operation program is based on identifying the liquid in the ampoule as on one of the indexed liquids, and further comprising selecting an operation program indexed to that identified liquid.
58. A method as in claim 52, further comprising: inhaling through the passageway to produce a gas flow through the passageway; sensing the gas flow with a sensor; and modifying the operation of the aerosol generator based on the characteristics of the gas flow information measured by the sensor.
59. A method of nebulizing a liquid, the method comprising: providing an aerosol generator; delivering a fluid from a nebule to the aerosol generator; reading an identification marker on the nebule; measuring one or more breathing characteristics of the patient's breath; and operating the aerosol generator based on the information read from the identification marker on the nebule and the one or more measured breathing characteristics of the patient.
60. A method as in claim 59 wherein coupling comprises keying the nebule with the interface, wherein the nebule can deliver fluid to the aerosol generator only if the nebule is properly keyed to the interface.
61. A method as in claim 59 wherein delivering fluid comprises passing a bottom end of the nebule through a slit seal membrane.
62. A method identifying a liquid that is to be delivered to an aerosolization device, the method comprising: inserting an ampoule into an ampoule interface of an aerosol generator; rotating a threaded element on the ampoule into engagement with a corresponding threaded feature in the interface so as to pass an identification marker by a sensor; and sensing the identification marker on the ampoule to identify the liquid in the ampoule.
63. A method as in claim 62 comprising pushing a tip of the ampoule through a slit seal during rotating.
64. A method as in claim 62 wherein sensing comprises reflecting a light off of the markers and detecting the reflected light.
65. A method as in claim 64 wherein the marker comprises at least one protrusion.
66. A method as in claim 64 wherein the at least one protrusion is disposed in a helical pattern that coincides with a pitch of the threaded element.
67. A method as in claim 62 wherein sensing comprises mechanical contact between an identification marker and an adjacent electromechanical sensor.
68. A method as in claim 62 wherein rotating and sensing are carried out simultaneously.
69. An aerosol generator system comprising: an aerosol generator comprising an interface; a sensing device coupled to the aerosol generator; and an ampoule that is attachable to the interface, wherein the ampoule comprises at least one identification marker that can be detected by the sensing device.
70. An aerosol generator system according to claim 69, wherein the interface is configured to receive the ampoule in such a manner that at least one identification marker reaches a proximity of the sensing device sufficient for the sensing device to sense the identification marker.
71. The aerosol generator of claim 69 comprising a controller coupled to the sensing device and to the aerosol generator, wherein the controller operates the aerosol generator based on the identification marker detected by the sensing device.
72. The system of claim 69 wherein the ampoule comprises a helical shaped thread that can threadedly attach to a threaded interior of the interface.
73. The system of claim 72 wherein the markers are disposed in a helical configuration that follows the pitch of the helical shaped thread.
74. The system of claim 69 wherein the sensing device comprises a lightsource and an optical detector.
75. The system of claim 74 wherein the markers comprise a double helical shape.
76. The system of claim 69 wherein the marker comprises a series of protrusions.
77. A nebulizer system comprising: a housing defining a passageway that is adapted to deliver an aerosolized liquid to a user; an aerosol generator disposed to provide an aerosolized liquid into the passageway; a controller having a memory and a plurality of aerosol generator operation programs that control operation of the aerosol generator; and a reader that is configured to read an identification marker on a nebule having a supply of liquid for the aerosol generator, and to send information from the identification marker to the controller, wherein the controller is further configured to operate the aerosol generator according to one of the operation programs based on the information from the marker.
78. A nebulizer system as in claim 77, further comprising a flow sensor that is adapted to sense gas flows through the passageway and to send gas flow information to the controller, and wherein the controller is further configured to control operation of the aerosol generator based on the gas flow information.
79. A nebulizer system as in claim 77, wherein the operation programs are configured to control start and stop times for the aerosol generator.
80. A nebulizer as in claim 77, wherein the identification marker includes a bar code.
81. A nebulizer system as in claim 77, wherein the operation programs are configured to control aerosol production rates of the aerosol generator.
82. A nebulizer system as in claim 77, wherein the controller is configured to estimate a user's tidal volume based on the gas flow information and to select one of the operation programs based on the tidal volume.
83. A nebulizer as in claim 77, wherein the aerosol generator comprises a plate having a plurality of apertures and a vibratable element to vibrate the plate.
84. A nebulizer system comprising: a housing defining a passageway that is adapted to deliver an aerosolized liquid to a user; an aerosol generator disposed to provide an aerosolized liquid into the passageway; a flow sensor disposed to sense gas flows through the passageway; and a controller that is configured to determine at least one characteristic of user inhalation based on information from the flow sensor and to control operation of the aerosol generator based on the user inhalation characteristic.
85. A nebulizer system as in claim 84, wherein the inhalation characteristic is selected from a group consisting of breathing patterns, one or more discrete points in a breathing cycle, peak inspiratory flow rate, breathing rate, exhalation parameters, regularity of breathing, and tidal volume.
86. A nebulizer system as in claim 84, wherein the controller is configured to control start and stop times for the aerosol generator based on the inhalation characteristic.
87. A nebulizer system as in claim 84, wherein the controller is configured to control aerosol production rates of the aerosol generator based on the inhalation characteristic.
88. A nebulizer system as in claim 84, further comprising a reader that is configured to read an identification marker on a nebule having a supply of liquid for the aerosol generator, and wherein the controller is further configured to control operation of the aerosol generator based on identification information from the reader.
89. A nebulizer system as in claim 84, wherein the aerosol generator comprises a plate having a plurality of apertures and a vibratable element to vibrate the plate.
90. A nebule comprising: a nebule body holding a liquid that is adapted to be supplied to an aerosol generator of a nebulizer; and an identification marker on the nebule body, the identification marker having information identifying the liquid, wherein the identification marker is readable by the nebulizer to control operation of the aerosol generator based on the information.
91. A method of creating an aerosol, the method comprising: providing an aerosolization element comprising a first face, a second face, and a plurality of apertures therethrough; providing a vibratory element in mechanical communication with the aerosolization element such that vibration of the vibratory element may cause the aerosolization element to vibrate; providing an interface to receive a nebule in such a manner that fluid from the nebule may be deposited on the first face of the aerosolization element; coupling a nebule to an interface of the aerosol generator; reading an identification marker on the nebule; and vibrating the aerosolization element generator according to an operation program based on the information read from the identification marker on the nebule.
92. A method as in claim 91 wherein operating comprises selecting the operating program from a plurality of stored operation programs.
93. A method as in claim 91 comprising informing a user of the type of liquid based on the information read from the identification marker.
94. A method as in claim 93 wherein information comprises displaying the type of liquid on an output display.
95. A method as in claim 91 wherein the identification marker comprises a bar code, and wherein the reading comprises reading the bar code with a bar code reader.
96. A method as in claim 91 wherein the identification marker comprises a protrusion, wherein reading comprises sensing the protrusions with an optical sensor.
97. A method as in claim 91 wherein the identification marker comprises a protrusion, wherein reading comprises contacting a sensor against the protrusion.
98. A method as in claim 91 wherein coupling comprises opening a sealing membrane with the nebule.
99. A method as in claim 91 wherein coupling comprises engaging at least one helical thread of the nebule with a threaded feature of the interface.
100. A method as in claim 99 wherein the identification markers are disposed in a helical configuration that follows a pitch of the helical thread(s).
101. A method of nebulizing a liquid, the method comprising: providing an aerosolization element comprising a first face, a second face, and a plurality of apertures therethrough; taking one or more breaths; measuring at least one breath characteristic; taking a subsequent breath; providing liquid to the first face of the aerosolization element; and vibrating the aerosolization element based on one or more of the measured breath characteristics.
102. A method as in claim 101 further comprising identifying a liquid in the aerosol generator and further modifying the operation of the aerosol generator based on the identification of the liquid provided to the aerosolization element.
103. A method as in claim 101 wherein the breath is a tidal breath.
104. A method as in claim 103 wherein identifying is carried out upon insertion of the nebule into a housing within which the aerosolization element is situated.
105. A method as in claim 101 wherein measuring comprises monitoring at least one of a group consisting of: breathing pattern, one or more discrete time points in a breath cycle, peak inspiratory flow rate, breathing rate, exhalation parameters, regularity of breathing, and tidal volume.
106. A method as in claim 101 wherein operating comprises controlling the start and stop times of vibration of the aerosolization element.
107. A method as in claim 101 wherein operating comprises establishing an operating program based on the measured breathing characteristics.
108. A method as in claim 107, wherein the operating program controls start and stop times of vibration of the aerosolization element.
109. A nebulizer system comprising: a housing defining a passageway that is adapted to deliver an aerosolized liquid to a user, wherein the housing further includes an nebule interface; an aerosol generator disposed to provide an aerosolized liquid into the passageway; a reservoir in the housing that is configured to hold liquid for the aerosol generator; a slit seal membrane disposed over the reservoir; and a nebule having a supply of liquid and a key that is configured to interface with the nebule interface and configured to protrude through the slit seal membrane when properly interfaced with the housing, whereby the slit seal membrane is opened to permit the liquid to be transferred from the nebule and into the reservoir.
110. A nebulizer as in claim 109, wherein the key comprises a slot in the nebule, and wherein the nebule interface comprises a tab that fits within the slot.
111. A nebulizer as in claim 109, wherein the aerosol generator comprises a plate having a plurality of apertures and a vibratable element to vibrate the plate.
112. A system for providing air with nebulized liquid to a patient receiving air from a ventilator, comprising: a ventilator; a ventilator circuit configured to deliver air from the ventilator to a patient; a nebulizer positioned to emit an aerosol into the ventilator circuit and a stream of air coming from the ventilator, the nebulizer comprising: a vibratory element; an aerosolizing element having a first face, a second face and a plurality of apertures therethrough; an actuator in mechanical communication with the vibratory element and with the aerosolizing element, such that a liquid at one face of the aerosolizing element can be drawn through the apertures and be emitted from the other face as an aerosol upon vibration of the vibratory element; and an electronic circuitry in electrical communication with the vibratory element such that upon a predetermined amount of electric current traveling within the electronic circuitry the vibratory element will be caused to vibrate; wherein the circuitry is configured to control vibration of the vibratory element between a resting state, in which substantially no aerosol would be produced by the nebulizer, and an active state, in which the vibratory element will vibrate such that aerosol would be produced by the nebulizer, based on an electrical signal provided to the vibratory element from the electronic circuitry.
113. The apparatus of claim 112 wherein the electronic circuitry can control operation of the nebulizer from substantially no aerosol being produced to aerosol being produced in a period of about 0.02 and about 50 milliseconds.
114. The apparatus of claim 112 wherein the electronic circuitry can control operation of the nebulizer from substantially no aerosol being produced to aerosol being produced in a period of about 0.2 and about 50 milliseconds.
115. The apparatus of claim 112 wherein the electronic circuitry can control operation of the nebulizer from substantially no aerosol being produced to aerosol being produced in a period of about 2 and about 50 milliseconds.
116. The apparatus of claim 112 wherein the electronic circuitry can control operation of the nebulizer from substantially no aerosol being produced to aerosol being produced in a period of about 0.02 and about 20 milliseconds.
117. The apparatus of claim 112 wherein the electronic circuitry can control operation of the nebulizer from substantially no aerosol being produced to aerosol being produced in a period of about 0.2 and about 20 milliseconds.
118. The apparatus of claim 112 wherein the electronic circuitry can control operation of the nebulizer from substantially no aerosol being produced to aerosol being produced in a period of about 0.02 and about 2 milliseconds.
119. The apparatus of claim 112 wherein the electronic circuitry can control operation of the nebulizer from aerosol being produced to substantially no aerosol being produced in a period of about 0.02 and about 50 milliseconds.
120. The apparatus of claim 112 wherein the electronic circuitry can control operation of the nebulizer from aerosol being produced to substantially no aerosol being produced in a period of about 0.2 and about 50 milliseconds.
121. The apparatus of claim 112 wherein the electronic circuitry can control operation of the nebulizer from aerosol being produced to substantially no aerosol being produced in a period of about 2 and about 50 milliseconds.
122. The apparatus of claim 112 wherein the electronic circuitry can control operation of the nebulizer from aerosol being produced to substantially no aerosol being produced in a period of about 0.02 and about 20 milliseconds.
123. The apparatus of claim 112 wherein the electronic circuitry can control operation of the nebulizer from aerosol being produced to substantially no aerosol being produced in a period of about 0.2 and about 20 milliseconds.
124. The apparatus of claim 112 wherein the electronic circuitry can control operation of the nebulizer from aerosol being produced to substantially no aerosol being produced in a period of about 2 and about 20 milliseconds.
125. The apparatus of claim 112 wherein the electronic circuitry can control operation of the nebulizer from aerosol being produced to substantially no aerosol being produced in a period of about 0.02 and about 2 milliseconds.
126. The apparatus of claim 112 wherein the electronic circuitry can control operation of the nebulizer from aerosol being produced to substantially no aerosol being produced in a period of about 0.2 and about 2 milliseconds.
127. The apparatus of claim 112 wherein the ventilator is configured to produce a continuous flow of air.
128. The apparatus of claim 112 wherein the ventilator is configured to generate inspiratory air for a predetermined time and cycle between generating inspiratory air and not generating inspiratory air at a predetermined frequency.
129. The apparatus of claim 112 wherein the ventilator is configured to produce inspiratory air for a predetermined time upon a patient's effort to begin an inspiration.
130. The apparatus of claim 112 wherein the ventilator is further configured to produce a constant basal level of inspiratory air when the ventilator is not producing inspiratory air in response to a patient's effort to begin an inspiration, and then produce inspiratory air for a predetermined time upon a patient's effort to begin an inspiration.
131. The apparatus of claim 112, wherein the nebulizer further comprises a pressure transducer that comprises a first location and a second location and which is configured to send a signal based on a predetermined sensed pressure differential between the first location and the second location.
132. The apparatus of claim 131, wherein the first location and the second location are within the breathing circuit.
133. The apparatus of claim 131, wherein the first location and the second location are in fluid communication with breathing circuit, such that air may flow from the first location to the second location based on air flowing from the ventilator to the patient.
134. The apparatus of claim 112, wherein the circuitry is configured to control vibration of the vibratory element between the resting state and the active state based on an electrical signal provided to the vibratory element from the electronic circuitry based at least in part on the state of production of air by the ventilator.
135. The apparatus of claim 131, wherein the nebulizer further comprises a pressure transducer that comprises a first location and a second location and which is configured to send a signal based on a predetermined sensed pressure differential between the first location and the second location, and wherein the pressure differential is based at least in part on a predetermined velocity of air provided by the ventilator.
136. The apparatus of claim 134, wherein the electronic circuitry is configured to activate vibration of the vibratory element of the nebulizer based on a first predetermined pressure differential and to stop vibration of the vibratory element of the nebulized based on a second predetermined pressure differential.
137. The apparatus of claim, 136 wherein the first predetermined pressure differential is determined based on a first velocity of air produced by the ventilator.
138. The apparatus of claim 137, wherein the second predetermined pressure differential is determined based on a second velocity of air produced by the ventilator.
139. The apparatus of claim 136 wherein the first predetermined pressure differential is determined based on a first velocity of air produced by the ventilator and the second predetermined pressure differential is determined based on a second velocity of air produced by the ventilator.
140. A nebulizer comprising: an aerosolization element; a piezoelectric element, in mechanical communication with the aerosolization element; an electronic circuitry in electrical communication with the piezoelectric element; a microprocessor in electrical communication with the electronic circuitry; a sensor to sense at least one predetermined point of the breathing cycle of a user of the nebulizer, the sensor in electrical communication with the microprocessor, wherein the sensor, the microprocessor, the electronic circuitry and the piezoelectric element are electronically configured and the piezoelectric element and the aerosolization element are mechanically configured so that the aerosolization element can reach a predetermined maximum aerosol production within a predetermined time period from the sensing of the occurrence of a predetermined point of the breathing cycle.
141. The apparatus of claim 140 wherein the predetermined time period is between 0.02 and about 50 milliseconds.
142. The apparatus of claim 140 wherein the predetermined time period is between about 0.2 and about 50 milliseconds.
143. The apparatus of claim 140 wherein the predetermined time period is between about 2 and about 50 milliseconds.
144. The apparatus of claim 140 wherein the predetermined time period is between about 0.02 and about 20 milliseconds.
145. The apparatus of claim 140 wherein the predetermined time period is between about 0.2 and about 20 milliseconds.
146. The apparatus of claim 140 wherein the predetermined time period is between about 0.02 and about 2 milliseconds.
147. A system for providing air with nebulized liquid to a patient receiving air from a ventilator, comprising: a ventilator; an inflow pathway configured to carry inhalation air from the ventilator to a patient being ventilated by the ventilator; an aerosolization element configured to dispense aerosol into the inflow pathway; a piezoelectric element, in mechanical communication with the aerosolization element; an electronic circuitry in electrical communication with the piezoelectric element; a microprocessor in electrical communication with the electronic circuitry; and a sensor configured to sense at least one predetermined point within the breathing cycle of patient using the ventilator, the sensor in electrical communication with the microprocessor, wherein the sensor, the microprocessor, the electronic circuitry and the piezoelectric element are electronically configured and the piezoelectric element and the aerosolization element are mechanically configured so that the aerosolization element can reach a predetermined maximum aerosol production within a predetermined time period from the sensing of the occurrence of a predetermined point in the breathing cycle.
148. A system for providing air with nebulized liquid to a patient receiving air from a ventilator, comprising; a ventilator; an inflow pathway configured to carry inhalation air from the ventilator to a patient being ventilated by the ventilator; an aerosolization element configured to dispense aerosol into the inflow pathway; a piezoelectric element, in mechanical communication with the aerosolization element; an electronic circuitry in electrical communication with the piezoelectric element; a microprocessor in electrical communication with the electronic circuitry; and a signal transmitter configured to generate a signal based on at least one first predetermined point within the breathing cycle of patient using the ventilator, the signal transmitter in electrical communication with the microprocessor; wherein, the signal transmitter, the microprocessor, the electronic circuitry and the piezoelectric element are electronically configured and the piezoelectric element and the aerosolization element are mechanically configured so that the vibration of the piezoelectric element and the aerosolization element is based on the at least one predetermined point within the breathing cycle.
149. The apparatus of claim 148 wherein the aerosolization element can reach a predetermined maximum aerosol production within a predetermined time period from the sensing of the occurrence of a predetermined point in the breathing cycle.
150. The apparatus of claim 149 wherein the predetermined time period is between 0.02 and about 50 milliseconds.
151. The apparatus of claim 149 wherein the predetermined time period is between about 0.2 and about 50 milliseconds.
152. The apparatus of claim 149 wherein the predetermined time period is between about 2 and about 50 milliseconds.
153. The apparatus of claim 149 wherein the predetermined time period is between about 0.02 and about 20 milliseconds.
154. The apparatus of claim 149 wherein the predetermined time period is between about 0.2 and about 20 milliseconds.
155. The apparatus of claim 149 wherein the predetermined time period is between about 0.02 and about 2 milliseconds.
156 The apparatus of claim 148, wherein the signal transmitter is controlled by the ventilator.
157. The apparatus of claim 156, wherein the signal transmitter is contained within the ventilator.
158. The apparatus of claim 148, wherein, wherein the signal transmitter is configured to halt its signal transmission based at least in part on the at least one second predetermined point within the breathing cycle of patient using the ventilator.
159. The apparatus of claim 148, wherein the signal transmitter is controlled by the ventilator.
160. The apparatus of claim 159, wherein the signal transmitter is contained within the ventilator.
161. The apparatus of claim 148, wherein, wherein the signal transmitter is configured to halt its signal transmission based at least in part on the at least one second predetermined point within the breathing cycle of patient using the ventilator.
162. A method for providing nebulized fluid to a person receiving air from a ventilator, comprising: identifying the drug to be administered; selecting an algorithm, the algorithm providing a sequence of starting aerosol production and stopping aerosol production so that the drug is delivered at a predetermined interval of choice in a breathing cycle; receiving a signal from the ventilator to establish a point of reference as to the operation of the ventilator in providing cycles of comprising inhalation phases; selecting an operating sequence based the selected algorithm and the reference point; beginning production of aerosol at a point in the ventilator cycle in accordance with the operating sequence; stopping production of aerosol at a point in the ventilator cycle in accordance with the operating sequence; wherein the operating sequence sets the time for beginning production of aerosol and stopping production of aerosol based on the particular drug being administered an based on the specific cycle time of the ventilator to achieve a predetermined efficacy of aerosol administration.
163. A method of providing nebulized fluid to a patient receiving at least a portion of air from an artificial air source, the method comprising: providing a nebulizing element; providing a controller to operate the nebulizing element, choosing a sequence of start and stop of aerosol production to maximize the effect of administered drug as provided in combination with the air provided by the artificial air source.
164. A system for providing nebulized fluid to a patient receiving air from an artificial air source, comprising: an aerosolization element; a controller configured to control operation of the aerosolization element; a plurality of operation algorithms providing for the controller to operate the aerosolization element at predetermined intervals to achieve different regime of administration with respect to an inspiratory cycle, said inspiratory cycle comprising an inhalation phase and an exhalation phase; wherein the controller may be adjusted to follow one of the algorithms to cany out a specific operation sequence of operating the aerosolization element.
165. The system of claim 164, wherein the controller is manually adjustable by a person operating the system.
166. The system of claim 165, wherein the controller may adjust automatically, by following an initial algorithm that leads the controller to chose an operation algorithm.
167. The system of claim 164, wherein the controller has the ability to chose an alternate operating sequence based on receipt of instantaneous information as to the status of one or more of the group consisting of the breathing rhythm of the patient and the ongoing aerosol production sequence.
168. The system of claim 164, wherein the controller has the ability to follow a portion of a first operation sequence and a portion of a second operation sequence to carry out a third operation sequence that comprises a portion of the first operation sequence and a portion of the second operation sequence.
169. The system of claim 164, wherein the controller selects the portions of the operation sequences based on a sensed parameter in the course of operation of the system by which nebulized fluid is provided in conjunction with air from an artificial air source.
170. A method of providing an apparatus for providing nebulized fluid to a patient receiving air flowing from a respirator, comprising: providing a nebulizing element, the nebulizing element comprising a first face, a second face and a plurality of apertures therebetween; providing a vibratory element capable of vibrating upon receiving a predetermined electrical signal, the vibratory element positioned such that the nebulizing element can be caused to vibrate by vibration of the vibratory element in such a manner that a fluid at the first face may be drawn through the apertures and emitted therefrom at the second face as a nebulized mist; providing a circuitry in electrical communication with the vibratory element; providing a switch in electrical communication with the circuitry, the switch being operable between an off position and an on position such that the switch maintains itself in the off position if a predetermined velocity of air flowing to the patient is not present and in the on position if the predetermined velocity of air flowing to the patient is present; wherein the time between the switch being moved from the off position to the on position to the time a nebulized mist can be emitted by vibration of the vibratory element is between about 2 milliseconds and about 50 milliseconds.
171. The method of claim 170 wherein the switch comprises a sensor capable of sensing a pressure differential.
172. The method of claim 171 wherein the pressure differential is calibrated to a predetermined velocity of air flowing to the patient.
173. The method of claim 172 wherein the switch maintains itself in the off position if a predetermined pressure differential is not present and in the on position if the predetermined pressure differential is present.
174. The method of claim 170 wherein the switch comprises a moveable member capable of moving from a first position to a second position.
175. The method of claim 174 wherein the first position corresponds to the absence of air flowing to the patient being of a predetermined velocity and the second position corresponds to the presence of air flowing to the patient being of a predetermined velocity.
176. The method of claim 170 further comprising a sensor to detect the presence of the moveable member in the second position.
177. The method of claim 170 wherein the sensor comprises a light sensor that can sense a difference of light received by it when the moveable member is in the second position than when the moveable member is not in the second position.
178. The method of claim 170 wherein the sensor comprises a film upon the moveable member, the film subject to a change in at least one physical characteristic when the moveable member is in the second position.
179. The method of claim 178 wherein the physical characteristic is electric resistance.
180. The method of claim 178 further comprising an electric sensor capable of sensing the electric resistance of the film corresponding to the moveable member being in the second position.
181. A method of providing nebulized fluid into an inspiratory flow of a user, comprising: providing a ventilator, providing tubing capable of carrying inspiratory air flowing to the user, providing a nebulizing element, the nebulizing element comprising a first face, a second face and a plurality of apertures therebetween; providing a vibratory element capable of vibrating upon receiving a predetermined electrical signal, the vibratory element positioned such that the nebulizing element can be caused to vibrate by vibration of the vibratory element in such a manner that a fluid at the first face may be drawn through the apertures and emitted therefrom at the second face as a nebulized mist; providing a circuitry in electrical communication with the vibratory element, the circuitry capable of supplying an electrical signal to the vibratory element to cause the vibratory element to vibrate; providing a switch that can be acted upon by inspiratory air, the switch in electrical communication with the circuitry, the switch being operable between an off position and an on position such that the switch maintains itself in the off position if a predetermined velocity of air flowing to the patient is not present and in the on position if the predetermined velocity of air flowing to the patient is present, the switch being arranged such that if it is in the on position, the circuitry may supply the electrical signal to the vibratory element; providing a fluid at the first face of the nebulizing element, providing inspiratory air flowing to the patient, wherein the velocity thereof becomes greater than or equal to the predetermined velocity, thus moving the switch to the on position, whereupon the nebulizing element is caused to vibrate; wherein the time between the switch being moved to the on position to the time a nebulized mist is emitted by vibration of the vibratory element is between about 2 milliseconds and about 50 milliseconds.
182. A method of providing nebulized fluid into an inspiratory flow of a user, comprising: providing a ventilator, providing tubing capable of carrying inspiratory air flowing to the user, providing a nebulizing element, the nebulizing element comprising a first face, a second face and a plurality of apertures therebetween; providing a vibratory element capable of vibrating upon receiving a predetermined electrical signal; positioning the vibratory element such that the nebulizing element can be caused to vibrate by vibration of the vibratory element in such a manner that a fluid at the first face may be drawn through the apertures and emitted therefrom at the second face as a nebulized mist; providing a circuitry in electrical communication with the vibratory element; providing a switch in electrical communication with the circuitry and positioned to be acted upon by at least a portion of a stream of inspiratory air, the switch being operable between an off position and an on position such that the switch maintains itself in the off position if a predetermined velocity of air flowing to the patient is not present and in the on position if the predetermined velocity of air flowing to the patient is present; providing a stream of inspiratory air of which at least a portion thereof comes from the respirator; allowing the switch to move to the on position upon the stream of inspiratory air attaining a predetermined velocity, whereupon the circuitry causes the vibratory element to vibrate in such a manner as to cause the nebulizing element to vibrate, thereby drawing fluid through the apertures thereof and therethrough emitting a nebulized mist within between about 2 milliseconds and about 50 milliseconds.
183. A method of providing an apparatus for providing nebulized fluid into an inspiratory flow of a user, comprising: providing a ventilator, providing tubing capable of carrying inspiratory air flowing to the user, providing a nebulizing element, the nebulizing element comprising a first face, a second face and a plurality of apertures therebetween; providing a vibratory element capable of vibrating upon receiving a predetermined electrical signal, the vibratory element positioned such that the nebulizing element can be caused to vibrate by vibration of the vibratory element in such a manner that a fluid at the first face may be drawn through the apertures and emitted therefrom at the second face as a nebulized mist; providing a circuitry in electrical communication with the vibratory element; providing a switch in electrical communication with the circuitry, the switch being operable between an off position and an on position such that the switch maintains itself in the off position if a predetermined velocity of air flowing to the patient is not present and in the on position if the predetermined velocity of air flowing to the patient is present; wherein the time between the switch being moved to the on position to the time a nebulized mist can be emitted by vibration of the vibratory element is between about 2 milliseconds and about 50 milliseconds.
184. A method of providing nebulized fluid to a patient receiving air flowing from a respirator, comprising: providing a nebulizing element, the nebulizing element comprising a first face, a second face and a plurality of apertures therebetween; providing a vibratory element capable of vibrating upon receiving a predetermined electrical signal; positioning the vibratory element such that the nebulizing element can be caused to vibrate by vibration of the vibratory element; providing a circuitry in electrical communication with the vibratory element; providing a switch that can be acted upon by inspiratory air and that is in electrical communication with the circuitry, the switch being operable between an off position and an on position such that the switch maintains itself in the off position if a predetermined velocity of air flowing to the patient is not present and in the on position if the predetermined velocity of air flowing to the patient is present; providing a timer in electrical communication with the circuitry; providing a stream of inspiratory air of which at least a portion thereof comes from the respirator; moving the switch to the on position upon the stream of inspiratory air attaining a predetermined velocity, sending a signal to the vibratory element to vibrate in such a manner as to cause the nebulizing element to vibrate, drawing fluid through the apertures of the nebulizing element; emitting a nebulized mist; setting a cycle start time from the sending of the signal to the vibratory element; moving the switch to the off position upon the velocity of the inspiratory stream falling below the predetermined amount; ceasing to send the signal to the vibratory element; noting the time of cessation of the signal; calculating a first length of time from the setting of the time to the noting the time of cessation; calculating a second length of time as a fraction of the first length of time; providing a second stream of inspiratory air of which at least a portion thereof comes from the respirator; moving the switch to the on position upon the second stream of inspiratory air attaining a predetermined velocity, sending a second signal to the vibratory element to vibrate in such a manner as to cause the nebulizing element to vibrate, drawing fluid through the apertures of the nebulizing element; emitting a nebulized mist; setting a second cycle start time from the sending of the second signal to the vibratory element and counting time therefrom; upon reaching the second length of time counting from the second cycle start time, ceasing to send the second signal to the vibratory element.
185. A method of providing nebulized fluid to a patient receiving air flowing from a respirator, comprising: providing a nebulizing element, the nebulizing element comprising a first face, a second face and a plurality of apertures therebetween; providing a vibratory element capable of vibrating upon receiving a predetermined electrical signal; positioning the vibratory element such that the nebulizing element can be caused to vibrate by vibration of the vibratory element; providing a circuitry in electrical communication with the vibratory element; providing a switch which can be acted upon by inspiratory air and in electrical communication with the circuitry, the switch being operable between an off position and an on position such that the switch maintains itself in the off position if a predetermined velocity of air flowing to the patient is not present and in the on position if the predetermined velocity of air flowing to the patient is present; providing a timer in electrical communication with the circuitry; providing a stream of inspiratory air of which at least a portion thereof comes from the respirator; allowing the switch to move to the on position upon the stream of inspiratory air attaining a predetermined velocity, allowing a signal to be generated and sent to the vibratory element causing it to vibrate in such a manner as to cause the nebulizing element to vibrate to draw fluid through the apertures of the nebulizing element and emit therefrom the fluid as a nebulized mist; setting a cycle start time from the sending of the signal to the vibratory element; moving the switch to the off position upon the velocity of the inspiratory stream falling below the predetermined amount; ceasing to send the signal to the vibratory element; noting the time of cessation of the signal; calculating a first length of time L from the setting of the start time to the noting the time of cessation; providing a second stream of inspiratory air of which at least a portion thereof comes from the respirator; allowing the switch to move to the on position upon the second stream of inspiratory air attaining a predetermined velocity, allowing a second signal to be generated and sent to the vibratory element causing it to vibrate in such a manner as to cause the nebulizing element to vibrate to draw fluid through the apertures of the nebulizing element and emit therefrom the fluid as a nebulized mist; upon reaching the length of time L counting from the second cycle start time, ceasing to send the second signal to the vibratory element.
186. A method of providing nebulized fluid to a patient receiving air flowing from a respirator, comprising: providing a respirator; providing a nebulizing element, the nebulizing element comprising a first face, a second face and a plurality of apertures therebetween; providing a vibratory element capable of vibrating upon receiving a predetermined electrical signal; positioning the vibratory element such that the nebulizing element can be caused to vibrate by vibration of the vibratory element; providing a circuitry in electrical communication with the vibratory element; providing a switch which can be acted upon by inspiratory air and in electrical communication with the circuitry, the switch being operable between an off position and an on position such that the switch maintains itself in the off position if a predetermined velocity of air flowing to the patient is not present and in the on position if the predetermined velocity of air flowing to the patient is present; providing a stream of inspiratory air of which at least a portion thereof comes from the respirator; providing information on the start and stop time of the firing of the respirator; sending a signal to the vibratory element, upon the firing of the respirator, to vibrate in such a manner as to cause the nebulizing element to vibrate to draw fluid through the apertures of the nebulizing element and emit the fluid therefrom as a nebulized; ceasing to send the signal to the vibratory element upon the cessation of the firing of the respirator.
187. A method of providing nebulized fluid to a patient receiving air flowing from a respirator, comprising: providing a respirator; providing a nebulizing element, the nebulizing element comprising a first face, a second face and a plurality of apertures therebetween; providing a vibratory element capable of vibrating upon receiving a predetermined electrical signal; positioning the vibratory element such that the nebulizing element can be caused to vibrate by vibration of the vibratory element; providing a circuitry in electrical communication with the vibratory element; providing a switch which can be acted upon by inspiratory air and in electrical communication with the circuitry, the switch being operable between an off position and an on position such that the switch maintains itself in the off position if a predetermined velocity of air flowing to the patient is not present and in the on position if the predetermined velocity of air flowing to the patient is present; providing a stream of inspiratory air of which at least a portion thereof comes from the respirator; providing information on the start and stop time of the firing of the respirator; sending a signal to the vibratory element, upon the elapsing of a predetermined time from firing of the respirator, to vibrate in such a manner as to cause the nebulizing element to vibrate to draw fluid through the apertures of the nebulizing element and emit the fluid therefrom as a nebulized; ceasing to send the signal to the vibratory element upon the cessation of the firing of the respirator.
188. A method of providing nebulized fluid to a patient receiving air flowing from a respirator, comprising: providing a respirator; providing a nebulizing element, the nebulizing element comprising a first face, a second face and a plurality of apertures therebetween; providing a vibratory element capable of vibrating upon receiving a predetermined electrical signal; positioning the vibratory element such that the nebulizing element can be caused to vibrate by vibration of the vibratory element; providing a circuitry in electrical communication with the vibratory element; providing a sensor that can sense inspiratory air and that is in electrical communication with the circuitry, the sensor providing information as to the presence or absence of a predetermined velocity of air flowing from the respirator; providing a stream of inspiratory air of which at least a portion thereof comes from the respirator; providing information on the start time of the firing of the respirator; vibrating the nebulizing element base upon a combination of information from the sensor and the inform on the start time of the firing of the respirator.
189. A method of providing nebulized fluid to a patient receiving air flowing from a respirator, comprising: providing a respirator; providing a nebulizing element, the nebulizing element comprising a first face, a second face and a plurality of apertures therebetween; providing a vibratory element capable of vibrating upon receiving a predetermined electrical signal; positioning the vibratory element such that the nebulizing element can be caused to vibrate by vibration of the vibratory element; providing a circuitry in electrical communication with the vibratory element; providing a switch which can be acted upon by inspiratory air and in electrical communication with the circuitry, the switch being operable between an off position and an on position such that the switch maintains itself in the off position if a predetermined velocity of air flowing to the patient is not present and in the on position if the predetermined velocity of air flowing to the patient is present; providing a stream of inspiratory air of which at least a portion thereof comes from the respirator; providing information on the start and stop time of the firing of the respirator; sending a signal to the vibratory element, at predetermined time following the firing of the respirator, to vibrate in such a manner as to cause the nebulizing element to vibrate to draw fluid through the apertures of the nebulizing element and emit the fluid therefrom as a nebulized; ceasing to send the signal to the vibratory element at predetermined period of time prior to the cessation of the firing of the respirator.
190. The method of claim 189 wherein the predetermined period of time following the firing of the respirator and the predetermined time prior to the cessation of the firing of the respirator occur such that the time during which nebulized fluid is emitted is a percentage of an inspiratory cycle.
191. The method of claim 190 wherein the percentage is from about 20 percent to about 50 percent of an inspiratory cycle.
192. An apparatus for providing aerosol to a person receiving air from a respirator, comprising: an aerosolization element having a first face, a second face, and a plurality of apertures therethrough; a vibratory element, capable of vibrating upon receiving an predetermined electrical signal, the vibratory element positioned to impart vibration to the aerosolization element; a circuitry in electrical communication with the vibratory element capable of delivering a predetermined electrical signal to the vibratory element for the vibratory element to vibrate; a control operable on the circuitry to switch between at least a first mode of operation providing for at least one operation sequence and a second mode of operation providing for at least one operation sequence different from the at least one operation sequence of the first mode.
193. The apparatus of claim 120, wherein at least one operation sequence provides for signaling the vibratory element to begin vibration based on a predetermined velocity of air provided by the respirator and to stop vibration based on a percentage of inhalation having transpired.
194. An apparatus for providing aerosol to a person receiving air from a respirator, comprising: an aerosolization element having a first face, a second face, and a plurality of apertures therethrough; a vibratory element, capable of vibrating upon receiving an predetermined electrical signal, the vibratory element positioned to impart vibration to the aerosolization element; a circuitry in electrical communication with the vibratory element capable of delivering a predetermined electrical signal to the vibratory element for the vibratory element to vibrate; a control operable on the circuitry to switch between three or more modes of operation; wherein each mode comprises at least one operation sequence different from an operation sequence of one of the other modes.
195. The apparatus of claim 194, wherein one of the modes provides that the circuitry delivers the predetermined signal to the vibratory element during inspiration if the velocity of inspiratory air is above a predetermined velocity, another of the modes provides that the circuitry delivers the predetermined signal to the vibratory element during a portion of the time period in which the velocity of inspiratory air is above a predetermined velocity, and another of the modes provides that the circuitry delivers the predetermined signal to the vibratory element during a portion of time during which the person is exhaling.
196. A system for providing aerosol to a person, comprising: an aerosol generator; and a controller configured to cause the aerosol generator to generate aerosol and to cause the aerosol generator to not generate aerosol; wherein the controller is configured to operate between a first mode and a second mode, wherein the first mode configures the controller to cause the aerosol generate to generate aerosol based on a predetermined inspiration level and to cause the aerosol generator to not generate aerosol based on the absence of a predetermined level of inspiration and the second mode configures the controller to cause the aerosol generator to generate aerosol based on a predetermined level of inspiration and to cause the aerosol generator to not generate aerosol at a predetermined time in the breathing cycle.
197. The system of claim 196 wherein the controller is configured to operate between the first mode, the second mode and a third mode wherein the controller is configured to cause the aerosol generator to generate aerosol at a first predetermined time in the breathing cycle and to stop the aerosol generator from generating aerosol at a second predetermined time in the breathing cycle.
198. The system of claim 193 wherein the predetermined time of the second mode is calculated as a time at which a predetermined percentage of the inspiration has taken place.
199. The system of claim 197 wherein the first predetermined time of the third mode is set to occur during exhalation and the second predetermined time of the third mode is set to occur during exhalation.
200. The system of claim 197 wherein the second predetermined time is set to occur in the subsequent inspiration.
201. The system of claim 193, wherein the controller is configured to cause the aerosol generator to generate aerosol based on a predetermined parameter.
202. The system of claim 201 wherein the predetermined parameter is selected from the group consisting of a level of inspiration and a time within a breath.
203. The system of claim wherein the controller is configured to not operate the aerosol generator to not generate aerosol based on a predetermined parameter.
204. The system of claim 193 wherein the predetermined parameter is selected from the group consisting of a level of inspiration and a time within a breath.
205. A system for providing nebulized fluid to a person comprising: an aerosol generator; and a controller, wherein the controller is configured to cause the aerosol generator to begin generation of aerosol at a first predetermined time in a breathing cycle and to stop generating aerosol at a second predetermined time in the breathing cycle.
206. A nebulizer comprising: an aerosolization element; a piezoelectric element, in mechanical communication with the aerosolization element; an electronic circuitry in electrical communication with the piezoelectric element; a microprocessor in electrical communication with the electronic circuitry; a sensor to sense at least one predetermined point of the breathing cycle of a user of the nebulizer, the sensor in electrical communication with the microprocessor, wherein the sensor, the microprocessor, the electronic circuitry and the piezoelectric element are electronically configured and the piezoelectric element and the aerosolization element are mechanically configured so that the aerosolization element can reach a predetermined maximum aerosol production within a predetermined time period from the sensing of the occurrence of a predetermined point of the breathing cycle.
207. A system for providing nebulized fluid into the inflow pathway of a ventilator, comprising; a ventilator; an inflow pathway configured to carry inhalation air from the ventilator to a patient being ventilated by the ventilator; an aerosolization element configured to dispense aerosol into the inflow pathway; a piezoelectric element, in mechanical communication with the aerosolization element; an electronic circuitry in electrical communication with the piezoelectric element; a microprocessor in electrical communication with the electronic circuitry; a sensor configured to sense at least one predetermined point within the breathing cycle of patient using the ventilator, the sensor in electrical communication with the microprocessor, wherein the sensor, the microprocessor, the electronic circuitry and the piezoelectric element are electronically configured and the piezoelectric element and the aerosolization element are mechanically configured so that the aerosolization element can reach a predetermined maximum aerosol production within a predetermined time period from the sensing of the occurrence of a predetermined point in the breathing cycle.
208. A fluid droplet ejection device for use with a ventilator, said device produces droplets by a vibratory apertured element during a selected interval of a breathing cycle.
209. A nebulizer for providing nebulized fluid into a ventilator breathing circuit, comprising: a vibratory aerosolization element having a first face, a second face and a plurality of apertures therethrough; a controller configured to control vibration of the vibratory aerosolization element, wherein the controller may be configured to vibrate the vibratory aerosolization element during a selected interval of a breathing cycle.
210. The apparatus of claim 209, wherein the apertures are of substantially uniform exit diameter.
211. The apparatus of claim 209, wherein the apertures are tapered such that liquid is drawn into the narrow portions of the tapers and aerosol of the liquid is emitted from the wide portions of the tapers.
212. The apparatus of claim 209, wherein the aerosolization element has a curvature.
213. The apparatus of claim 209, wherein the aerosolization element comprises a dome shape.
214. The apparatus of claim 209, wherein the vibratory aerosolization element comprises palladium.
215. The apparatus of claim 209, wherein the vibratory aerosolization element consists of palladium.
216. The apparatus of claim 209, wherein the vibratory aerosolization element consists essentially of palladium.
217. The apparatus of claim 209, wherein the controller is configured to provide aerosol for substantially an entire inhalation phase.
218. The apparatus of claim 209, wherein the controller is configured to provide aerosol for an interval comprising a portion of an inhalation phase beginning at the start of the inhalation phase and ending prior to completion of the inhalation phase.
219. The apparatus of claim 209, wherein the controller is configured to provide aerosol for an interval comprising a portion of an inhalation phase beginning at a first predetermined point after the start of the inhalation phase and ending at a second predetermined point prior to completion of the inhalation phase.
220. The apparatus of claim 209, wherein the controller is configured to provide aerosol for an interval comprising a portion of an inhalation phase beginning at a first predetermined point after the start of the inhalation phase and ending at the end of the inhalation phase.
221. The apparatus of claim 209, wherein the controller is configured to provide aerosol for an interval comprising a portion of an inhalation phase and a portion of an exhalation phase, beginning at a first predetermined point after the start and before the end of the inhalation phase and ending after the end of the inhalation phase during the exhalation phase.
222. The apparatus of claim 209, wherein the controller is configured to provide aerosol for an interval comprising a portion of the inhalation phase and an entire exhalation phase, beginning at a first predetermined point after the start and before the end of the inhalation phase and ending at the end of the exhalation phase.
223. The apparatus of claim 209, wherein the controller is configured to provide aerosol for an interval comprising an entire exhalation phase.
224. The apparatus of claim 209, wherein the controller is configured to provide aerosol for an interval comprising a portion of an exhalation phase, after the start of the exhalation phase and ending to completion of the exhalation phase.
225. The apparatus of claim 209, wherein the controller is configured to provide aerosol for an interval comprising a portion of an exhalation phase and a portion of the successive inhalation phase, beginning after the start of the exhalation phase and ending during the successive inhalation phase.
226. The apparatus of claim 209, wherein the controller may select an interval from the group of intervals comprising: an entire inhalation phase; a portion of an inhalation phase beginning at the start of the inhalation phase and ending prior to completion of the inhalation phase; a portion of an inhalation phase beginning at a first predetermined point after the start of the inhalation phase and ending at a second predetermined point prior to completion of the inhalation phase; a portion of an inhalation phase beginning at a first predetermined point after the start of the inhalation phase and ending at the end of the inhalation phase; a portion of an inhalation phase and a portion of an exhalation phase, beginning at a first predetermined point after the start and before the end of the inhalation phase and ending after the end of the inhalation phase during the exhalation phase; a portion of the inhalation phase and an entire exhalation phase, beginning at a first predetermined point after the start and before the end of the inhalation phase and ending at the end of the exhalation phase; an entire exhalation phase; a portion of an exhalation phase, after the start of the exhalation phase and ending to completion of the exhalation phase; and a portion of an exhalation phase and a portion of the successive inhalation phase, beginning after the start of the exhalation phase and ending during the successive inhalation phase.
227. The apparatus of claim 226, wherein the portions of the inhalation phases and the portions of the exhalation phases are predetermined percentages of the respective phase.
228. The apparatus of claim 209, wherein the vibratory aerosolization element is configured to produce a low velocity aerosol cloud.
229. The apparatus of claim 228, wherein the low velocity cloud is of such a velocity so as to remain substantially within the inlet portion of a Y connector, such Y connector comprising an inlet portion, an endotracheal tube portion and an outlet portion when the nebulizer is positioned to emit aerosol into the inlet portion of a Y connector.
230. The apparatus of claim 209, wherein the vibratory aerosolization element may be replaced by a second apertured vibratory element having a plurality of apertures of a different size than the apertures of the first apertured vibratory aerosolization element.
231. The apparatus of claim 210, further comprising: a vibratory element in mechanical communication with the aerosolization element; wherein the aerosolization element is vibrated by vibration of the vibratory element.
232. The apparatus of claim 231 , further comprising an aerosol actuator; wherein the aerosolization element and the vibratory element are each mechanically connected to the aerosol actuator.
233. The apparatus of claim 232, wherein the aerosolization element, the aerosol actuator and the vibratory element may be removed as a unit and replaced with a second assembly comprising a second aerosolization element, a second aerosol actuator and a second vibratory element; wherein the apertures of the second aerosolization element have a substantially uniform exit diameter that is different from the substantially uniform exit diameter of the apertures of the first aerosolization element.
234. A method of varying the particle size of nebulized fluid administered to a patient comprising: providing a first aerosolization element having a first face, a second face and a plurality of apertures therethrough, the apertures having a substantially uniform exit diameter at the second face, such that a liquid that may be provided at the first face may be drawn through the apertures and emitted from the aperture exits at the second face as a mist having a first particle size distribution; replacing the first aerosolization element with a second aerosolization element having a first face, a second face and a plurality of apertures therethrough, the apertures having a substantially uniform exit diameter at the second face that is different form the substantially uniform exit diameter of the apertures of the first aerosolization element, such that a liquid that may be provided at the first face of the second aerosolization element may be drawn through the apertures thereof and be emitted from the aperture exits at the second face as a mist having a second particle size distribution different than the first particle size distribution.
235. The method of claim 234 further comprising: vibrating the second aerosolization element to draw liquid into the apertures at the first face thereof and emit the liquid from the apertures at the second face thereof as a mist.
236. A nebulizing device for providing aerosol to a ventilated patient, comprising: a breathing circuit comprising a Y connector, the Y connector having an inlet portion, an endotracheal tube portion and an outlet portion, the inlet portion providing air from the ventilator to the patient via the endotracheal tube portion and the outlet portion providing an exhaust route, a nebulizer, comprising an apertured vibratory aerosolization element; a controller for controlling the vibratory operation of the apertured vibratory aerosolization element; wherein the vibratory aerosolization element is configured to vibrate in such a manner so as to provide an aerosol cloud that travels substantially no further into the breathing circuit than the inlet portion of the Y connector when there is no inspiratory air flowing through the inlet portion.
237. The apparatus of claim 236, wherein the apertured vibratory aerosolization element may be replaced by a second apertured vibratory element having a plurality of apertures of a different size than the apertures of the first apertured vibratory aerosolization element.
238. A system for providing nebulized fluid to a ventilated patient, comprising: a ventilator, a breathing circuit, a vibratory aerosolization element having a first face, a second face and a plurality of apertures therethrough; a controller configured to control vibration of the vibratory aerosolization element, wherein the controller may be configured to vibrate the vibratory aerosolization element during a selected interval of a breathing cycle.
239. The system of claim 238, wherein the selected interval is based on a predetermined point of the breath cycle provided by the ventilator.
240. The system of claim 239, wherein the predetermined point is the commencement of an inhalation phase provided by the ventilator
241. The system of claim 239, wherein the interval begins at a first predetermined point in the breathing cycle and ends at a second predetermined point in the breathing cycle.
242. A system for providing nebulized fluid to a patient receiving air from a ventilator, comprising: a breathing circuit comprising a Y connector, the Y connector comprising an inlet portion, an endotracheal tube portion and an outlet portion; a nebulizer positioned to provide nebulized fluid into the inlet portion of the Y connector, the nebulizer comprising: a vibratory aerosolization element having a first face, a second face and a plurality of apertures therethrough; wherein the vibratory element may be caused to vibrate at least in part by an electrical signal in a manner so as to draw fluid into the apertures at the first face thereof and emit the fluid as a low velocity nebulized cloud from the second face, and wherein the force of the emitted cloud is small enough that substantially no aerosol is lost through the outlet portion when there is no inspiratory flow through the inlet portion.
243. The apparatus of claim 242, wherein substantially no aerosol travels into the endotracheal tube portion of the Y connector when there is no inspiratory flow through the inlet portion.
244. A system for providing nebulized fluid to a patient receiving air from a ventilator, comprising: a breathing circuit comprising a Y connector, the Y connector comprising an inlet portion, an endotracheal tube portion and an outlet portion; a nebulizer positioned to provide nebulized fluid into the inlet portion of the Y connector, the nebulizer comprising: a vibratory aerosolization element having a first face, a second face and a plurality of apertures therethrough; wherein the vibratory element may be caused to vibrate at least in part by an electrical signal in a manner so as to draw fluid into the apertures at the first face thereof and emit the fluid as a low velocity nebulized cloud from the second face, and wherein the force of the emitted cloud is small enough that substantially all of the cloud may travel no further than the inlet portion of the Y connector when there is no inspiratory flow through the inlet portion.
245. A method of providing nebulized fluid to a patient receiving air from a ventilator, comprising: providing a ventilator, providing a breathing circuit to connect the ventilator to a patient, the breathing circuit comprising a Y connector, the Y connector comprising an inlet portion, an endotracheal portion and an outlet portion, providing a nebulizer positioned to provide aerosol into the inlet portion of the Y connector, the nebulizer comprising a vibratory aerosolization element, the vibratory aerosolization element operable in part by an electronic signal; providing an electronic signal that causes the aerosolization element to vibrate in such a manner as to deliver a cloud of mist into the inlet portion of the inlet portion during an interval in which there is substantially no inhalation flow through the inlet portion, such that the cloud remains substantially within the inlet portion; providing an inhalation flow from the ventilator in such a manner as to sweep substantially the entire cloud of nebulized fluid through the endotracheal tube portion to the patient substantially upon the commencement of the inhalation flow.
246. A method of providing nebulized fluid to a neonatal patient receiving air from a ventilator, comprising: providing a ventilator, providing a breathing circuit to connect the ventilator to a patient, the breathing circuit comprising a Y connector, the Y connector comprising an inlet portion, an endotracheal portion and an outlet portion, providing a nebulizer positioned to provide aerosol into the inlet portion of the Y connector, the nebulizer comprising a vibratory aerosolization element, the vibratory aerosolization element operable in part by an electronic signal; providing an electronic signal that causes the aerosolization element to vibrate in such a manner as to deliver a cloud of mist into the inlet portion of the inlet portion during an interval in which there is substantially no inhalation flow through the inlet portion, such that the cloud remains substantially within the inlet portion; providing an inhalation flow from the ventilator in such a manner as to sweep substantially the entire cloud of nebulized fluid through the endotracheal tube portion to the patient substantially upon the commencement of the inhalation flow.
247. A method for providing nebulized fluid to a patient receiving air from a ventilator, comprising: providing an aerosolization element; providing a controller configured to operate the aerosolization element; providing at least one algorithm that the controller may follow to determine a point to begin operation of the aerosolization element; wherein the controller can operate the aerosolization element independent of the instantaneous state of the ventilator.
248. The method of claim 247, further comprising: the controller receiving a signal from the ventilator which the controller may use in executing the algorithm.
249. A system for providing nebulized fluid to a patient receiving air from a ventilator, comprising: an aerosolization element; a controller configured to operate the aerosolization element; at least one algorithm accessible by the controller that the controller may follow to determine a point to begin operation of the aerosolization element; wherein the controller can operate the aerosolization element independent of the instantaneous state of the ventilator.
250. The system of claim 249, further comprising a signal receiver by which the controller may receive a signal from the ventilator.
251. A system for providing aerosol into a ventilator circuit, comprising; a ventilator capable of providing at least one cycle of inhalation air; a ventilator circuit comprising an inhalation tube, and exhalation tube and an intubation tube, and a Y connector therebetween; a sensor configured to monitor a point within an inhalation cycle of the ventilator; a nebulizer comprising a microprocessor, the microprocessor configured to calculate an inhalation profile based on the sensed point of operation of the ventilator, the microprocessor further configured to follow at least one algorithm for operating the nebulizer based on an inhalation profile, wherein the algorithm is configured to provide a point for the commencement of aerosolization and a point for the cessation of aerosolization.
252. The system of claim 251, wherein the of aerosolization and the point for cessation of aerosolization are not designed to coincide with the commencement of an inhalation phase and the cessation of an inhalation phase of an inhalation cycle provided by the nebulizer.
253. The system of claim 125, wherein the point for commencement of aerosolization and the point for cessation of aerosolization are not designed to coincide with the commencement of an exhalation phase and the cessation of an exhalation phase of an inhalation cycle provided by the nebulizer, nebulizer is mounted in a T connector in the inhalation tube of the ventilator circuit and wherein the nebulizer is configured to provide a mist propelled at low velocity such that the mist may occupy a portion of the ventilator circuit between the T and the Y connectors without any force of air.
254. The system of claim 251, wherein the point for commencement.
255. The system of claim 251, wherein the point for commencement of aerosolization and the point for cessation of aerosolization are chosen to maximize actual inhalation of aerosolized liquid.
256. The system of claim 255, wherein the point for commencement of aerosolization is a point following the completion of a predetermined portion of the inhalation phase of the inhalation cycle
257. The system of claim 256, wherein the point for cessation of aerosolization is a point prior to a predetermined portion of the inhalation phase of the inhalation cycle has occurred.
258. The system of claim 255, wherein the point for cessation of aerosolization is a point following the completion of a predetermined portion of the subsequent exhalation phase of the inhalation cycle.
259. The system of claim 255, wherein the point for commencement of aerosolization is a point following the completion of a predetermined portion of the exhalation phase of the inhalation cycle.
260. The system of claim 259, wherein the point for cessation of aerosolization is a point following the completion of a predetermined portion of the exhalation phase of the inhalation cycle
261. The system of claim 259, wherein the point for cessation of aerosolization is a point following the completion of a predetermined portion of the subsequent inhalation phase of the subsequent inhalation cycle.
262. The system of claim 252, wherein the nebulizer is configured to provide a mist propelled at low velocity such that between about 50%> and about 90%> of the mist generated in an inhalation cycle may occupy a portion of the ventilator circuit between the T and the Y connectors without any force of air.
263. The system of claim 252, wherein the nebulizer is configured to provide a mist propelled at low velocity such that between about 60 %> and about 80 % of the mist generated in an inhalation cycle may occupy a portion of the ventilator circuit between the T and the Y connectors without any force of air.
264. The system of claim 252, wherein the nebulizer is configured to provide a mist propelled at low velocity such that between about 65 %> and about 75 % of the mist generated in an inhalation cycle may occupy a portion of the ventilator circuit between the T and the Y connectors without any force of air.
265. A method of providing aerosol into the circuit of a ventilator over a predetermined portion of an inhalation cycle independent of the instantaneous point in the inhalation cycle provided by the ventilator, comprising: providing a ventilator circuit; providing an aerosolization element positioned to provide aerosol into the ventilator circuit; providing a controller to control the operation of the aerosolization element; providing an algorithm accessible by the controller; providing a reference signal from the ventilator; formulating an operation sequence for the controller to power the aerosolization element and to stop powering the aerosolization element, the formulation comprising utilizing the reference signal in combination with the algorithm to determine a time interval for providing aerosol into the ventilator circuit; and providing aerosol into the ventilator circuit according the operation sequence.
266. The method of claim 265, wherein the detection comprises detecting a pressure drop within the ventilation circuit.
267. The method of claim 265, wherein the algorithm is designed to have the controller start aerosol production based on the completion of a predetermined portion of an inhalation phase of an inhalation cycle.
268. The method of claim 265, wherein the algorithm is designed to have the controller stop aerosol production based on the completion of a predetermined portion of the inhalation phase of the inhalation cycle.
269. The method of claim 265, wherein the algorithm is designed to have the controller start aerosol production based on the completion of a predetermined portion of an exhalation phase of an inhalation cycle.
270. The method of claim 265, wherein the algorithm is designed to have the controller stop aerosol production based on the completion of a predetermined portion of the exhalation phase of the inhalation cycle.
271. A system for providing nebulized fluid to a person receiving air from a ventilator, comprising: an aerosolization element; a controller configured to cause the aerosol generator to begin aerosol production at a first predetermined time in a breathing cycle and to stop production of aerosol at a second predetermined time in the breathing cycle; an algorithm accessible by the controller, the algorithm configured to allow the controller to calculate an operating sequence based at least in part on the identity of a drug to be aerosolized.
272. The system of claim 271, further comprising a nebule containing drug to be aerosolized.
273. The system of claim 272, wherein the nebule comprises a marker identifying the drug therein.
274. The system of claim 273, further comprising a reader that can read the identifying marker and provide the identity of the drug to the controller.
275. The system of claim 274, wherein the drug is an antibiotic.
276. The system of claim 275, wherein the antibiotic is an aminoglycoside.
277. The system of claim 276, wherein the aminoglycoside is amikacin.
278. The system of claim 271, wherein the operation sequence calls for aerosol production to begin substantially at the start of an inhalation provided by the ventilator and for aerosol production to at a point at which substantially half of the inhalation phase has been completed.
279. The system of claim 276, wherein the operation sequence calls for aerosol production to begin substantially at the start of an inhalation provided by the ventilator and for aerosol production to at a point at which substantially half of the inhalation phase has been completed.
280. The system of claim 274, wherein the drug is an antibody.
281. They system of claim 280, wherein the drug is IgG.
282. A method of providing a particular drug as a nebulized fluid to a patient receiving air from a ventilator, the method comprising: providing an aerosolization element; providing a controller that is configured to cause the aerosol generator to begin aerosol production at a first predetermined time in a breathing cycle and to stop production of aerosol at a second predetermined time in the breathing cycle; providing an algorithm accessible by the controller, the algorithm configured to allow the controller to calculate an operating sequence based at least in part on the identity of a drug to be aerosolized.
283. The method of claim 282, further comprising providing a nebule that contains a drug to be aerosolized.
284. The method of claim 283, wherein the nebule comprises a marker identifying the drug therein.
285. The method of claim 284, further comprising: providing a reader that can read the identifying marker and that can provide the identity of the drug to the controller.
286. The method of claim 285, further comprising: having the reader read the identity of the drug; having the controller receive the identity of the drug; and having the controller establish an operating sequence based at least in part on the identity of the drug that it received.
287. The method of claim 286, wherein the drug is an antibiotic.
288. The method of claim 287, wherein the antibiotic is an aminoglycoside.
289. The method of claim 288, wherein the aminoglycoside is amikacin.
290. The method of claim 282, wherein the operation sequence calls for aerosol production to begin substantially at the start of an inhalation provided by the ventilator and for aerosol production to at a point at which substantially half of the inhalation phase has been completed.
291. The method of claim 289, wherein the operation sequence calls for aerosol production to begin substantially at the start of an inhalation provided by the ventilator and for aerosol production to at a point at which substantially half of the inhalation phase has been completed.
292. The method of claim 282, wherein the drug is an antibody.
293. They method of claim 292, wherein the drug is IgG.
294. A system for providing nebulized fluid to a person receiving air from a ventilator, comprising: an aerosolization element; a controller configured to cause the aerosol generator to begin aerosol production at a first predetermined time in a breathing cycle and to stop production of aerosol at a second predetermined time in the breathing cycle; wherein the controller is configured to adjust the time interval of aerosol production based on a change in the breath rhythm of a ventilated patient.
PCT/US2003/001516 2002-01-15 2003-01-15 Methods and systems for operating an aerosol generator WO2003059424A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP03702161.5A EP1474196B1 (en) 2002-01-15 2003-01-15 Methods and systems for operating an aerosol generator
AU2003203043A AU2003203043A1 (en) 2002-01-15 2003-01-15 Methods and systems for operating an aerosol generator
JP2003559584A JP4761709B2 (en) 2002-01-15 2003-01-15 Method and system for operating an aerosol generator
ES03702161.5T ES2603067T3 (en) 2002-01-15 2003-01-15 Methods and systems for operating an aerosol generator

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US34976302P 2002-01-15 2002-01-15
US34980502P 2002-01-15 2002-01-15
US60/349,805 2002-01-15
US60/349,763 2002-01-15
US38065502P 2002-05-14 2002-05-14
US60/380,655 2002-05-14
US38183002P 2002-05-20 2002-05-20
US60/381,830 2002-05-20
US40874302P 2002-09-05 2002-09-05
US60/408,743 2002-09-05
US10/284,068 2002-10-30
US10/284,068 US7600511B2 (en) 2001-11-01 2002-10-30 Apparatus and methods for delivery of medicament to a respiratory system
US43904503P 2003-01-08 2003-01-08
US60/439,045 2003-01-08

Publications (1)

Publication Number Publication Date
WO2003059424A1 true WO2003059424A1 (en) 2003-07-24

Family

ID=27569583

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/001516 WO2003059424A1 (en) 2002-01-15 2003-01-15 Methods and systems for operating an aerosol generator

Country Status (6)

Country Link
US (3) US6968840B2 (en)
EP (1) EP1474196B1 (en)
JP (2) JP4761709B2 (en)
AU (1) AU2003203043A1 (en)
ES (1) ES2603067T3 (en)
WO (1) WO2003059424A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006102345A3 (en) * 2005-03-24 2007-01-25 Aerogen Inc Methods and systems for operating an aerosol generator
WO2010035252A2 (en) * 2008-09-26 2010-04-01 Stamford Devices Limited A nebuliser system
EP2399636A1 (en) * 2010-06-23 2011-12-28 Philip Morris Products S.A. An improved aerosol generator and liquid storage portion for use with the aerosol generator
EP2735328A1 (en) * 2012-11-27 2014-05-28 PARI Pharma GmbH Fluid reservoir for an aerosol generation device, combination of fluid reservoir and primary fluid package, and aerosol generation device for use with the fluid reservoir
EP2848275A3 (en) * 2008-05-09 2015-07-08 PARI Pharma GmbH Atomiser for respiration machines and respiration machine with such an atomiser
WO2015150510A1 (en) 2014-04-03 2015-10-08 Csl Behring Ag Nebulization of immunoglobulin
EP2448622A4 (en) * 2009-07-01 2016-03-16 Microdose Therapeutx Inc Nebulizer for infants and respiratory compromised patients
WO2017019428A1 (en) * 2015-07-24 2017-02-02 Rai Strategic Holdings, Inc. Radio-frequency identification (rfid) authentication system for aerosol delivery devices
EP2620176B1 (en) * 2012-01-24 2018-01-17 NEBU-TEC GmbH Inhaler with breath-controlled piezo crystal
WO2018057058A1 (en) * 2016-09-24 2018-03-29 Sanmina Corporation System and method for atomizing and monitoring a drug cartridge during inhalation treatments
US10238821B2 (en) 2016-10-11 2019-03-26 Microdose Therapeutx, Inc. Inhaler and methods of use thereof
US10500354B2 (en) 2015-09-25 2019-12-10 Sanmina Corporation System and method for atomizing and monitoring a drug cartridge during inhalation treatments
US10857191B2 (en) 2015-10-07 2020-12-08 Santalis Pharmaceuticals, Inc. Sandalwood oil and its uses related to oral mucositis
US11744964B2 (en) 2016-04-27 2023-09-05 Nicoventures Trading Limited Electronic aerosol provision system and vaporizer therefor
RU2808418C1 (en) * 2020-10-12 2023-11-28 Вектура Деливери Дивайсиз Лимитед Aerosol generator for nebulizer

Families Citing this family (198)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5758637A (en) 1995-08-31 1998-06-02 Aerogen, Inc. Liquid dispensing apparatus and methods
US6235177B1 (en) 1999-09-09 2001-05-22 Aerogen, Inc. Method for the construction of an aperture plate for dispensing liquid droplets
AU2001223397A1 (en) * 2000-02-01 2001-08-14 Disetronic Licensing Ag Configurable device and method for releasing a substance
US8336545B2 (en) 2000-05-05 2012-12-25 Novartis Pharma Ag Methods and systems for operating an aerosol generator
US7100600B2 (en) * 2001-03-20 2006-09-05 Aerogen, Inc. Fluid filled ampoules and methods for their use in aerosolizers
US7677467B2 (en) 2002-01-07 2010-03-16 Novartis Pharma Ag Methods and devices for aerosolizing medicament
EP1471960B1 (en) 2002-01-07 2019-03-13 Novartis AG Devices for nebulizing fluids for inhalation
AU2003203043A1 (en) 2002-01-15 2003-07-30 Aerogen, Inc. Methods and systems for operating an aerosol generator
US6865957B1 (en) * 2002-04-17 2005-03-15 Nathaniel Hughes Adaptable fluid mass flow meter device
US7607436B2 (en) * 2002-05-06 2009-10-27 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
US8245708B2 (en) * 2002-05-07 2012-08-21 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
ES2572770T3 (en) 2002-05-20 2016-06-02 Novartis Ag Apparatus for providing spray for medical treatment and methods
US6966649B2 (en) * 2002-08-12 2005-11-22 John H Shadduck Adaptive optic lens system and method of use
US8001962B2 (en) 2002-08-23 2011-08-23 Sheiman Ultrasonic Research Foundation Pty Ltd. Nebulizing and drug delivery device
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
CN1747738B (en) * 2002-10-29 2010-11-24 川塞夫有限公司 Sustained release of antifectives
US8545463B2 (en) * 2003-05-20 2013-10-01 Optimyst Systems Inc. Ophthalmic fluid reservoir assembly for use with an ophthalmic fluid delivery device
EP1624938B1 (en) * 2003-05-20 2011-03-16 James F. Collins Ophthalmic drug delivery system
US8616195B2 (en) 2003-07-18 2013-12-31 Novartis Ag Nebuliser for the production of aerosolized medication
FR2858236B1 (en) 2003-07-29 2006-04-28 Airox DEVICE AND METHOD FOR SUPPLYING RESPIRATORY GAS IN PRESSURE OR VOLUME
US7191780B2 (en) * 2003-09-22 2007-03-20 Comedica Incorporated Continuous high-frequency oscillation breathing treatment apparatus
GB2398065A (en) * 2003-10-16 2004-08-11 Bespak Plc Dispensing apparatus
DE102004005311A1 (en) * 2004-02-03 2005-08-18 Tecpharma Licensing Ag ampoules recognition
DE102004009434A1 (en) 2004-02-24 2005-12-15 Boehringer Ingelheim International Gmbh atomizer
EP1737517B1 (en) * 2004-04-02 2010-10-06 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services Aerosol delivery systems
US7946291B2 (en) 2004-04-20 2011-05-24 Novartis Ag Ventilation systems and methods employing aerosol generators
EP1755720A1 (en) * 2004-05-20 2007-02-28 Discovery Laboratories, Inc. Methods , systems and devices for noninvasive pulmonary delivery
FR2875138B1 (en) 2004-09-15 2008-07-11 Mallinckrodt Dev France Sa CONTROL METHOD FOR A HEATING HUMIDIFIER
DE202004017346U1 (en) * 2004-11-08 2005-01-05 Hansen, Bernd container
US7631643B2 (en) * 2005-03-09 2009-12-15 Ric Investments, Llc Nebulizing drug delivery device with interlock detection and temperature protection
US8028697B2 (en) 2005-04-28 2011-10-04 Trudell Medical International Ventilator circuit and method for the use thereof
WO2006125251A1 (en) * 2005-05-23 2006-11-30 Biosonic Australia Pty. Ltd. Apparatus for atomisation and liquid filtration
WO2006127181A2 (en) 2005-05-25 2006-11-30 Aerogen, Inc. Vibration systems and methods
US8496001B2 (en) * 2005-06-08 2013-07-30 Dräger Medical GmbH Process and device for the automatic identification of breathing tubes
DE102005038619A1 (en) * 2005-08-16 2007-02-22 Pari GmbH Spezialisten für effektive Inhalation An inhalation therapy device with an ampoule for storing a medicament to be nebulised
KR20080039503A (en) * 2005-08-22 2008-05-07 메디-스트림 피티와이 리미티드 Medication dispenser and carrier therefor
WO2007024812A1 (en) * 2005-08-23 2007-03-01 Aerogen, Inc. Self-sealing t-piece and valved t-piece
CN101287446A (en) 2005-09-29 2008-10-15 尼克塔治疗公司 Antibiotic formulations, unit doses, kits, and methods
JP4789567B2 (en) * 2005-10-04 2011-10-12 キヤノン株式会社 Liquid ejection device
DK1962805T3 (en) 2005-12-08 2016-09-26 Insmed Inc Lipid-based compositions of the anti-infective agents for the treatment of lung infections
DE102006006183A1 (en) * 2006-02-10 2007-08-16 Pari GmbH Spezialisten für effektive Inhalation Inhalation therapy device for use in premature babies and toddlers
US8460223B2 (en) 2006-03-15 2013-06-11 Hill-Rom Services Pte. Ltd. High frequency chest wall oscillation system
WO2007117550A2 (en) * 2006-04-06 2007-10-18 Transave, Inc. Methods for coacervation induced liposomal encapsulation and formulations thereof
US7909033B2 (en) 2006-05-03 2011-03-22 Comedica Incorporated Breathing treatment apparatus
US7980245B2 (en) * 2006-05-12 2011-07-19 The General Electric Company Informative accessories
WO2008008281A2 (en) 2006-07-07 2008-01-17 Proteus Biomedical, Inc. Smart parenteral administration system
US8051854B2 (en) 2006-09-15 2011-11-08 Comedica Incorporated Continuous high-frequency oscillation breathing treatment apparatus
US20080066739A1 (en) * 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
US20080110452A1 (en) * 2006-11-15 2008-05-15 Delphi Technologies Inc. Nebulizer and method for controlling an amount of liquid that is atomized by the nebulizer
JP2008199905A (en) * 2007-02-16 2008-09-04 Snow Brand Milk Prod Co Ltd Improving agent for survivability of lactic acid bacterium
WO2008117265A1 (en) * 2007-03-28 2008-10-02 Stamford Devices Limited Humidification in breathing circuits
WO2008137717A1 (en) * 2007-05-04 2008-11-13 Transave, Inc. Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) * 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9050434B2 (en) 2007-05-18 2015-06-09 Comedica Incorporated Lung therapy device
US8297280B2 (en) * 2007-07-20 2012-10-30 Canon Kabushiki Kaisha Inhaler
MX2010003263A (en) * 2007-09-25 2010-06-02 Novartis Ag Treatment of pulmonary disorders with aerosolized medicaments such as vancomycin.
WO2009055733A1 (en) 2007-10-25 2009-04-30 Proteus Biomedical, Inc. Fluid transfer port information system
WO2009067463A1 (en) 2007-11-19 2009-05-28 Proteus Biomedical, Inc. Body-associated fluid transport structure evaluation devices
JP2011502737A (en) 2007-11-19 2011-01-27 ケアフュージョン2200、インコーポレイテッド Respiratory therapy system with electromechanical driver
DE102007056462B4 (en) 2007-11-23 2011-10-27 Pari Pharma Gmbh Disposable ampoule for a device for generating aerosols
US20100312384A1 (en) * 2007-11-29 2010-12-09 Searete LLC, limited liability corporation of the state of Delaware Programmed dispensing of consumable compositions
US20090254215A1 (en) * 2007-11-29 2009-10-08 Searete Llc Programmed dispensing of consumable compositions
US9111324B2 (en) * 2007-11-29 2015-08-18 The Invention Science Fund I, Llc Programmed dispensing of consumable compositions
US20090212133A1 (en) * 2008-01-25 2009-08-27 Collins Jr James F Ophthalmic fluid delivery device and method of operation
US20090188500A1 (en) * 2008-01-29 2009-07-30 Joseph Dee Faram Combination breathing treatment method
KR101259246B1 (en) 2008-03-17 2013-04-29 디스커버리 라보라토리스, 인크. Ventilation circuit adaptor and proximal aerosol delivery system
DK2285439T3 (en) 2008-04-04 2014-03-24 Nektar Therapeutics Aerosoliseringsanorning
US8457706B2 (en) 2008-05-16 2013-06-04 Covidien Lp Estimation of a physiological parameter using a neural network
WO2010014340A1 (en) * 2008-07-26 2010-02-04 Hewlett-Packard Development Company, L.P. Fluid supply contact
WO2010036816A1 (en) 2008-09-25 2010-04-01 Nellcor Puritan Bennett Llc Inversion-based feed-forward compensation of inspiratory trigger dynamics in medical ventilators
US8302602B2 (en) 2008-09-30 2012-11-06 Nellcor Puritan Bennett Llc Breathing assistance system with multiple pressure sensors
US8707954B2 (en) * 2008-10-09 2014-04-29 Daniel A. McCarthy Air/oxygen supply system and method
EP2179760B1 (en) 2008-10-22 2013-02-27 Trudell Medical International Modular Aerosol Delivery System
AT507187B1 (en) * 2008-10-23 2010-03-15 Helmut Dr Buchberger INHALER
EP2201850A1 (en) 2008-12-24 2010-06-30 Philip Morris Products S.A. An article including identification information for use in an electrically heated smoking system
US8267081B2 (en) * 2009-02-20 2012-09-18 Baxter International Inc. Inhaled anesthetic agent therapy and delivery system
US8434479B2 (en) 2009-02-27 2013-05-07 Covidien Lp Flow rate compensation for transient thermal response of hot-wire anemometers
US20130255678A1 (en) * 2009-07-01 2013-10-03 Microdose Therapeutx, Inc. Nebulizer for infants and respiratory compromised patients
US20110056493A1 (en) * 2009-09-10 2011-03-10 Kim Iola Miller Sleep apnea vapor inhaler adapter
US9151425B2 (en) 2009-11-02 2015-10-06 Comedica Incorporated Multiple conduit connector apparatus and method
US8945066B2 (en) * 2009-11-06 2015-02-03 Crisi Medical Systems, Inc. Medication injection site and data collection system
RU2550668C2 (en) * 2009-11-11 2015-05-10 Конинклейке Филипс Электроникс Н.В. Method and device for medication delivery
US8439036B2 (en) 2009-12-01 2013-05-14 Covidien Lp Exhalation valve assembly with integral flow sensor
US8469031B2 (en) 2009-12-01 2013-06-25 Covidien Lp Exhalation valve assembly with integrated filter
US8439037B2 (en) 2009-12-01 2013-05-14 Covidien Lp Exhalation valve assembly with integrated filter and flow sensor
US8469030B2 (en) 2009-12-01 2013-06-25 Covidien Lp Exhalation valve assembly with selectable contagious/non-contagious latch
US9545488B2 (en) 2010-01-12 2017-01-17 Dance Biopharm Inc. Preservative-free single dose inhaler systems
US20130269684A1 (en) 2012-04-16 2013-10-17 Dance Pharmaceuticals, Inc. Methods and systems for supplying aerosolization devices with liquid medicaments
US9180261B2 (en) 2010-01-12 2015-11-10 Dance Biopharm Inc. Preservative free insulin formulations and systems and methods for aerosolizing
US20110180063A1 (en) 2010-01-28 2011-07-28 General Electric Company Compensation for unmeasurable inspiratory flow in a critical care ventilator
EP2531099B1 (en) 2010-02-01 2018-12-12 Proteus Digital Health, Inc. Data gathering system
CN102905612A (en) 2010-02-01 2013-01-30 普罗秋斯数字健康公司 Two-wrist data gathering system
US8844521B2 (en) 2010-04-09 2014-09-30 Daniel A. McCarthy Air/oxygen ventilator system and method
USD653749S1 (en) 2010-04-27 2012-02-07 Nellcor Puritan Bennett Llc Exhalation module filter body
USD655809S1 (en) 2010-04-27 2012-03-13 Nellcor Puritan Bennett Llc Valve body with integral flow meter for an exhalation module
USD655405S1 (en) 2010-04-27 2012-03-06 Nellcor Puritan Bennett Llc Filter and valve body for an exhalation module
WO2011154276A1 (en) * 2010-06-07 2011-12-15 Boehringer Ingelheim International Gmbh Safety system with a transponder and a reading device of an rfid system
CN103118642B (en) 2010-07-15 2015-09-09 艾诺维亚股份有限公司 Drop formation device
WO2012009696A2 (en) 2010-07-15 2012-01-19 Corinthian Ophthalmic, Inc. Ophthalmic drug delivery
US10154923B2 (en) 2010-07-15 2018-12-18 Eyenovia, Inc. Drop generating device
WO2012009702A1 (en) 2010-07-15 2012-01-19 Corinthian Ophthalmic, Inc. Method and system for performing remote treatment and monitoring
US8689439B2 (en) 2010-08-06 2014-04-08 Abbott Laboratories Method for forming a tube for use with a pump delivery system
JP6165628B2 (en) * 2010-08-19 2017-07-19 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Method and system for determining information relating to a drug reservoir using an electronic sensor
CN103328028B (en) 2010-08-24 2016-10-26 特鲁德尔医学国际公司 aerosol delivery device
US8377000B2 (en) 2010-10-01 2013-02-19 Abbott Laboratories Enteral feeding apparatus having a feeding set
US8377001B2 (en) 2010-10-01 2013-02-19 Abbott Laboratories Feeding set for a peristaltic pump system
EP2457609A1 (en) * 2010-11-24 2012-05-30 PARI Pharma GmbH Aerosol generator
EP2468118A1 (en) 2010-12-24 2012-06-27 Philip Morris Products S.A. An aerosol generating system with means for disabling a consumable
US9629971B2 (en) 2011-04-29 2017-04-25 Covidien Lp Methods and systems for exhalation control and trajectory optimization
WO2012156725A1 (en) * 2011-05-16 2012-11-22 The Technology Partnership Plc Dose container
WO2012161685A1 (en) * 2011-05-23 2012-11-29 Boehringer Ingelheim International Gmbh Nebulizer
US8826904B2 (en) 2011-07-12 2014-09-09 Cardeas Pharma Corporation Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
JP2014523909A (en) 2011-07-12 2014-09-18 カーディアス ファーマ コーポレイション Formulation and method and system of amikacin and fosfomycin combination for the treatment of ventilator-associated pneumonia (VAP) and ventilator-associated trachea (VAT) bronchitis
DE102011079810B4 (en) * 2011-07-26 2013-04-04 Pari Pharma Gmbh Disposable ampoule for insertion into an aerosol generator
GB201116271D0 (en) * 2011-09-21 2011-11-02 Univ Cardiff Dispersion anaesthetic device
TWI546023B (en) 2011-10-27 2016-08-21 菲利浦莫里斯製品股份有限公司 An electrically operated aerosol generating system having aerosol production control
US9364624B2 (en) 2011-12-07 2016-06-14 Covidien Lp Methods and systems for adaptive base flow
WO2013090468A1 (en) 2011-12-12 2013-06-20 Corinthian Ophthalmic, Inc. High modulus polymeric ejector mechanism, ejector device, and methods of use
US9498589B2 (en) 2011-12-31 2016-11-22 Covidien Lp Methods and systems for adaptive base flow and leak compensation
US9144658B2 (en) 2012-04-30 2015-09-29 Covidien Lp Minimizing imposed expiratory resistance of mechanical ventilator by optimizing exhalation valve control
LT2852391T (en) 2012-05-21 2022-03-10 Insmed Incorporated Systems for treating pulmonary infections
JP6385922B2 (en) * 2012-06-11 2018-09-05 スタムフォード・ディバイセズ・リミテッド Method of manufacturing an aperture plate for a nebulizer
US10507294B2 (en) * 2012-08-13 2019-12-17 Koninklijke Philips N.V. Handheld dyspnea treatment device with drug and gas delivery
AU2013352259B2 (en) 2012-11-29 2018-06-14 Insmed Incorporated Stabilized vancomycin formulations
US9795752B2 (en) 2012-12-03 2017-10-24 Mhs Care-Innovation, Llc Combination respiratory therapy device, system, and method
USD731049S1 (en) 2013-03-05 2015-06-02 Covidien Lp EVQ housing of an exhalation module
USD701601S1 (en) 2013-03-08 2014-03-25 Covidien Lp Condensate vial of an exhalation module
USD731048S1 (en) 2013-03-08 2015-06-02 Covidien Lp EVQ diaphragm of an exhalation module
USD736905S1 (en) 2013-03-08 2015-08-18 Covidien Lp Exhalation module EVQ housing
USD693001S1 (en) 2013-03-08 2013-11-05 Covidien Lp Neonate expiratory filter assembly of an exhalation module
USD744095S1 (en) 2013-03-08 2015-11-24 Covidien Lp Exhalation module EVQ internal flow sensor
USD692556S1 (en) 2013-03-08 2013-10-29 Covidien Lp Expiratory filter body of an exhalation module
USD731065S1 (en) 2013-03-08 2015-06-02 Covidien Lp EVQ pressure sensor filter of an exhalation module
US9950135B2 (en) 2013-03-15 2018-04-24 Covidien Lp Maintaining an exhalation valve sensor assembly
CA2882405C (en) 2013-03-15 2019-12-03 Trudell Medical International Ventilator circuit, adapter for use in ventilator circuit and methods for the use thereof
US10512741B2 (en) * 2013-09-13 2019-12-24 Mallinckrodt Hospital Products IP Limited Clinical decision support system and methods
KR101520857B1 (en) * 2014-01-23 2015-05-18 (주)알메카 Portable nebulizer of artificial intelligence spraying type
ES2926985T3 (en) 2014-05-15 2022-10-31 Insmed Inc Methods for treating nontuberculous mycobacterial lung infections
US11273271B2 (en) 2014-07-01 2022-03-15 Aerami Therapeutics, Inc. Aerosolization system with flow restrictor and feedback device
US10857313B2 (en) 2014-07-01 2020-12-08 Aerami Therapeutics, Inc. Liquid nebulization systems and methods
US10471222B2 (en) 2014-07-01 2019-11-12 Dance Biopharm Inc. Aerosolization system with flow restrictor and feedback device
WO2016033419A1 (en) 2014-08-28 2016-03-03 Microdose Therapeutx, Inc. Compliance monitoring module for a breath-actuated inhaler
EP3037120A1 (en) 2014-12-23 2016-06-29 PARI Pharma GmbH Aerosol delivery device and operating method for the aerosol delivery device
CN107106325B (en) 2015-01-12 2021-05-25 科达莱昂治疗公司 Droplet delivery apparatus and method
CN107206199B (en) * 2015-01-22 2021-02-09 皇家飞利浦有限公司 Inhalation aid for feature distribution
AU2016225111B2 (en) 2015-02-27 2021-12-09 Board Of Regents, The University Of Texas System Polypeptide therapeutics and uses thereof
CN107735135B (en) 2015-04-02 2020-06-26 希尔-罗姆服务私人有限公司 Manifold for a respiratory device
USD775345S1 (en) 2015-04-10 2016-12-27 Covidien Lp Ventilator console
EP3302658B1 (en) * 2015-06-03 2019-09-04 Novopyxis, Inc. Fluid delivery devices
US11419818B2 (en) * 2015-06-16 2022-08-23 Kathryn Cashman System for managing inhalant and breath analysis devices
CA3008793A1 (en) * 2015-06-16 2016-12-22 Kathryn CASHMAN Inhalant device
US10556074B2 (en) 2015-07-17 2020-02-11 Daniel A. McCarthy Artificial respiration system with timing control and automatic mask detection
CN117256964A (en) 2015-08-14 2023-12-22 菲利普莫里斯生产公司 Electrically operated smoking device for receiving a smoking article
US11291252B2 (en) * 2015-12-18 2022-04-05 Rai Strategic Holdings, Inc. Proximity sensing for an aerosol delivery device
CN105717812B (en) * 2016-01-25 2019-03-29 深圳市合元科技有限公司 A kind of Intelligentized control method based on electronic cigarette, control system and electronic cigarette
EP3210495B1 (en) * 2016-02-23 2022-03-16 Braun GmbH Cosmetic device with exchangeable application head
US10478586B2 (en) 2016-03-02 2019-11-19 Daniel A. McCarthy Artificial respiration system and method having automatic mask detection
KR102122887B1 (en) 2016-05-03 2020-06-16 뉴마 레스퍼러토리 인코포레이티드 Droplet delivery device and method of use for delivery of fluids to the waste relationship
ES2929335T3 (en) * 2016-05-27 2022-11-28 Proveris Scient Corporation Devices for the use of medication devices
DE102017100012A1 (en) 2017-01-02 2018-07-05 Nebu-Tec Med. Produkte Eike Kern Gmbh Nebulizer unit with directly connectable ampoule
CA3039106A1 (en) * 2017-01-20 2018-07-26 Kedalion Therapeutics, Inc. Piezoelectric fluid dispenser
US10987474B2 (en) 2017-03-23 2021-04-27 Stamford Devices Ltd. Retrofit aerosol delivery system and method
AU2018240521B2 (en) * 2017-03-23 2023-06-01 Stamford Devices Ltd Retrofit aerosol delivery system and method
US11529476B2 (en) 2017-05-19 2022-12-20 Pneuma Respiratory, Inc. Dry powder delivery device and methods of use
EP3634550A4 (en) 2017-06-10 2021-03-03 Eyenovia, Inc. Methods and devices for handling a fluid and delivering the fluid to the eye
GB2553031B (en) 2017-06-27 2021-12-29 Kohler Mira Ltd Additive dispenser
TWM552818U (en) * 2017-07-11 2017-12-11 益寵生醫股份有限公司 Medical injection and aspiration apparatus
JP2020536614A (en) 2017-10-04 2020-12-17 ニューマ・リスパイラトリー・インコーポレイテッド In-line droplet delivery device and usage that is electrically operated by breathing
WO2019079461A1 (en) 2017-10-17 2019-04-25 Pneuma Respiratory, Inc. Nasal drug delivery apparatus and methods of use
CN111479604B (en) 2017-11-08 2022-12-30 精呼吸股份有限公司 Electrically breath actuated in-line droplet delivery device with small volume ampoule and method of use
US11305073B2 (en) * 2018-02-07 2022-04-19 Monitored Therapeutics, Inc Device and method for targeted delivery of aerosolized particles to the lungs
EP3758603A4 (en) * 2018-03-02 2021-12-01 Singapore Health Services Pte Ltd Device and method for measuring respiratory air flow
GB201805268D0 (en) * 2018-03-29 2018-05-16 Nicoventures Trading Ltd Apaaratus for generating aerosol from an aerosolisable medium, an article of aerosolisable medium and a method of operating an aerosol generating apparatus
US10881844B2 (en) * 2018-03-30 2021-01-05 L'oreal Systems for producing an aerosol and related methods of use
EP3773505A4 (en) 2018-03-30 2021-12-22 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
US20210106772A1 (en) * 2018-04-02 2021-04-15 Pneuma Respiratory, Inc. Handheld digital nebulizer device and methods of use
CN112739367A (en) 2018-09-10 2021-04-30 肺疾治疗公司 Modified peptide fragments of CAV-1 protein and their use in the treatment of fibrosis
TWI672607B (en) * 2018-12-05 2019-09-21 心誠鎂行動醫電股份有限公司 Atomization system and method having authentication mechanism
CN109621108B (en) * 2019-01-15 2021-03-19 青岛大学附属医院 Medicine device is spouted in children's atomizing with adjustable
GB201901066D0 (en) * 2019-01-25 2019-03-13 Nicoventures Trading Ltd Aerosol generating apparatus, aerosol generating article and method of determining data associated with an aerosol generating article
US11679028B2 (en) 2019-03-06 2023-06-20 Novartis Ag Multi-dose ocular fluid delivery system
US11666931B2 (en) 2019-05-14 2023-06-06 Kohler Co. Inline shower device
KR102272405B1 (en) * 2019-08-05 2021-07-02 주식회사 케이티앤지 Aerosol generating device, operating method therefor, and computer readable recording medium with program for the method
GB202002211D0 (en) * 2020-02-18 2020-04-01 Nicoventures Trading Ltd Aerosol provision device, aerosol generating article and aerosol provision system
US11896767B2 (en) 2020-03-20 2024-02-13 Covidien Lp Model-driven system integration in medical ventilators
CR20220500A (en) 2020-04-03 2022-11-18 Bayer Ag Pharmaceutical formulations polyethylene glycol-based prodrugs of adrenomedullin and use
US20230149553A1 (en) 2020-04-03 2023-05-18 Bayer Aktiengesellschaft Liquid pharmaceutical formulations polyethylene glycol-based prodrugs of adrenomedullin and use
WO2021212033A1 (en) 2020-04-17 2021-10-21 Kedallon Therapeutics, Inc. Hydrodynamically actuated preservative free dispensing system
US11938057B2 (en) 2020-04-17 2024-03-26 Bausch + Lomb Ireland Limited Hydrodynamically actuated preservative free dispensing system
WO2021226105A1 (en) * 2020-05-05 2021-11-11 Bioventures, Llc Endotracheal tube cuff with integrated sensors
CN115768289A (en) * 2020-06-12 2023-03-07 日本烟草国际股份有限公司 Smoking article including information encoding for an aerosol-generating device
US20220016365A1 (en) * 2020-07-14 2022-01-20 Stamford Devices Limited Vaccine administration apparatus and method
WO2022271848A1 (en) 2021-06-22 2022-12-29 Pneuma Respiratory, Inc. Droplet delivery device with push ejection
US11944993B1 (en) * 2022-11-22 2024-04-02 John A. Burgener Semi concentric enhanced parallel path pneumatic nebulizer
US11925748B1 (en) * 2023-06-08 2024-03-12 Microneb Tech Holdings, Inc. Apparatus, methods, and systems for administering a medication to a patient from a capsule using an atomizer

Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4934358A (en) * 1986-03-24 1990-06-19 Sven-Erik Nilsson Device for self-administration of physiologically active substances, with prevention of overdosing
WO1992017231A1 (en) * 1991-03-28 1992-10-15 Innomed, Inc. Microelectronic inhaler having a counter and timer
US5164740A (en) 1991-04-24 1992-11-17 Yehuda Ivri High frequency printing mechanism
US5322057A (en) * 1987-07-08 1994-06-21 Vortran Medical Technology, Inc. Intermittent signal actuated nebulizer synchronized to operate in the exhalation phase, and its method of use
US5479920A (en) * 1994-03-01 1996-01-02 Vortran Medical Technology, Inc. Breath actuated medicinal aerosol delivery apparatus
US5515842A (en) * 1993-08-09 1996-05-14 Disetronic Ag Inhalation device
US5586550A (en) 1995-08-31 1996-12-24 Fluid Propulsion Technologies, Inc. Apparatus and methods for the delivery of therapeutic liquids to the respiratory system
US5758637A (en) 1995-08-31 1998-06-02 Aerogen, Inc. Liquid dispensing apparatus and methods
US5819730A (en) * 1993-06-09 1998-10-13 Glaxo Wellcome Australia Ltd. Device for administering pharmaceutical substances
US5938117A (en) 1991-04-24 1999-08-17 Aerogen, Inc. Methods and apparatus for dispensing liquids as an atomized spray
US5950619A (en) * 1995-03-14 1999-09-14 Siemens Aktiengesellschaft Ultrasonic atomizer device with removable precision dosating unit
US5970974A (en) * 1995-03-14 1999-10-26 Siemens Aktiengesellschaft Dosating unit for an ultrasonic atomizer device
US6014970A (en) 1998-06-11 2000-01-18 Aerogen, Inc. Methods and apparatus for storing chemical compounds in a portable inhaler
US6085740A (en) 1996-02-21 2000-07-11 Aerogen, Inc. Liquid dispensing apparatus and methods
US6235177B1 (en) 1999-09-09 2001-05-22 Aerogen, Inc. Method for the construction of an aperture plate for dispensing liquid droplets
US6269810B1 (en) * 1998-03-05 2001-08-07 Battelle Memorial Institute Pulmonary dosing system and method

Family Cites Families (414)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2735427A (en) * 1956-02-21 Hypodermic syringe
US550315A (en) 1895-11-26 Frank napoleon allen
US809159A (en) * 1905-09-30 1906-01-02 Richard M Willis Dispensing bottle or jar.
US1680616A (en) 1922-06-06 1928-08-14 Horst Friedrich Wilhelm Sealed package
US2022520A (en) 1934-07-07 1935-11-26 Parsons Ammonia Company Inc Bottle
US2101304A (en) 1936-06-05 1937-12-07 Sheaffer W A Pen Co Fountain pen
US2187528A (en) * 1937-06-07 1940-01-16 Russell T Wing Fountain pen
US2158615A (en) 1937-07-26 1939-05-16 Sheaffer W A Pen Co Fountain pen
US2266706A (en) 1938-08-06 1941-12-16 Stanley L Fox Nasal atomizing inhaler and dropper
NL62585C (en) 1939-01-06
US2292381A (en) 1940-12-24 1942-08-11 Esterbrook Steel Pen Mfg Co Fountain pen feed
US2283333A (en) 1941-05-22 1942-05-19 Sheaffer W A Pen Co Fountain pen
US2383098A (en) * 1942-07-21 1945-08-21 Jr Frank H Wheaton Double-mouthed bottle
US2375770A (en) 1943-11-19 1945-05-15 Arthur O Dahiberg Fountain pen
US2430023A (en) 1944-01-27 1947-11-04 Esterbrook Pen Co Writing implement
NL63900C (en) 1944-04-10
US2404063A (en) 1944-04-27 1946-07-16 Parker Pen Co Fountain pen
US2521657A (en) 1944-07-07 1950-09-05 Scripto Inc Fountain pen
US2512004A (en) 1945-03-05 1950-06-20 Russell T Wing Fountain pen
US2474996A (en) 1945-10-12 1949-07-05 Sheaffer W A Pen Co Fountain pen
BE473698A (en) 1946-06-08
US2705007A (en) * 1951-09-10 1955-03-29 Louis P Gerber Inhaler
US2764979A (en) 1953-04-09 1956-10-02 Henderson Edward Medicament dispensing unit
US2764946A (en) 1954-04-05 1956-10-02 Scognamillo Frank Rotary pump
US2779623A (en) * 1954-09-10 1957-01-29 Bernard J Eisenkraft Electromechanical atomizer
US2935970A (en) 1955-03-23 1960-05-10 Sapphire Products Inc Fountain pen ink reservoir
DE1103522B (en) 1957-10-24 1961-03-30 Transform Roentgen Matern Veb Exhalation device for aerosols generated by means of ultrasound
US3103310A (en) 1961-11-09 1963-09-10 Exxon Research Engineering Co Sonic atomizer for liquids
GB973458A (en) 1962-10-16 1964-10-28 Exxon Research Engineering Co Improvements in or relating to methods and apparatus for atomising liquids
FR1449600A (en) 1964-09-14 1966-05-06 Fr Des Laboratoires Labaz Soc Improvements to flexible material bottles, especially for medicinal products
DE1461628A1 (en) 1965-04-30 1969-03-27 Montblanc Simplo Gmbh Ink feed for fountain pen
US3680954A (en) 1965-04-30 1972-08-01 Eastman Kodak Co Electrography
DE1654994A1 (en) 1967-02-17 1970-03-26 Neff Werke Carl Neff Gmbh Bret Floor-free cooking appliances, especially for large kitchens
US3550864A (en) 1967-12-11 1970-12-29 Borg Warner High efficiency flashing nozzle
US3561444A (en) * 1968-05-22 1971-02-09 Bio Logics Inc Ultrasonic drug nebulizer
US3515348A (en) 1968-07-22 1970-06-02 Lewbill Ind Inc Mist-producing device
US3558052A (en) * 1968-10-31 1971-01-26 F I N D Inc Method and apparatus for spraying electrostatic dry powder
US3563415A (en) * 1969-06-04 1971-02-16 Multi Drop Adapter Corp Multidrop adapter
US3719328A (en) * 1970-10-22 1973-03-06 C Hindman Adjustable spray head
US3738574A (en) 1971-06-15 1973-06-12 Siemens Ag Apparatus for atomizing fluids with a piezoelectrically stimulated oscillator system
NO134730L (en) 1971-07-19 1900-01-01
US3838686A (en) 1971-10-14 1974-10-01 G Szekely Aerosol apparatus for inhalation therapy
US3983740A (en) 1971-12-07 1976-10-05 Societe Grenobloise D'etudes Et D'applications Hydrauliques (Sogreah) Method and apparatus for forming a stream of identical drops at very high speed
US3790079A (en) * 1972-06-05 1974-02-05 Rnb Ass Inc Method and apparatus for generating monodisperse aerosol
US3778786A (en) 1972-06-28 1973-12-11 Nasa Data storage, image tube type
US3812854A (en) 1972-10-20 1974-05-28 A Michaels Ultrasonic nebulizer
US3842833A (en) 1972-12-11 1974-10-22 Ims Ltd Neb-u-pack
FR2224175B1 (en) 1973-04-04 1978-04-14 Isf Spa
AT323114B (en) 1973-05-07 1975-06-25 Voest Ag PROCEDURE FOR PRILLING
US3804329A (en) * 1973-07-27 1974-04-16 J Martner Ultrasonic generator and atomizer apparatus and method
US3903884A (en) * 1973-08-15 1975-09-09 Becton Dickinson Co Manifold nebulizer system
DE2361781A1 (en) * 1973-12-12 1975-06-19 Philips Patentverwaltung WRITING WORK FOR WRITING WITH LIQUID INK
US3865106A (en) * 1974-03-18 1975-02-11 Bernard P Palush Positive pressure breathing circuit
US3951313A (en) * 1974-06-05 1976-04-20 Becton, Dickinson And Company Reservoir with prepacked diluent
US3993223A (en) 1974-07-25 1976-11-23 American Home Products Corporation Dispensing container
US3908654A (en) 1974-08-02 1975-09-30 Rit Rech Ind Therapeut Dispensing package for a dry biological and a liquid diluent
DE2445791C2 (en) 1974-09-25 1984-04-19 Siemens AG, 1000 Berlin und 8000 München Ultrasonic liquid atomizer
AR205589A1 (en) 1974-10-09 1976-05-14 Reckitt & Colmann Prod Ltd INTRODUCING DEVICE OF AN AQUEOUS COMPOSITION INTO A BODY CAVITY
US3958249A (en) 1974-12-18 1976-05-18 International Business Machines Corporation Ink jet drop generator
US4059384A (en) 1975-01-20 1977-11-22 Misto2 Gen Equipment Co. Two-step injection molding
AT337345B (en) * 1975-02-05 1977-06-27 Draegerwerk Ag BREATHING ASSISTANCE DEVICE AND / OR ARTIFICIAL VENTILATION DEVICE FOR HUMAN USE
US4005435A (en) * 1975-05-15 1977-01-25 Burroughs Corporation Liquid jet droplet generator
AU67278S (en) 1975-06-04 1975-11-12 Warner Lambert Co Bottle
DE2537765B2 (en) 1975-08-25 1981-04-09 Siemens AG, 1000 Berlin und 8000 München Medical inhalation device for the treatment of diseases of the respiratory tract
GB1571304A (en) 1976-02-24 1980-07-16 Lucas Industries Ltd Drive circuit for a piezo electric crystal
US4094317A (en) 1976-06-11 1978-06-13 Wasnich Richard D Nebulization system
US4121583A (en) 1976-07-13 1978-10-24 Wen Yuan Chen Method and apparatus for alleviating asthma attacks
US4076021A (en) * 1976-07-28 1978-02-28 Thompson Harris A Positive pressure respiratory apparatus
US4083368A (en) * 1976-09-01 1978-04-11 Freezer Winthrop J Inhaler
USD249958S (en) 1977-01-10 1978-10-17 Warner-Lambert Company Dispensing container for pharmaceutical diluents
US4106503A (en) 1977-03-11 1978-08-15 Richard R. Rosenthal Metering system for stimulating bronchial spasm
US4159803A (en) 1977-03-31 1979-07-03 MistO2 Gen Equipment Company Chamber for ultrasonic aerosol generation
US4113809A (en) 1977-04-04 1978-09-12 Champion Spark Plug Company Hand held ultrasonic nebulizer
US4101041A (en) 1977-08-01 1978-07-18 Becton, Dickinson And Company Prefillable, hermetically sealed container adapted for use with a humidifier or nebulizer head
US4268460A (en) 1977-12-12 1981-05-19 Warner-Lambert Company Nebulizer
USD259213S (en) 1978-03-13 1981-05-12 Automatic Liquid Packaging, Inc. Vial suitable for pharmaceuticals
DE2811248C3 (en) 1978-03-15 1981-11-26 Bosch-Siemens Hausgeräte GmbH, 7000 Stuttgart Liquid atomizer
US4298045A (en) 1978-04-17 1981-11-03 Automatic Liquid Packaging, Inc. Dispensing container with plural removable closure means unitary therewith
US4338576A (en) 1978-07-26 1982-07-06 Tdk Electronics Co., Ltd. Ultrasonic atomizer unit utilizing shielded and grounded elements
US4210155A (en) * 1978-08-03 1980-07-01 Jerry Grimes Inspirational inhalation spirometer apparatus
DE2843756B2 (en) * 1978-10-06 1981-07-09 Hense GmbH & Co, 4930 Detmold Device for generating an aerosol
US4240081A (en) 1978-10-13 1980-12-16 Dennison Manufacturing Company Ink jet printing
DE2849493C2 (en) 1978-11-15 1982-01-14 Carl Heyer Gmbh, Inhalationstechnik, 5427 Bad Ems Hand-held aerosol dispenser
DE2854841C2 (en) 1978-12-19 1981-03-26 Bosch-Siemens Hausgeräte GmbH, 7000 Stuttgart Liquid atomizer, preferably inhalation device
JPS5848225B2 (en) * 1979-01-09 1983-10-27 オムロン株式会社 Atomization amount control method of ultrasonic liquid atomization device
DE2907348A1 (en) * 1979-02-24 1980-09-04 Boehringer Sohn Ingelheim IMPROVED INHALATION DEVICES
US4207990A (en) 1979-05-03 1980-06-17 Automatic Liquid Packaging, Inc. Hermetically sealed container with plural access ports
US4226236A (en) 1979-05-07 1980-10-07 Abbott Laboratories Prefilled, vented two-compartment syringe
US4248227A (en) * 1979-05-14 1981-02-03 Bristol-Myers Company Fluid unit dispensing device
US4240417A (en) * 1979-06-13 1980-12-23 Holever Bernard K Tracheal tube adapter for ventilating apparatus
DE7917568U1 (en) 1979-06-19 1979-09-20 Bosch-Siemens Hausgeraete Gmbh, 7000 Stuttgart INHALATION DEVICE
JPS5689569A (en) 1979-12-19 1981-07-20 Canon Inc Ink jet recording head
US4368850A (en) * 1980-01-17 1983-01-18 George Szekely Dry aerosol generator
DE3010178C2 (en) * 1980-03-17 1985-10-03 Kraftwerk Union AG, 4330 Mülheim Slotted nozzle equipped with a quick-acting valve to induce pulsed gas flows
US4402458A (en) 1980-04-12 1983-09-06 Battelle-Institut E.V. Apparatus for atomizing liquids
US4336544A (en) 1980-08-18 1982-06-22 Hewlett-Packard Company Method and apparatus for drop-on-demand ink jet printing
JPS5929118B2 (en) * 1980-09-19 1984-07-18 セイコーエプソン株式会社 Palladium/nickel alloy plating liquid
CA1178191A (en) 1980-10-06 1984-11-20 Naoyoshi Maehara Electric liquid atomizing apparatus
US4474251A (en) 1980-12-12 1984-10-02 Hydronautics, Incorporated Enhancing liquid jet erosion
US4389071A (en) 1980-12-12 1983-06-21 Hydronautics, Inc. Enhancing liquid jet erosion
US4374707A (en) * 1981-03-19 1983-02-22 Xerox Corporation Orifice plate for ink jet printing machines
US5862802A (en) * 1981-04-03 1999-01-26 Forrest M. Bird Ventilator having an oscillatory inspiratory phase and method
US4454877A (en) 1981-05-26 1984-06-19 Andrew Boettner Portable nebulizer or mist producing device
NL8202263A (en) 1981-06-06 1983-01-03 Rowenta Werke Gmbh ULTRASONORE RESPIRATOR.
US4408719A (en) 1981-06-17 1983-10-11 Last Anthony J Sonic liquid atomizer
US4475113A (en) 1981-06-18 1984-10-02 International Business Machines Drop-on-demand method and apparatus using converging nozzles and high viscosity fluids
JPS5861857A (en) 1981-10-09 1983-04-13 Matsushita Electric Works Ltd Liquid atomizer
AU553251B2 (en) 1981-10-15 1986-07-10 Matsushita Electric Industrial Co., Ltd. Arrangement for ejecting liquid
US4474326A (en) 1981-11-24 1984-10-02 Tdk Electronics Co., Ltd. Ultrasonic atomizing device
CA1206996A (en) 1982-01-18 1986-07-02 Naoyoshi Maehara Ultrasonic liquid ejecting apparatus
US5073484A (en) 1982-03-09 1991-12-17 Bio-Metric Systems, Inc. Quantitative analysis apparatus and method
DE3311956A1 (en) 1982-03-31 1983-10-13 Ricoh Co., Ltd., Tokyo COLOR JET PRINTER HEAD
US4566452A (en) * 1982-07-12 1986-01-28 American Hospital Supply Corporation Nebulizer
JPS5912775A (en) 1982-07-14 1984-01-23 Matsushita Electric Ind Co Ltd Atomizing pump unit
DE3229921A1 (en) 1982-08-11 1984-02-16 Linde Ag, 6200 Wiesbaden METHOD FOR THE SIMULTANEOUS FILLING OF SEVERAL ACETYLENE-FILLED BOTTLES OF SOLVENTS
US4973493A (en) 1982-09-29 1990-11-27 Bio-Metric Systems, Inc. Method of improving the biocompatibility of solid surfaces
US5258041A (en) 1982-09-29 1993-11-02 Bio-Metric Systems, Inc. Method of biomolecule attachment to hydrophobic surfaces
US4722906A (en) * 1982-09-29 1988-02-02 Bio-Metric Systems, Inc. Binding reagents and methods
US5512329A (en) 1982-09-29 1996-04-30 Bsi Corporation Substrate surface preparation
US5002582A (en) * 1982-09-29 1991-03-26 Bio-Metric Systems, Inc. Preparation of polymeric surfaces via covalently attaching polymers
US5217492A (en) 1982-09-29 1993-06-08 Bio-Metric Systems, Inc. Biomolecule attachment to hydrophobic surfaces
IT1156090B (en) 1982-10-26 1987-01-28 Olivetti & Co Spa INK JET PRINTING METHOD AND DEVICE
US4512341A (en) * 1982-11-22 1985-04-23 Lester Victor E Nebulizer with capillary feed
US4632311A (en) 1982-12-20 1986-12-30 Matsushita Electric Industrial Co., Ltd. Atomizing apparatus employing a capacitive piezoelectric transducer
DE3320441A1 (en) 1983-06-06 1984-12-06 Siemens AG, 1000 Berlin und 8000 München WRITING DEVICE WORKING WITH LIQUID DROPLETS WITH ROD-SHAPED PIEZOELECTRIC TRANSFORMERS CONNECTED ON BOTH ENDS WITH A NOZZLE PLATE
ATE27405T1 (en) 1983-08-02 1987-06-15 Trutek Research Inc RESPIRATORY VALVE.
US4544933A (en) 1983-09-20 1985-10-01 Siemens Aktiengesellschaft Apparatus and method for ink droplet ejection for a printer
EP0156409A3 (en) 1984-02-23 1986-06-25 Jean Michel Anthony Device for moistening parts of the human body
US4593291A (en) 1984-04-16 1986-06-03 Exxon Research And Engineering Co. Method for operating an ink jet device to obtain high resolution printing
DE3574344D1 (en) 1984-08-29 1989-12-28 Omron Tateisi Electronics Co Ultrasonic atomizer
US4628890A (en) 1984-08-31 1986-12-16 Freeman Winifer W Fuel atomizer
DE3582287D1 (en) 1984-09-07 1991-05-02 Omron Tateisi Electronics Co VIBRATION GENERATOR FOR AN INHALATION DEVICE WITH ULTRASONIC SPRAYING.
US4826759A (en) 1984-10-04 1989-05-02 Bio-Metric Systems, Inc. Field assay for ligands
NZ209900A (en) 1984-10-16 1989-08-29 Univ Auckland Automatic inhaler
US4550325A (en) 1984-12-26 1985-10-29 Polaroid Corporation Drop dispensing device
DE3500985A1 (en) 1985-01-14 1986-07-17 Siemens AG, 1000 Berlin und 8000 München ARRANGEMENT FOR PRODUCING SINGLE DROPLES IN INK WRITING DEVICES
SE447318B (en) 1985-05-21 1986-11-03 Nils Goran Stemme INTEGRATED SEMICONDUCTOR CIRCUIT WITH JOINT OF THERMALLY INSULATING SUBJECT, SET TO MAKE CIRCUIT AND ITS USE IN A FLOOD METER
DE3523947A1 (en) 1985-07-04 1987-01-08 Draegerwerk Ag NARCOSIS EVAPORATOR WITH INTERCHANGEABLE EVAPORATOR CHAMBER
DE3524701A1 (en) 1985-07-11 1987-01-15 Bosch Gmbh Robert ULTRASONIC SPRAYER NOZZLE
US4613326A (en) 1985-07-12 1986-09-23 Becton, Dickinson And Company Two-component medication syringe assembly
US4659014A (en) * 1985-09-05 1987-04-21 Delavan Corporation Ultrasonic spray nozzle and method
US4702418A (en) 1985-09-09 1987-10-27 Piezo Electric Products, Inc. Aerosol dispenser
ATE91752T1 (en) 1985-12-02 1993-08-15 Marco Alfredo Ganser CONTROL DEVICE FOR ELECTRO-HYDRAULICALLY ACTUATED FUEL INJECTION VALVES.
US4753579A (en) 1986-01-22 1988-06-28 Piezo Electric Products, Inc. Ultrasonic resonant device
US4678680A (en) 1986-02-20 1987-07-07 Xerox Corporation Corrosion resistant aperture plate for ink jet printers
JPS62221352A (en) 1986-03-22 1987-09-29 株式会社新素材総合研究所 Liquid drug containing container preventing deterioratioan of liquid drug by oxygen and its production
US4658269A (en) * 1986-06-02 1987-04-14 Xerox Corporation Ink jet printer with integral electrohydrodynamic electrodes and nozzle plate
US4849303A (en) 1986-07-01 1989-07-18 E. I. Du Pont De Nemours And Company Alloy coatings for electrical contacts
US4799622A (en) * 1986-08-05 1989-01-24 Tao Nenryo Kogyo Kabushiki Kaisha Ultrasonic atomizing apparatus
DE3627222A1 (en) 1986-08-11 1988-02-18 Siemens Ag ULTRASONIC POCKET SPRAYER
US4819834A (en) * 1986-09-09 1989-04-11 Minnesota Mining And Manufacturing Company Apparatus and methods for delivering a predetermined amount of a pressurized fluid
US4871489A (en) 1986-10-07 1989-10-03 Corning Incorporated Spherical particles having narrow size distribution made by ultrasonic vibration
US5263992A (en) 1986-10-17 1993-11-23 Bio-Metric Systems, Inc. Biocompatible device with covalently bonded biocompatible agent
US4979959A (en) 1986-10-17 1990-12-25 Bio-Metric Systems, Inc. Biocompatible coating for solid surfaces
DE3636669C2 (en) * 1986-10-28 2001-08-16 Siemens Ag Arrangement for delivering aerosol to a patient's airways and / or lungs
DE3637631C1 (en) 1986-11-05 1987-08-20 Philips Patentverwaltung Process for applying small amounts of molten, drop-shaped solder from a nozzle to surfaces to be wetted and device for carrying out the process
US4976259A (en) 1986-12-22 1990-12-11 Mountain Medical Equipment, Inc. Ultrasonic nebulizer
EP0282616B1 (en) * 1987-03-17 1989-10-04 Lechler GmbH & Co.KG Ultrasonic liquid sprayer
JPS63230957A (en) 1987-03-20 1988-09-27 Hitachi Ltd Liquid atomizing device
US4850534A (en) 1987-05-30 1989-07-25 Tdk Corporation Ultrasonic wave nebulizer
EP0295337B1 (en) * 1987-06-16 1991-12-04 Akzo Nobel N.V. Two compartment syringe and method of manufacturing
US5522382A (en) * 1987-06-26 1996-06-04 Rescare Limited Device and method for treating obstructed breathing having a delay/ramp feature
US5199424A (en) 1987-06-26 1993-04-06 Sullivan Colin E Device for monitoring breathing during sleep and control of CPAP treatment that is patient controlled
IL86799A (en) 1987-07-02 1993-03-15 Kabi Pharmacia Ab Method and device for injection
US5080093A (en) * 1987-07-08 1992-01-14 Vortran Medical Technology, Inc. Intermittant signal actuated nebulizer
US5388571A (en) * 1987-07-17 1995-02-14 Roberts; Josephine A. Positive-pressure ventilator system with controlled access for nebulizer component servicing
US4805609A (en) * 1987-07-17 1989-02-21 Josephine A. Roberts Pressurized ventilation system for patients
DE3724629A1 (en) 1987-07-22 1989-02-02 Siemens Ag PIEZOELECTRICALLY REQUIRED RESONANCE SYSTEM
US5139016A (en) 1987-08-07 1992-08-18 Sorin Biomedica S.P.A. Process and device for aerosol generation for pulmonary ventilation scintigraphy
FI82808C (en) * 1987-12-31 1991-04-25 Etelae Haemeen Keuhkovammayhdi Ultraljudfinfördelningsanordning
DE3808308A1 (en) * 1988-03-12 1989-09-21 Merck Patent Gmbh OPENING AID FOR AMPOULES
US5115971A (en) 1988-09-23 1992-05-26 Battelle Memorial Institute Nebulizer device
NL8801260A (en) 1988-05-16 1989-12-18 Mobacc Bv NOZZLE FOR A SPRAY CAN.
DE3818682A1 (en) 1988-06-01 1989-12-21 Deussen Stella Kg AMPOULE
US5201322A (en) 1988-08-17 1993-04-13 Elf Atochem North America, Inc. Device for detecting air flow through a passageway
US4922901A (en) 1988-09-08 1990-05-08 R. J. Reynolds Tobacco Company Drug delivery articles utilizing electrical energy
DE3916840A1 (en) 1988-09-21 1990-03-29 Bernd Hansen Ampoule with specified shape of neck - for passage of air but not liq. when syringe neck is inserted for extn.
US5511726A (en) 1988-09-23 1996-04-30 Battelle Memorial Institute Nebulizer device
US5021701A (en) 1988-10-20 1991-06-04 Tdk Corporation Piezoelectric vibrator mounting system for a nebulizer
USD312209S (en) 1988-10-21 1990-11-20 Becton, Dickinson And Company Dispensing vial or the like
EP0373237A1 (en) 1988-12-13 1990-06-20 Siemens Aktiengesellschaft Pocket inhaler device
SE466684B (en) 1989-03-07 1992-03-23 Draco Ab DEVICE INHALATOR AND PROCEDURE TO REGISTER WITH THE DEVICE INHALATOR MEDICATION
JPH02269058A (en) 1989-03-14 1990-11-02 Seiko Epson Corp Liquid drop jet device by use of rayleigh mode surface acoustic wave
WO1990012655A1 (en) 1989-04-14 1990-11-01 Azerbaidzhansky Politekhnichesky Institut Imeni Ch.Ildryma Device for ultrasonic dispersion of a liquid medium
US5022587A (en) * 1989-06-07 1991-06-11 Hochstein Peter A Battery powered nebulizer
US5086785A (en) * 1989-08-10 1992-02-11 Abrams/Gentille Entertainment Inc. Angular displacement sensors
US5562608A (en) * 1989-08-28 1996-10-08 Biopulmonics, Inc. Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
US5024733A (en) 1989-08-29 1991-06-18 At&T Bell Laboratories Palladium alloy electroplating process
US5007419A (en) * 1989-09-25 1991-04-16 Allan Weinstein Inhaler device
US5227168A (en) 1989-11-21 1993-07-13 Bruce Barber Method of treating a wound
US5152456A (en) 1989-12-12 1992-10-06 Bespak, Plc Dispensing apparatus having a perforate outlet member and a vibrating device
US5002048A (en) * 1989-12-12 1991-03-26 Makiej Jr Walter J Inhalation device utilizing two or more aerosol containers
CH680546A5 (en) 1989-12-15 1992-09-15 Klaus Weigelt Dr Ing
US4971665A (en) 1989-12-18 1990-11-20 Eastman Kodak Company Method of fabricating orifice plates with reusable mandrel
US5016024A (en) 1990-01-09 1991-05-14 Hewlett-Packard Company Integral ink jet print head
US4954225A (en) 1990-01-10 1990-09-04 Dynamics Research Corporation Method for making nozzle plates
DE59001705D1 (en) * 1990-02-07 1993-07-15 Vetter & Co Apotheker DOUBLE CHAMBER SYRINGE AND METHOD OF USE.
SG45171A1 (en) * 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
US5122116A (en) 1990-04-24 1992-06-16 Science Incorporated Closed drug delivery system
FR2662672B1 (en) 1990-05-31 1992-08-21 Aerosols & Bouchage MIXTURE DISPENSER.
GB9015077D0 (en) 1990-07-09 1990-08-29 Riker Laboratories Inc Inhaler
US5157372A (en) 1990-07-13 1992-10-20 Langford Gordon B Flexible potentiometer
US5309135A (en) 1990-07-13 1994-05-03 Langford Gordon B Flexible potentiometer in a horn control system
FR2665849B1 (en) * 1990-08-20 1995-03-24 Dynamad ULTRASONIC DEVICE FOR THE CONTINUOUS PRODUCTION OF PARTICLES.
US5086765A (en) * 1990-08-29 1992-02-11 Walter Levine Nebulizer
USD327008S (en) 1990-08-29 1992-06-16 True Products Sampling, Inc. Cosmetic sample container
US5115803A (en) 1990-08-31 1992-05-26 Minnesota Mining And Manufacturing Company Aerosol actuator providing increased respirable fraction
GB9020555D0 (en) 1990-09-20 1990-10-31 Bespak Plc Dispensing apparatus
DE69117127T2 (en) 1990-10-11 1996-11-07 Toda Koji Ultrasonic atomizer
CA2027690A1 (en) * 1990-10-18 1992-04-19 Christian Laing Plastic ampul
US5129579A (en) 1990-10-25 1992-07-14 Sun Microsystems, Inc. Vacuum attachment for electronic flux nozzle
GB9023281D0 (en) 1990-10-25 1990-12-05 Riker Laboratories Inc Inhaler
DE69127826T2 (en) * 1990-12-17 1998-04-09 Minnesota Mining & Mfg INHALATION DEVICE
US5062419A (en) 1991-01-07 1991-11-05 Rider Donald L Nebulizer with valved "T" assembly
US5217148A (en) 1991-02-11 1993-06-08 Spruhventile Gmbh Pharmaceutical pump dispenser
US5147073A (en) 1991-02-11 1992-09-15 Spruhventile Gmbh Fluid pump dispenser for pharmaceutical use
DE69430303T2 (en) 1991-03-05 2002-11-28 Aradigm Corp METHOD AND DEVICE FOR CORRECTING A ZERO SIGNAL OF A PRESSURE SENSOR FOR A FLOW METER
US5404871A (en) * 1991-03-05 1995-04-11 Aradigm Delivery of aerosol medications for inspiration
US5186164A (en) * 1991-03-15 1993-02-16 Puthalath Raghuprasad Mist inhaler
US5993805A (en) 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
US5348189A (en) 1991-04-10 1994-09-20 Bespak Plc Air purge pump dispenser
US6540154B1 (en) * 1991-04-24 2003-04-01 Aerogen, Inc. Systems and methods for controlling fluid feed to an aerosol generator
US6629646B1 (en) 1991-04-24 2003-10-07 Aerogen, Inc. Droplet ejector with oscillating tapered aperture
DE69210096T2 (en) 1991-05-27 1996-09-19 Tdk Corp Ultrasonic atomizer
JPH0614756Y2 (en) 1991-06-26 1994-04-20 株式会社アルテ Assembled dual chamber syringe
AU662919B2 (en) 1991-07-02 1995-09-21 Inhale, Inc. Method and device for delivering aerosolized medicaments
WO1993001404A1 (en) 1991-07-08 1993-01-21 Yehuda Ivri Ultrasonic fluid ejector
DE4124032A1 (en) 1991-07-19 1993-01-21 Bosch Gmbh Robert MEASURING ELEMENT
US5180482A (en) * 1991-07-22 1993-01-19 At&T Bell Laboratories Thermal annealing of palladium alloys
US5230496A (en) * 1991-08-06 1993-07-27 Med-Safe Systems, Inc. Pole mounting clamp
US5601077A (en) * 1991-08-07 1997-02-11 Becton, Dickinson And Company Nasal syringe sprayer with removable dose limiting structure
DE4127650C1 (en) 1991-08-21 1993-02-25 Arzneimittel Gmbh Apotheker Vetter & Co Ravensburg, 7980 Ravensburg, De
CZ282972B6 (en) 1991-08-29 1997-11-12 Broncho-Air Medizintechnik Ag Medicinal apparatus for inhaling of proportioned aerosols
US5170782A (en) 1991-09-12 1992-12-15 Devilbiss Health Care, Inc. Medicament nebulizer with improved aerosol chamber
DE59108798D1 (en) 1991-11-07 1997-08-28 Ritzau Pari Werk Gmbh Paul Nebulizers, in particular for use in devices for inhalation therapy
DE69206824C5 (en) 1991-12-04 2009-07-09 The Technology Partnership PLC, Melbourn, Royston DEVICE AND METHOD FOR PRODUCING FLUID FLUIDS
DE69218901T2 (en) 1991-12-10 1997-07-17 Tdk Corp Ultrasonic atomizer
DE69328523T2 (en) 1992-02-13 2000-09-21 Surmodics Inc IMMOBILIZATION OF A CHEMICAL SPECIES IN A NETWORKED MATRIX
US5355872B1 (en) * 1992-03-04 1998-10-20 John H Riggs Low flow rate nebulizer apparatus and method of nebulization
US5186166A (en) * 1992-03-04 1993-02-16 Riggs John H Powder nebulizer apparatus and method of nebulization
JPH05271980A (en) 1992-03-30 1993-10-19 Yazaki Corp Palladium-nickel alloy plating liquid
EP0933138B1 (en) 1992-04-09 2004-03-03 Omron Healthcare Co., Ltd. Ultrasonic atomizer
DE69333443T2 (en) 1992-04-09 2005-03-24 Omron Healthcare Co., Ltd. ultrasonic nebulizer
GB9207940D0 (en) 1992-04-10 1992-05-27 Alcan Int Ltd Motors
US5248087A (en) 1992-05-08 1993-09-28 Dressler John L Liquid droplet generator
US5512474A (en) 1992-05-29 1996-04-30 Bsi Corporation Cell culture support containing a cell adhesion factor and a positively-charged molecule
US5431155A (en) 1992-06-03 1995-07-11 Elettro Plastica S.P.A. Single-dose nasal dispenser for atomized liquid drugs
JP3178945B2 (en) 1992-08-25 2001-06-25 日本碍子株式会社 Inkjet print head
DE4230645C2 (en) * 1992-09-12 1996-03-07 Bernd Hansen ampoule
US5372126A (en) 1992-09-14 1994-12-13 Blau; Anthony D. Pulmonary sampling chamber
US5392769A (en) * 1992-10-06 1995-02-28 Vinatroics Division One-way valve
US5445141A (en) * 1992-10-19 1995-08-29 Sherwood Medical Company Respiratory support system
US5357946A (en) * 1992-10-19 1994-10-25 Sherwood Medical Company Ventilator manifold with accessory access port and adaptors therefore
ATE156312T1 (en) 1992-10-27 1997-08-15 Canon Kk METHOD FOR PUMPING LIQUIDS
US5313955A (en) 1992-10-30 1994-05-24 Rodder Jerome A Pulmonary flow head
GB2272389B (en) 1992-11-04 1996-07-24 Bespak Plc Dispensing apparatus
US5414075A (en) 1992-11-06 1995-05-09 Bsi Corporation Restrained multifunctional reagent for surface modification
US5346132A (en) 1992-11-12 1994-09-13 Gary S. Hahn Mist generator
GB9225098D0 (en) 1992-12-01 1993-01-20 Coffee Ronald A Charged droplet spray mixer
US5452711A (en) 1992-12-24 1995-09-26 Exar Corporation Small form factor atomizer
US5449502A (en) 1992-12-30 1995-09-12 Sanden Corp. Sterilizing apparatus utilizing ultrasonic vibration
US5342011A (en) 1993-01-19 1994-08-30 Sherwood Medical Company Fluid container attachment adaptor for an ambulatory fluid delivery system
US5558085A (en) 1993-01-29 1996-09-24 Aradigm Corporation Intrapulmonary delivery of peptide drugs
EP0681491B1 (en) 1993-01-29 2000-12-13 Aradigm Corporation Intrapulmonary delivery of hormones
US5724957A (en) * 1993-01-29 1998-03-10 Aradigm Corporation Intrapulmonary delivery of narcotics
US6012450A (en) * 1993-01-29 2000-01-11 Aradigm Corporation Intrapulmonary delivery of hematopoietic drug
US5350116A (en) 1993-03-01 1994-09-27 Bespak Plc Dispensing apparatus
US5458289A (en) 1993-03-01 1995-10-17 Bespak Plc Liquid dispensing apparatus with reduced clogging
US5303854A (en) 1993-03-08 1994-04-19 Spruhventile Gmbh Pharmaceutical pump dispenser having hydraulically closed outlet port
US5279568A (en) * 1993-04-30 1994-01-18 Spruhventile Gmbh Pharmaceutical pump dispenser for fluid suspensions and fluid mixtures
GB9305975D0 (en) 1993-03-23 1993-05-12 Minnesota Mining & Mfg Metered-dose aerosol valves
US5383906A (en) * 1993-05-12 1995-01-24 Burchett; Mark T. Nursing bottle with medication dispenser
US5396883A (en) * 1993-05-18 1995-03-14 Knupp; Jacob E. Nebulizer valve assembly for use in a ventilation circuit
US5709202A (en) * 1993-05-21 1998-01-20 Aradigm Corporation Intrapulmonary delivery of aerosolized formulations
US5497763A (en) * 1993-05-21 1996-03-12 Aradigm Corporation Disposable package for intrapulmonary delivery of aerosolized formulations
FR2705911B1 (en) 1993-06-02 1995-08-11 Oreal Piezoelectric nebulization device.
GB9312984D0 (en) 1993-06-23 1993-08-04 Bespak Plc Atomising dispenser
KR100314138B1 (en) 1993-06-29 2001-12-28 마틴 보게스 로버트 Metering device
US5437267A (en) 1993-08-03 1995-08-01 Weinstein; Allan Device for delivering aerosol to the nasal membranes and method of use
US5426458A (en) 1993-08-09 1995-06-20 Hewlett-Packard Corporation Poly-p-xylylene films as an orifice plate coating
US5918637A (en) 1993-08-16 1999-07-06 Fleischman; William H. Plates perforated with venturi-like orifices
US5415161A (en) 1993-09-15 1995-05-16 Ryder; Steven L. Intermittant demand aerosol control device
GB9324250D0 (en) 1993-11-25 1994-01-12 Minnesota Mining & Mfg Inhaler
GB9412669D0 (en) 1994-06-23 1994-08-10 The Technology Partnership Plc Liquid spray apparatus
US5752502A (en) * 1993-12-16 1998-05-19 King; Russell Wayne General purpose aerosol inhalation apparatus
US5489266A (en) * 1994-01-25 1996-02-06 Becton, Dickinson And Company Syringe assembly and method for lyophilizing and reconstituting injectable medication
US5632878A (en) 1994-02-01 1997-05-27 Fet Engineering, Inc. Method for manufacturing an electroforming mold
US5579757A (en) 1994-02-02 1996-12-03 Baxter International, Inc. Anti-siphon flow restricter for a nebulizer
US5664557A (en) 1994-03-10 1997-09-09 Respiratory Delivery Systems, Inc. Releasably engageable coupling for an inhaler
USD375352S (en) 1994-03-14 1996-11-05 Columbia Laboratories, Inc. Dispensing vial for feminine hygiene products
US5505236A (en) * 1994-04-04 1996-04-09 Abbott Laboratories Anesthetic vaporizer filling system
SE503175C2 (en) * 1994-05-06 1996-04-15 Siemens Elema Ab Safety systems for anesthesia equipment with at least two anesthetic carburetors
US5435282A (en) 1994-05-19 1995-07-25 Habley Medical Technology Corporation Nebulizer
GB9410658D0 (en) 1994-05-27 1994-07-13 Electrosols Ltd Dispensing device
USD362390S (en) 1994-06-02 1995-09-19 Automatic Liquid Packaging, Inc. Hermetically sealed vial
US5516043A (en) 1994-06-30 1996-05-14 Misonix Inc. Ultrasonic atomizing device
US5666946A (en) * 1994-07-13 1997-09-16 Respirogenics Corporation Apparatus for delivering drugs to the lungs
FR2722765B1 (en) 1994-07-25 1996-08-23 Oreal CONTAINER ALLOWING THE STORAGE OF AT LEAST TWO PRODUCTS, THE MIXTURE OF THESE PRODUCTS AND THE DISTRIBUTION OF THE MIXTURE THUS OBTAINED
US5664706A (en) 1994-10-13 1997-09-09 Bespak Plc Apparatus for dispensing liquid in aerosol spray form
AU128844S (en) 1994-10-21 1996-12-05 Glaxo Wellcome Australia Ltd Ampoule
GB9421687D0 (en) 1994-10-27 1994-12-14 Aid Medic Ltd Dosimetric spacer
US5560837A (en) 1994-11-08 1996-10-01 Hewlett-Packard Company Method of making ink-jet component
US5707818A (en) * 1994-12-13 1998-01-13 Bsi Corporation Device and method for simultaneously performing multiple competitive immunoassays
US5582330A (en) 1994-12-28 1996-12-10 Allergan, Inc. Specific volume dispenser
US5588166A (en) * 1995-01-04 1996-12-31 Burnett; John Medical attachment device
US5685491A (en) 1995-01-11 1997-11-11 Amtx, Inc. Electroformed multilayer spray director and a process for the preparation thereof
GB2298406B (en) 1995-02-21 1998-05-06 Bespak Plc Dual component dispensing apparatus
NO950760L (en) 1995-02-28 1996-08-29 Elkem Materials Process for the preparation of alkyl halosilanes
DK0730858T3 (en) * 1995-03-09 1999-09-27 Hansen Bernd Plastic bottle and method for its manufacture
US5503628A (en) 1995-03-15 1996-04-02 Jettek, Inc. Patient-fillable hypodermic jet injector
US5533497A (en) 1995-03-27 1996-07-09 Ryder; Steven L. Sidestream aerosol generator and method in variable positions
US6427682B1 (en) 1995-04-05 2002-08-06 Aerogen, Inc. Methods and apparatus for aerosolizing a substance
US6205999B1 (en) * 1995-04-05 2001-03-27 Aerogen, Inc. Methods and apparatus for storing chemical compounds in a portable inhaler
US6782886B2 (en) 1995-04-05 2004-08-31 Aerogen, Inc. Metering pumps for an aerosolizer
US20020121274A1 (en) 1995-04-05 2002-09-05 Aerogen, Inc. Laminated electroformed aperture plate
US5474059A (en) 1995-04-08 1995-12-12 Cooper; Guy F. Aerosol dispensing apparatus for dispensing a medicated vapor into the lungs of a patient
US5657926A (en) 1995-04-13 1997-08-19 Toda; Kohji Ultrasonic atomizing device
DE59603985D1 (en) * 1995-05-02 2000-01-27 Alexander Aloy DEVICE FOR DELIVERING A VENTILATION GAS
WO1996037165A1 (en) 1995-05-26 1996-11-28 Bsi Corporation Method and implantable article for promoting endothelialization
JP3320261B2 (en) 1995-06-01 2002-09-03 株式会社ユニシアジェックス Inhaler type dispenser
US5584285A (en) * 1995-06-07 1996-12-17 Salter Labs Breathing circuit apparatus for a nebulizer
US5609798A (en) * 1995-06-07 1997-03-11 Msp Corporation High output PSL aerosol generator
US5654007A (en) 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
US5829723A (en) * 1995-06-28 1998-11-03 Medex, Inc. Medical device mounting structure
US5904773A (en) 1995-08-11 1999-05-18 Atotech Usa, Inc. Fluid delivery apparatus
US6000396A (en) * 1995-08-17 1999-12-14 University Of Florida Hybrid microprocessor controlled ventilator unit
SE9502957D0 (en) 1995-08-28 1995-08-28 Pharmacia Ab Device for displacing a member in a container
US5639851A (en) * 1995-10-02 1997-06-17 Ethicon, Inc. High strength, melt processable, lactide-rich, poly(lactide-CO-P-dioxanone) copolymers
JP3317827B2 (en) 1995-10-09 2002-08-26 株式会社ユニシアジェックス Dosing device
US6254219B1 (en) 1995-10-25 2001-07-03 Hewlett-Packard Company Inkjet printhead orifice plate having related orifices
US6123413A (en) 1995-10-25 2000-09-26 Hewlett-Packard Company Reduced spray inkjet printhead orifice
US5714360A (en) * 1995-11-03 1998-02-03 Bsi Corporation Photoactivatable water soluble cross-linking agents containing an onium group
US5807335A (en) 1995-12-22 1998-09-15 Science Incorporated Fluid delivery device with conformable ullage and fill assembly
FR2743313B1 (en) 1996-01-04 1998-02-06 Imra Europe Sa HIGH-YIELD SPRAYING DEVICE, ESPECIALLY MICRO-DROPLET WATER
US6026809A (en) * 1996-01-25 2000-02-22 Microdose Technologies, Inc. Inhalation device
US5823179A (en) * 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
USD392184S (en) * 1996-02-21 1998-03-17 Automatic Liquid Packaging, Inc. Vial with a frangible closure
FR2746656B1 (en) * 1996-03-26 1999-05-28 System Assistance Medical PRESSURE SENSOR NEBULIZER
US5790151A (en) 1996-03-27 1998-08-04 Imaging Technology International Corp. Ink jet printhead and method of making
SE9601719D0 (en) * 1996-05-06 1996-05-06 Siemens Elema Ab Dosage for supply of additive gas or liquid to respiratory gas in anesthesia or ventilator
AUPN976496A0 (en) * 1996-05-10 1996-05-30 Glaxo Wellcome Australia Ltd Unit dose dispensing device
US5976344A (en) 1996-05-10 1999-11-02 Lucent Technologies Inc. Composition for electroplating palladium alloys and electroplating process using that composition
JP3418507B2 (en) 1996-08-07 2003-06-23 ワイケイケイ株式会社 Piezoelectric vibration control method
AUPO247496A0 (en) 1996-09-23 1996-10-17 Resmed Limited Assisted ventilation to match patient respiratory need
US5775506A (en) 1996-09-25 1998-07-07 Abbott Laboratories Pharmaceutical ampul
DE19647947A1 (en) 1996-11-20 1998-05-28 Pfeiffer Erich Gmbh & Co Kg Discharge device for media
AUPP855099A0 (en) * 1999-02-09 1999-03-04 Resmed Limited Gas delivery connection assembly
US5954268A (en) 1997-03-03 1999-09-21 Joshi; Ashok V. Fluid delivery system
US5948483A (en) 1997-03-25 1999-09-07 The Board Of Trustees Of The University Of Illinois Method and apparatus for producing thin film and nanoparticle deposits
US6336454B1 (en) * 1997-05-16 2002-01-08 Resmed Limited Nasal ventilation as a treatment for stroke
US6055869A (en) 1997-06-12 2000-05-02 Stemme; Erik Lift force fluid flow sensor for measuring fluid flow velocities
US5839617A (en) 1997-07-29 1998-11-24 Owens-Illinois Closure Inc. Pump dispenser
US6045215A (en) 1997-08-28 2000-04-04 Hewlett-Packard Company High durability ink cartridge printhead and method for making the same
US6145963A (en) 1997-08-29 2000-11-14 Hewlett-Packard Company Reduced size printhead for an inkjet printer
US6139674A (en) 1997-09-10 2000-10-31 Xerox Corporation Method of making an ink jet printhead filter by laser ablation
EP1829618A3 (en) 1997-10-06 2007-09-19 Omron Healthcare Co., Ltd. Atomizer
EP1021172B1 (en) 1997-10-08 2002-04-10 Sepracor, Inc. Dosage form for aerosol administration
US6155676A (en) 1997-10-16 2000-12-05 Hewlett-Packard Company High-durability rhodium-containing ink cartridge printhead and method for making the same
US6037587A (en) * 1997-10-17 2000-03-14 Hewlett-Packard Company Chemical ionization source for mass spectrometry
US6039696A (en) * 1997-10-31 2000-03-21 Medcare Medical Group, Inc. Method and apparatus for sensing humidity in a patient with an artificial airway
AUPP026997A0 (en) 1997-11-07 1997-12-04 Resmed Limited Administration of cpap treatment pressure in presence of apnea
EP1149602B1 (en) 1997-11-19 2015-01-07 Aptar France SAS Spray device for an inhaler suitable for respiratory therapies
US6096011A (en) 1998-01-29 2000-08-01 Medrad, Inc. Aseptic connector and fluid delivery system using such an aseptic connector
US6358058B1 (en) * 1998-01-30 2002-03-19 1263152 Ontario Inc. Aerosol dispensing inhaler training device
US6223746B1 (en) 1998-02-12 2001-05-01 Iep Pharmaceutical Devices Inc. Metered dose inhaler pump
US6158431A (en) 1998-02-13 2000-12-12 Tsi Incorporated Portable systems and methods for delivery of therapeutic material to the pulmonary system
US6204182B1 (en) 1998-03-02 2001-03-20 Hewlett-Packard Company In-situ fluid jet orifice
GB9808182D0 (en) 1998-04-17 1998-06-17 The Technology Partnership Plc Liquid projection apparatus
US6068148A (en) * 1998-05-26 2000-05-30 Automatic Liquid Packaging, Inc. Hermetically sealed container including a nozzle with a sealing bead
US20020104530A1 (en) 1998-06-11 2002-08-08 Aerogen, Inc. Piezoelectric polymer flow sensor and methods
US6152130A (en) 1998-06-12 2000-11-28 Microdose Technologies, Inc. Inhalation device with acoustic control
US6142146A (en) 1998-06-12 2000-11-07 Microdose Technologies, Inc. Inhalation device
US6106504A (en) 1998-07-15 2000-08-22 Urrutia; Hector Drip chamber for medical fluid delivery system
US6182662B1 (en) * 1998-07-23 2001-02-06 Mcghee Chad J. Intravenous transport/support device
AUPP496198A0 (en) * 1998-07-31 1998-08-20 Resmed Limited Switches with graphical display
FR2783431B1 (en) * 1998-09-23 2001-02-02 System Assistance Medical NEBULIZER FOR DELIVERING A FOG TO A PATIENT AND METHOD FOR OPERATING SUCH A NEBULIZER
AUPP693398A0 (en) 1998-11-05 1998-12-03 Resmed Limited Fault diagnosis in CPAP and NIPPV devices
EP1005917B1 (en) 1998-12-01 2006-11-02 Microflow Engineering SA Inhaler with ultrasonic wave nebuliser having nozzle openings superposed on peaks of a standing wave pattern
JP3312216B2 (en) 1998-12-18 2002-08-05 オムロン株式会社 Spraying equipment
US6163588A (en) 1998-12-23 2000-12-19 General Electric Company Core plate and reactor internal pump differential pressure lines for a boiling water reactor
US6116234A (en) 1999-02-01 2000-09-12 Iep Pharmaceutical Devices Inc. Metered dose inhaler agitator
US6196218B1 (en) 1999-02-24 2001-03-06 Ponwell Enterprises Ltd Piezo inhaler
US6328030B1 (en) 1999-03-12 2001-12-11 Daniel E. Kidwell Nebulizer for ventilation system
AUPQ019899A0 (en) * 1999-05-06 1999-06-03 Resmed Limited Control of supplied pressure in assisted ventilation
US6328033B1 (en) 1999-06-04 2001-12-11 Zohar Avrahami Powder inhaler
US6216916B1 (en) * 1999-09-16 2001-04-17 Joseph S. Kanfer Compact fluid pump
US6530370B1 (en) * 1999-09-16 2003-03-11 Instrumentation Corp. Nebulizer apparatus
JP3673893B2 (en) 1999-10-15 2005-07-20 日本碍子株式会社 Droplet discharge device
DE19962280A1 (en) 1999-12-23 2001-07-12 Draeger Medizintech Gmbh Ultrasonic evaporator for liquids has exciter circuit to operate transducer at optimum vibration range
US6539937B1 (en) * 2000-04-12 2003-04-01 Instrumentarium Corp. Method of maximizing the mechanical displacement of a piezoelectric nebulizer apparatus
US6948491B2 (en) 2001-03-20 2005-09-27 Aerogen, Inc. Convertible fluid feed system with comformable reservoir and methods
US7600511B2 (en) 2001-11-01 2009-10-13 Novartis Pharma Ag Apparatus and methods for delivery of medicament to a respiratory system
MXPA02010884A (en) * 2000-05-05 2003-03-27 Aerogen Ireland Ltd Apparatus and methods for the delivery of medicaments to the respiratory system.
US7100600B2 (en) 2001-03-20 2006-09-05 Aerogen, Inc. Fluid filled ampoules and methods for their use in aerosolizers
US6341732B1 (en) * 2000-06-19 2002-01-29 S. C. Johnson & Son, Inc. Method and apparatus for maintaining control of liquid flow in a vibratory atomizing device
US6543443B1 (en) 2000-07-12 2003-04-08 Aerogen, Inc. Methods and devices for nebulizing fluids
US6769626B1 (en) 2000-10-30 2004-08-03 Instrumentarium Corp. Device and method for detecting and controlling liquid supply to an apparatus discharging liquids
US6581595B1 (en) 2000-11-14 2003-06-24 Sensormedics Corporation Positive airway pressure device with indirect calorimetry system
US20020078958A1 (en) 2000-12-21 2002-06-27 Sensormedics Corporation Infant CPAP system with airway pressure control
US6546927B2 (en) 2001-03-13 2003-04-15 Aerogen, Inc. Methods and apparatus for controlling piezoelectric vibration
US6550472B2 (en) 2001-03-16 2003-04-22 Aerogen, Inc. Devices and methods for nebulizing fluids using flow directors
US6732944B2 (en) 2001-05-02 2004-05-11 Aerogen, Inc. Base isolated nebulizing device and methods
US20020162551A1 (en) 2001-05-02 2002-11-07 Litherland Craig M. Cymbal-shaped actuator for a nebulizing element
US6554201B2 (en) 2001-05-02 2003-04-29 Aerogen, Inc. Insert molded aerosol generator and methods
US6851626B2 (en) * 2002-01-07 2005-02-08 Aerogen, Inc. Methods and devices for nebulizing fluids
EP1471960B1 (en) 2002-01-07 2019-03-13 Novartis AG Devices for nebulizing fluids for inhalation
US6745770B2 (en) 2002-01-08 2004-06-08 Resmed Limited Flow diverter for controlling the pressure and flow rate in a CPAP device
JP4669224B2 (en) * 2002-01-15 2011-04-13 エアロジェン,インコーポレイテッド System and method for purifying aerosols from an effective anatomical dead space
AU2003203043A1 (en) 2002-01-15 2003-07-30 Aerogen, Inc. Methods and systems for operating an aerosol generator
US6860268B2 (en) * 2002-02-06 2005-03-01 Shelly Bohn Pediatric ventilation mask and headgear system
US8245708B2 (en) * 2002-05-07 2012-08-21 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
ES2572770T3 (en) * 2002-05-20 2016-06-02 Novartis Ag Apparatus for providing spray for medical treatment and methods
NZ562412A (en) 2003-02-21 2009-02-28 Resmed Ltd Nasal assembly for pillow mask
US8616195B2 (en) * 2003-07-18 2013-12-31 Novartis Ag Nebuliser for the production of aerosolized medication

Patent Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4934358A (en) * 1986-03-24 1990-06-19 Sven-Erik Nilsson Device for self-administration of physiologically active substances, with prevention of overdosing
US5322057A (en) * 1987-07-08 1994-06-21 Vortran Medical Technology, Inc. Intermittent signal actuated nebulizer synchronized to operate in the exhalation phase, and its method of use
WO1992017231A1 (en) * 1991-03-28 1992-10-15 Innomed, Inc. Microelectronic inhaler having a counter and timer
US5164740A (en) 1991-04-24 1992-11-17 Yehuda Ivri High frequency printing mechanism
US5938117A (en) 1991-04-24 1999-08-17 Aerogen, Inc. Methods and apparatus for dispensing liquids as an atomized spray
US5819730A (en) * 1993-06-09 1998-10-13 Glaxo Wellcome Australia Ltd. Device for administering pharmaceutical substances
US5515842A (en) * 1993-08-09 1996-05-14 Disetronic Ag Inhalation device
US5479920A (en) * 1994-03-01 1996-01-02 Vortran Medical Technology, Inc. Breath actuated medicinal aerosol delivery apparatus
US5950619A (en) * 1995-03-14 1999-09-14 Siemens Aktiengesellschaft Ultrasonic atomizer device with removable precision dosating unit
US5970974A (en) * 1995-03-14 1999-10-26 Siemens Aktiengesellschaft Dosating unit for an ultrasonic atomizer device
US5758637A (en) 1995-08-31 1998-06-02 Aerogen, Inc. Liquid dispensing apparatus and methods
US5586550A (en) 1995-08-31 1996-12-24 Fluid Propulsion Technologies, Inc. Apparatus and methods for the delivery of therapeutic liquids to the respiratory system
US6085740A (en) 1996-02-21 2000-07-11 Aerogen, Inc. Liquid dispensing apparatus and methods
US6269810B1 (en) * 1998-03-05 2001-08-07 Battelle Memorial Institute Pulmonary dosing system and method
US6014970A (en) 1998-06-11 2000-01-18 Aerogen, Inc. Methods and apparatus for storing chemical compounds in a portable inhaler
US6235177B1 (en) 1999-09-09 2001-05-22 Aerogen, Inc. Method for the construction of an aperture plate for dispensing liquid droplets

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1474196A4

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008536546A (en) * 2005-03-24 2008-09-11 エアロジェン, インコーポレイテッド Method and system for operating an aerosol generator
WO2006102345A3 (en) * 2005-03-24 2007-01-25 Aerogen Inc Methods and systems for operating an aerosol generator
EP2848275A3 (en) * 2008-05-09 2015-07-08 PARI Pharma GmbH Atomiser for respiration machines and respiration machine with such an atomiser
WO2010035252A2 (en) * 2008-09-26 2010-04-01 Stamford Devices Limited A nebuliser system
WO2010035252A3 (en) * 2008-09-26 2010-07-01 Stamford Devices Limited A nebuliser system
US8517010B2 (en) 2008-09-26 2013-08-27 Stamford Devices Limited Nebuliser system
EP2448622A4 (en) * 2009-07-01 2016-03-16 Microdose Therapeutx Inc Nebulizer for infants and respiratory compromised patients
EP3117858A1 (en) * 2009-07-01 2017-01-18 MicroDose Therapeutx, Inc. Nebulizer for infants and respiratory compromised patients
EP2399636A1 (en) * 2010-06-23 2011-12-28 Philip Morris Products S.A. An improved aerosol generator and liquid storage portion for use with the aerosol generator
EP2620176B1 (en) * 2012-01-24 2018-01-17 NEBU-TEC GmbH Inhaler with breath-controlled piezo crystal
US10245391B2 (en) 2012-11-27 2019-04-02 Pari Pharma Gmbh Fluid reservoir for an aerosol generation device, combination of fluid reservoir and primary fluid package, and aerosol generation device for use with the fluid reservoir
EP2735328A1 (en) * 2012-11-27 2014-05-28 PARI Pharma GmbH Fluid reservoir for an aerosol generation device, combination of fluid reservoir and primary fluid package, and aerosol generation device for use with the fluid reservoir
WO2014082818A1 (en) * 2012-11-27 2014-06-05 Pari Pharma Gmbh Fluid reservoir for an aerosol generation device, combination of fluid reservoir and primary fluid package, and aerosol generation device for use with the fluid reservoir
WO2015150510A1 (en) 2014-04-03 2015-10-08 Csl Behring Ag Nebulization of immunoglobulin
US11471617B2 (en) 2014-04-03 2022-10-18 Csl Behring Ag Nebultzation of immunoglobulin
US11033054B2 (en) 2015-07-24 2021-06-15 Rai Strategic Holdings, Inc. Radio-frequency identification (RFID) authentication system for aerosol delivery devices
WO2017019428A1 (en) * 2015-07-24 2017-02-02 Rai Strategic Holdings, Inc. Radio-frequency identification (rfid) authentication system for aerosol delivery devices
US10500354B2 (en) 2015-09-25 2019-12-10 Sanmina Corporation System and method for atomizing and monitoring a drug cartridge during inhalation treatments
US10857191B2 (en) 2015-10-07 2020-12-08 Santalis Pharmaceuticals, Inc. Sandalwood oil and its uses related to oral mucositis
US11744964B2 (en) 2016-04-27 2023-09-05 Nicoventures Trading Limited Electronic aerosol provision system and vaporizer therefor
WO2018057058A1 (en) * 2016-09-24 2018-03-29 Sanmina Corporation System and method for atomizing and monitoring a drug cartridge during inhalation treatments
US10238821B2 (en) 2016-10-11 2019-03-26 Microdose Therapeutx, Inc. Inhaler and methods of use thereof
RU2808418C1 (en) * 2020-10-12 2023-11-28 Вектура Деливери Дивайсиз Лимитед Aerosol generator for nebulizer

Also Published As

Publication number Publication date
US6968840B2 (en) 2005-11-29
US7748377B2 (en) 2010-07-06
US7331339B2 (en) 2008-02-19
ES2603067T3 (en) 2017-02-23
US20080060641A1 (en) 2008-03-13
US20050172954A1 (en) 2005-08-11
EP1474196B1 (en) 2016-08-17
EP1474196A4 (en) 2007-04-25
JP2005514991A (en) 2005-05-26
US20030140921A1 (en) 2003-07-31
JP4761709B2 (en) 2011-08-31
JP2006150093A (en) 2006-06-15
AU2003203043A1 (en) 2003-07-30
EP1474196A1 (en) 2004-11-10

Similar Documents

Publication Publication Date Title
EP1474196B1 (en) Methods and systems for operating an aerosol generator
CA3064005C (en) Dry powder delivery device and methods of use
CN111479604B (en) Electrically breath actuated in-line droplet delivery device with small volume ampoule and method of use
US11738158B2 (en) Electronic breath actuated in-line droplet delivery device and methods of use
US20170368275A1 (en) Nebulizer for infants and respiratory compromised patients
CA3022916A1 (en) Droplet delivery device for delivery of fluids to the pulmonary system and methods of use
EP3697481A1 (en) Nasal drug delivery apparatus and methods of use
AU2003202925A1 (en) Devices and methods for nebulizing fluids for inhalation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003559584

Country of ref document: JP

REEP Request for entry into the european phase

Ref document number: 2003702161

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2003702161

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003702161

Country of ref document: EP